|
![]()
|
Exploring Episode-Based Approaches for Medicare Performance Measurement, Accountability and Payment
Final Report
Cheryl l. Damberg, Melony E. Sorbero, Peter S. Hussey, Susan Lovejoy, hangsheng liu, and ateev mehrotra
WR-633-ASPE
February 2009
Assistant Secretary for Planning and Evaluation
U.S. Department of Health and Human ServicesThe report was prepared by the contractor (RAND). The findings and conclusions are those of the authors and do not necessarily reflect the views of ASPE or HHS.
This product is part of the RAND Health working paper series. RAND working papers are intended to share researchers' latest findings and to solicit informal peer review. They have been approved for circulation by RAND Health but have not been formally edited or peer reviewed. Unless otherwise indicated, working paper scan be quoted and cited without permission of the author, provided the source is clearly referred to as a working paper. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors. RAND® is a registered trademark.
3. PERFORMANCE MEASURES REPORTED TO MEDICARE
4. LITERATURE REVIEW AND EXPERT DISCUSSIONS
5. ANALYSIS OF EPISODES OF CARE
APPENDIX A. DIAGNOSIS AND PROCEDURE CODES TO IDENTIFY CONDITIONS OF FOCUS
APPENDIX B. SPECIFICATIONS USED TO CREATE EPISODES
APPENDIX C. EPISODES RELATED TO CONDITIONS OF FOCUS
APPENDIX D. STANDARDIZED PAYMENT METHODOLOGY
APPENDIX F. DEFINING PROFESSIONAL COSTS AND EVALUATION AND MANAGEMENT (E&M) VISITS
We gratefully acknowledge the participation of numerous individuals who were instrumental in helping us complete this project. In particular, we appreciate the contributions made by our Technical Expert Panel members, who provided feedback on our data analyses and who served as external reviewers of this report. The panel members were: Robert Berenson, MD (Senior Fellow, Urban Institute), Gary Kaplan, MD (CEO and Chairman, Virginia Mason Medical Center), Robert Mecklenberg, MD (Medical Director, Virginia Mason Medical Center), Mark Rattray, MD (President, Care Variance), Mark Miller (Executive Director, MedPAC), Debra Saliba, MD (Director, UCLA/ JHA Borun Center for Gerontological Research), and Karen Milgate (Director, Office of Policy, CMS). We also want to thank the individuals who participated in our expert discussions, for contributing their time and their knowledge to helping identify key considerations associated with applying episodes of care to payment and performance measurement.
We wish to acknowledge Acumen, LLC for the work they performed to run the commercial episode groupers and to provide RAND with constructed episodes and helping with interpretation of the output. We are grateful to the support provided by Symmetry and Thomson-Medstat (now Thomson-Reuters) for making their episode grouping software tools available for this research application.
Our ASPE project officer, Susan Bogasky, provided guidance, support and expert counsel throughout the project. Karen Milgate, from CMS, also provided ongoing guidance and critical feedback throughout the project, as did a broader set of individuals at CMS, including Fred Thomas, Craig Caplan, Lisa Grabert, Rene Mentnech, Curt Mueller, and Jesse Levy. We acknowledge the contributions to this project and report made by Susan Lovejoy, Kristin Leuschner, and Magdalen Paskell from RAND. Any errors of fact or interpretation are the responsibility of the RAND authors.
| Abbreviation | Definition |
| ACEI | Angiotensin converting enzyme inhibitor |
| ACO | Accountable care organizations |
| AMI | Acute myocardial infarction |
| APC | Ambulatory payment classification |
| APU | Annual payment update |
| ARB | Angiotensin receptor blocker |
| ASC | Ambulatory surgical center |
| ASPE | Assistant Secretary for Planning and Evaluation |
| BMI | Body mass index |
| CABG | Coronary artery bypass graft |
| CAD | Coronary artery disease |
| CKD | Chronic kidney disease |
| CMG | Case-mix group |
| CMS | Centers for Medicare and Medicaid Services |
| COPD | Chronic obstructive pulmonary disease |
| COLA | Cost of living adjustment |
| CPI | Consumer price index |
| CPT | Current procedural terminology |
| CT | Computed tomography |
| DHHS | Department of Health and Human Services |
| DRG | Diagnosis related group |
| DSH | Disproportionate share |
| ECT | Electroconvulsive therapy |
| E&M | Evaluation and management |
| ESRD | End stage renal disease |
| ETG | Episode treatment group |
| FEHB | Federal employee health benefits |
| FFS | Fee-for-service |
| GAO | Government accountability office |
| GDP | Gross domestic product |
| GERD | Gastroesophageal reflux disease |
| HCC | Hierarchical condition category |
| HCPCS | Healthcare common procedure coding system |
| HHA | Home health agency |
| HHQI | Home health quality initiative |
| HF | Heart failure |
| HHRG | Home health resource group |
| HOP QDRP | Hospital outpatient quality data reporting program |
| IDS | Integrated delivery system |
| IOM | Institute of Medicine |
| IPPS | Inpatient prospective payment system |
| IRF | Inpatient rehabilitation facility |
| LDL | Low-density lipoprotein |
| LTC | Long term care |
| LTCH | Long term care hospital |
| LVSD | Left ventricular systolic dysfunction |
| MA | Medicare Advantage |
| MCP | Monthly capitation payment |
| MedPAC | Medicare payment advisory committee |
| MEG | Medical episode grouper |
| MDS | Myelodysplastic syndrome |
| MRI | Magnetic resonance imaging |
| MSA | Metropolitan statistical area |
| MS DRG | Medicare severity diagnosis related group |
| MSIS | Medicaid statistical information system |
| MS LTC DRG | Medicare severity long term care diagnosis related group |
| NHQI | Nursing home quality initiative |
| NLA | National limitation amount |
| OASIS | Outcome assessment and information set |
| OME | Otis media with effusion |
| PCI | Percutaneous coronary intervention |
| PHO | Physician hospital organization |
| PN | Community acquired bacterial pneumonia |
| PPS | Prospective payment system |
| PQRI | Physician quality reporting initiative |
| P4P | Pay for performance |
| P4R | Pay for reporting |
| RAP | Radiology, anesthesiology, pathology |
| RHQDAPU | Reporting hospital quality data for annual update |
| RPL | Rehabilitation, psychiatric and long term care |
| RUG | Resource utilization group |
| Rx HCC | Prescription drug hierarchical condition category |
| SGR | Sustainable growth rate |
| SNF | Skilled nursing facility |
| UI | Urinary incontinence |
| VBP | Value-based purchasing |
Substantial deficits in the quality of health care and persistent and unsustainable growth in health care spending have led to calls for reforms of the Medicare system, including such steps as increasing performance accountability and making changes in payment policies (IOM, 2001; IOM, 2006). Deficiencies in the quality of care delivered to patients in the United States are well documented (Schuster et al., 1998; Institute of Medicine, 2001; Wenger et al., 2003), with adults receiving approximately 55 percent of recommended care (McGlynn et al., 2003). The deficits exist across all sociodemographic subgroups with substantial underuse of recommended care regardless of income, race, or age (Asch et al., 2006). Although there have been some improvements in the quality of care delivered to Medicare beneficiaries (Jencks et al., 2003; Lindenauer et al., 2007), quality of care remains a problem for the Medicare population (Higashi et al., 2007), especially in coordinating the care.
Existing Medicare fee-for-service (FFS) performance measurement and payment policies focus on individual providers in each distinct health care setting. However, the actual care delivered to beneficiaries for an episode of illness reflects a continuum of care that can cross settings and providers. On an annual basis, Medicare beneficiaries receive care from a median of seven physicians who practice in multiple different health care settings, and it is common for beneficiaries to move from one setting to another as they experience changes in health and functional status (Pham et al., 2007). The number of physicians seen in a year is even greater for beneficiaries with common chronic conditions such as diabetes and coronary artery disease (CAD) and increases with the number of conditions experienced by the beneficiary (Pham et al., 2007). In the current fragmented system of care, no one provider or set of providers claim ownership or responsibility for managing a patient's care, and this fragmentation contributes to the overuse of services, duplication of services and use of costly services rather than efficient, high-quality care (Davis, 2007).
In addition to quality of care problems, health care costs continue to rise and account for an increasing amount of theUnited States ' gross domestic product (GDP). In 2007, health expenditures were projected to make up 16.3 percent of the GDP and are anticipated to account for 19.5 percent of GDP by 2017 (Keehan et al., 2008). Medicare's 2007 expenditures were $432 billion and accounted for 3.2 percent of GDP (Boards of Trustees, Federal Hospital Insurance and Federal Supplementary Medicare Insurance Trust Funds, 2008). One of the contributors to the spending problem is the substantial geographic variation in the use of health care services, which has raised concerns about the over use of health services (Fisher et al., 2003a; Fisher et al., 2003b). The Fisher study demonstrated that regions with higher utilization did not achieve better patient outcomes or greater patient satisfaction with care as compared to lower utilization areas—suggesting over use of services (i.e., greater resource consumption) absent benefits to Medicare beneficiaries.
The unsustainable growth has resulted in a level of spending that, in each of the past three years, has resulted in the Board of Trustees issuing in their 2006, 2007 and 2008 reports a determination of “excess general revenue Medicare funding.” As established by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA),this finding in two consecutive years in turn triggers the “Medicare funding warning,” which were present in the Board of Trustees Reports in 2007 and 2008, Triggering of the Medicare funding warning requires the President to propose and Congress to consider legislation to control Medicare spending. In response to the Medicare funding warning in the Board of Trustees 2007 Report, the Medicare Funding Warning Response Act of 2008 was proposed in February 2008. Title I of this proposed bill, contains language that, if enacted, would provide the Secretary of the Department of Health and Human Services (DHHS) with the authority and responsibility to introduce initiatives to make the Medicare program a value-based purchaser of health care services, consistent with President Bush's August 2006 Executive Order, “Promoting Quality and Efficient Health Care.” The urgency for reform to reign in spending was underscored by a 2008 projection from the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds that, without intervention, the trust fund for Medicare Part A will be completely depleted in 2019 (Boards of Trustees, Federal Hospital Insurance and Federal Supplementary Medicare Insurance Trust Funds, 2008). MedPAC stated in their 2008 Report to the Congress: Medicare Payment Policy that multiple strategies will be necessary to reform Medicare (Medicare Payment Advisory Commission, 2008).
A variety of reform mechanisms are being considered to address the problems of underuse and overuse of services, including the establishment of performance accountability mechanisms and incentives that reward the delivery of the right care compared to the current approach which fosters lack of coordination of care, overuse of services, and lack of accountability and ownership for management of patient care. Among the reforms being considered and tested in demonstrations, are competitive bidding, pay for performance, gainsharing, and—the subject of this study—the alignment of performance measurement and financial incentives for service delivery around a beneficiary' episodes of care.
The Assistant Secretary for Planning and Evaluation (ASPE) contracted with RAND to explore how episodes of care could be defined for a limited set of clinical events/conditions and, based on varying definitions, to consider ways in which the alignment of performance measurement, accountability, and incentives to providers could be improved within the current Medicare payment and performance measurement systems in the near term. RAND was also tasked to provide ASPE with options to consider in moving toward broader episode-based performance measurement and payment reforms to encourage high-quality, efficient, and coordinated care. A core piece of the work involved using two commercially available episode grouping software tools to construct episodes of care, which were then used to identify the issues that would need to be considered in applying episodes as a basis for payment and/or performance measurement.
Efforts to focus on an episode of care for a patient attempt to change the current fragmented environment which is service oriented to one that takes a more holistic view of the care process. A recent Institute of Medicine (IOM) report entitled Rewarding Provider Performance: Aligning Incentives in Medicare recommended that “CMS should build towards an ultimate vision of aggregating funds for rewards into one integrated pool that would accommodate shared accountability and encourage coordination of care” and that the current measure sets “…should evolve over time to provide more comprehensive and longitudinal assessments of provider and system performance” (IOM, 2007).
For the purposes of this discussion, we define an “episode of care” as a series of health care services for a Medicare beneficiary that are related to the treatment of a specific illness or injury (e.g., the treatment of a specific acute illness or the ongoing care for a chronic disease). The way in which the definition of an episode is operationalized could vary making the defined unit of measurement more or less expansive. An episode of care could be narrowly constructed to reflect the services delivered by one provider in a single setting for a specific illness or injury, broadly constructed to encompass the entire continuum of services received across multiple setting for a specific condition, or could be constructed to reflect something between these two ends of the spectrum.
There are a range of services that could be included in an episode of care, making the defined unit of measurement more or less expansive. At one end of the spectrum would be an episode that includes the services delivered by one provider in a single setting. A current example of this type of episode construction is a Diagnosis Related Group (DRG) used by CMS for making payments to IPPS hospitals; the DRG includes all of the facility services for an inpatient stay. An example of an intermediate stage could be an episode construction that captures the facility services as well as the physicians services provided during an inpatient stay. An expansive episode of care construction would include the continuum of Medicare services a beneficiary receives for a condition. An example of an inclusive episode could be one that reaches beyond the inpatient stay to capture post-acute care that is delivered to the patient.
There are a variety of approaches that could be used to move towards the IOM vision of shared accountability and coordinated care. For example, performance measurement programs could be designed to assess the care delivered across the entirety of an episode and be aligned across different types of providers. Another mechanism is to link payment to episodes of care (Davis, 2007), with the payment rate adjusted based on performance measures such as clinical quality and patient experience (Schoen et al., 2007; MedPAC, 2008). The Commonwealth Fund estimates that by linking payment to an episodes involving hospitalizations that include inpatient, physician and related services from the time of admission through a post-discharge period (e.g. 90 days) and using the 75th percentile of the Metropolitan Statistical Area (MSA) with the lowest severity-adjusted Medicare costs nationally to set payment rates would save $96.4 billion over five years and $229.2 billion over 10 years (Schoen et al., 2007). This proposed approach does not link any quality or outcome measures to the episode.
CMS is in the process of developing a Medicare demonstration that will test a competitive bidding approach to determining global payments (i.e. a single overall payment) for acute care episodes for select orthopedic and cardiovascular inpatient procedures. After the first year of the demonstration, CMS and the demonstration sites may consider extending the episode of care to include some post-acute care services as well.
The Assistant Secretary for Planning and Evaluation (ASPE) contracted with RAND in September 2007 to examine episodes of care for different clinical events/conditions and to consider ways in which the alignment of quality and financial incentives could be improved within the current Medicare payment and performance measurement systems and to explore broader episode-based performance and payment reforms to encourage coordination, shared accountability and efficiency. To address selected policy questions related to the potential use of episodes of care for performance measurement, payment, and value-based purchasing (VBP), the project is applying two commercially available episode groupers, the Symmetry Episode Treatment Groups (ETGs) and the Thomson Healthcare Medical Episode Grouper (MEG), on Medicare claims data for 2004 - 2006 from three states.
The project is using a “building block” framework to examine the construction and application of episodes of care. In the context of a building block approach, an episode of care could be constructed (1) narrowly to reflect the services delivered by one provider in a single setting for a specific illness or injury, (2) more broadly to reflect the services delivered in a single setting by multiple providers, such as the physician and the hospital during an inpatient stay, (3) very broadly to encompass the entire continuum of services received across multiple settings and providers for treatment/management of a specific condition, or (4) other variations along this continuum.
Analyses of the output from the grouper software runs focused on specific clinical conditions and will utilize three definitions of episodes of care that start from the current “silo-based” foundation, and expand out to include multiple provider types and settings including, but not limited to:
Using the episode of care as the unit of analysis, data on the episodes derived from the ETG and MEG grouper tools will be used to calculate descriptive statistics that will provide an array of summary information to better understand trends of care for similarly situated beneficiaries.
The scope of work addressed by this project focused on seven key tasks:
The remaining chapters of this report address an overview of Medicare's payment policies across settings and providers (Chapter 2), a summary of performance measures that are currently supplied to CMS through its' various reporting programs for health care providers and assesses the alignment of these programs (Chapter 3), a review of the literature on the use and potential use of episodes of care for performance measurement and payment and findings from discussions with experts (Chapter 4), a summary of findings from our analysis of the episodes constructed for nine clinical conditions (Chapter 5), and a synthesis of findings and discussion of issues related to application of episodes of care and possible areas for future research and demonstration projects (Chapter 6).
Medicare uses separate payment mechanisms for each of its FFS provider settings and Medicare Advantage plans. Our review finds that these payments are currently not aligned in ways that stimulate coordination, shared accountabilities, and delivery of high quality care.
We summarized the current Medicare payment systems for each provider or supplier type and benefit category.
The purpose of this discussion is to understand whether and how current payment policies create incentives for providers across a patient's continuum of care, as a starting point for any types of applications or reforms that would involve using episodes of care in the context of provider payments to better align financial incentives in various settings.
In Table 1, we summarize the payment mechanism used by provider type and setting. The format used in this table mirrors a table presented in the MedPAC 2003 Report to Congress, however the content has been updated utilizing the October 2007 MedPAC Payment Basics reports, information on the CMS website and Federal Register. We report the fiscal year (FY) the payment method began, basis of payment, method used to determine payments, source of the base payment amount and any provider-specific adjustments made to the amount, and method to update payments, reporting incentives and other related policies.
Medicare predominantly uses prospective rate systems for paying providers, through which providers agree to accept as payment in full a predetermined amount for each separately billable Medicare covered product, service, admission or set of services. Cost-based payment continues for Critical Access Hospitals (CAHs) and selected other categories of service or patients.
CMS developed and implemented prospective payment systems separately for each of the other FFS settings, beginning with acute hospital inpatient care in 1984 and, most recently, with ambulatory surgical centers in 2008. Payments to providers are based on a unit of service, which varies by type of provider. These units of service may be per-discharge (hospital-based care), per-diem (SNF, hospice), per-episode (HHA), per-treatment (dialysis) or on a fee schedule (hospital outpatient, physician, outpatient therapy, outpatient labs, durable medical equipment). Typically, base payments are adjusted for patient characteristics, geographic factors, and in the case of physician payments, for practice expenses and professional liability costs. Payment rates for most settings are updated annually to account for changes in market conditions, technology or practice patterns.
FFS payments create incentives for providers to increase the number of reimbursable units provided (e.g. the number of discharges for hospitals, unique services for physicians) to maximize reimbursement. When the reimbursable unit encompasses a bundle of services, which occurs under DRG payments for hospitals, there are incentives created that encourage the provider to be more efficient in the use of services in order to maximize profits. This has been evidenced by hospitals reducing lengths of stay in response to prospective payments, in contrast to cost based payment subject to limits.
In contrast to the payment per unit of service for most Medicare FFS providers, the Medicare Advantage program and the Part D prescription drug program make monthly capitated payments to private health plans or drug plans. In the case of the Medicare Advantage program, Medicare pays a base payment rate that is the lesser of the plan's bid and the local or regional benchmark, which is then risk-adjusted based on enrolled beneficiary characteristics. Health plans participating in the Part D program receive payments based on their annual bids during a competitive bidding process. Under the capitation arrangement, plans face incentives to limit resource use and to keep members healthier to maximize profits,
While the payment systems described above create incentives for provider behavior, often to provide more services, with only one exception do they specifically reward providers for delivering high quality, efficient care. The exception is CMS' recent policy change, implemented in FY 2008, where the Medicare program no longer reimburses hospitals for the additional costs (i.e., a higher MS-DRG payment) associated with eight preventable complications, including three “never events,” unless the condition was documented as being present on admission (CMS, 2007c). The final rule for hospital inpatient services for FY 2009 includes an additional seven conditions.
Due to the lack of differentiation in payment based on quality and efficiency and calls from many policy leaders to align payments with the delivery of high quality, efficient care, CMS has instituted value-based purchasing (VBP) initiatives for several settings as a means of better aligning payment and performance. Currently, several Medicare FFS provider settings are provided a financial incentive for the reporting of quality data to CMS as the first step toward the longer term goal of differentiating payment based on performance or “pay for performance.” Currently, the hospital inpatient, hospital outpatient and home health settings have pay-for-reporting programs in place through which providers must report on a set of measures in order to receive their full payment updates. In contrast, the Physician Quality Reporting Initiative (PQRI) provides a bonus to physicians who report on a minimum of three measures during the reporting period.
In the future, some or all of these programs could potentially transition to pay for performance (i.e., financial incentive linked directly to actual performance on measures rather than the reporting of measures). In November 2007, the Secretary of Health and Human Services submitted a Report to Congress detailing a plan to implement a hospital value-based purchasing program for Medicare services as mandated by the 2005 Deficit Reduction Act[1] (DRA). The Medicare Improvements for Patients and Providers Act of 2008[2] (MIPPA) requires the Secretary of Health and Human Services submit no later than May 2010 a plan to transition to value based purchasing for physicians and other practitioners. Furthermore, MIPPA calls for the establishment of a P4P program for ESRD providers effective January 1, 2012. Additionally, CMS has pay-for-performance (P4P) demonstration projects in process for hospitals, physician group practices, and home health agencies and is developing plans for P4P demonstrations in other settings.
Performance reporting initiatives are not the only value-based purchasing activities in which CMS is engaged. CMS is also exploring competitive bidding as a mechanism to contain costs and potentially ensure quality. A competitive bidding program was planned to start in 2008 for select durable medical equipment (DME) in 10 MSAs with a planned expansion to 80 MSAs in 2009; in addition, a competitive bidding demonstration was planned for clinical laboratories starting in 2008. However, MIPPA delays until after 2011 full implementation of the DME competitive acquisition program, and repeals the competitive bidding demonstration for clinical laboratory services.
CMS will test the use of gainsharing between hospitals and physicians as a mechanism to improve the quality and efficiency of care delivered to beneficiaries through two demonstrations (CMS, 2006): the Hospital Gainsharing Demonstration, which was authorized by section 5007 of the DRA and started in October 2008 and the Physician Hospital Collaboration Demonstration, which was authorized by section 646 of the MMSA and is targeted to start in spring 2009. In May of 2008, CMS announced its plans for the Acute Care Episode demonstration through which it will provide a single bundled payment for both Part A and Part B Medicare services provided during an inpatient stay for a select set of cardiac and orthopedic surgical procedures.
| Payment System Description | Acute Inpatient Care | Ambulatory Care | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute care hospitals | Critical access hospitals (CAH) | Psychiatric hospitals | Physicians | Hospital outpatient departments | Ambulatory surgical centers (ASC) | Outpatient laboratories | |||
| Fiscal Year Began | 1984 | 1997 | 2005 | 2000 | 2000 | 2008 | 1984 | ||
| Basis of Payment | Prospective | Cost-based | Prospective | Prospective | Prospective | Prospective | Prospective | ||
| Product Definition | Method of Payment | The labor portion of the base payment is adjusted by the hospital wage index and added to the non labor portion. The total is multiplied by the MS-DRG[3] weight. The adjusted base payment is further adjusted for indirect medical education, share of low income patients, transfers and high cost outliers | Medicare pays each CAH 101% of its reported costs for outpatient, inpatient, laboratory, and therapy services, as well as SNF level post-hospital extended care- in the hospital's swing beds | The labor portion of the per-diem base rate is adjusted by the hospital wage index and added to the non-labor portion. The total is adjusted for facility and patient characteristics through the PPS[4]adjustment factor. The base rate is then further modified by the per diem adjustor, the presence of an emergency department, ECT[7] treatments and high cost outliers | The 3 RVUs[5](work, practice expense, and professional liability insurance) are each adjusted for complexity of service/expenses and geographic factors then are added together and multiplied by the conversion factor. Payment modifiers are then applied to arrive at the adjusted fee schedule payment rate. That rate is then adjusted for provider type (decrease) or geographic area(increase). For most services, Medicare pays the provider 80% of the fee schedule amount, and the beneficiary is liable for the 20% coinsurance | The labor portion of the conversion factor is adjusted by the hospital wage index and added to the non-labor portion. The adjusted conversion factor is then multiplied by the APC[6] relative weight. The payment amount may be further adjusted for rural status, hold harmless payments and high cost outliers. | The labor portion of the ASC conversion factor is adjusted by the hospital wage index and added to the non-labor portion. The adjusted conversion factor is then multiplied by the APC relative weight. | Payment for the lab service is the lesser of the provider's charge, the carrier fee schedule amount and the National Limitation Amount (NLA) | |
| Unit of payment | Discharge | Service | Day | Service | Service | Procedure | Test | ||
| Classification system | 743 MS-DRGs | None | 15 DRGs | ~6700 HCPCS[8]codes | HCPCS grouped in APCs | 3300 procedures grouped in APCs | 1100+ HCPCS codes | ||
| Policies defining boundaries | 72 hour rule short stay transfers; high cost outliers | None | High cost outliers | Differentials by setting; multiple or atypical services | High-cost outliers; multiple services discount | Multiple services discount | None | ||
| Product Relative Values (RV) | Components of RV | Single value for each MS DRG | NA- Captured in costs | DRGs | Physician work; practice expenses; liability insurance | Single value for each APC | Single value for each APC | Combined with base amount | |
| Source of RV | Hospitals' billed charges | None | Billed charges | Expert judgment; practice expense data; premium survey | Median of estimated service costs | Median of estimated service costs | None | ||
| Base payment rate/conversion factor | Components of base amt | Labor-related; nonlabor; capital | NA | Labor-related; nonlabor; capital | Single conversion factor (for sum of relative values) | Labor-related; non-labor | Labor-related; non-labor | Carrier specific rates with limit | |
| Source of base amt | Updated providers' 1982 costs | NA | Updated providers' 2002 costs | Projected spending under preceding method | 1996 outpatient department charges adjusted to costs | 1986 Survey of ASCs | Updated 1983 lab charges | ||
| Adjustments for local market conditions | Labor input prices | Hospital wage index | NA | Hospital wage index | Separate Geographic Practice Cost Indexes (work, practice expense, liability insurance) | Hospital wage index | Hospital Wage Index | None | |
| Other input prices | COLA (Alaska, Hawaii) | NA | COLA (Alaska, Hawaii) | None | None | None | None | ||
| Other payment adjustments | Low-income patients (DSH)[9];GME[10] | None | Patient characteristics; facility characteristics (teaching, rural, emergency dept); additional payment for ECT treatment | Reduced rates for non-physician practitioners | None | None | |||
| Payment update method | Hospital market basket index | NA | Hospital market basket index | Relative weights updated at least every 5 years; HCPCS codes updated annually, conversion factor updated annually according to SGR[11]system | Hospital market index; Expert review of APC and relative weights annually | Annual review of APCs and relative weights; conversion factor updated annually based on CPI starting 2010 | Congress specifies update factors | ||
| Reporting incentives | Reporting Hospital Quality Data for Annual Payment Update
|
None | None | Physician Quality Reporting Initiative (PQRI) 2.0 % bonus for reporting on quality measures for FYs 2009 and 2010 | Hospital Outpatient Quality Data Reporting Program (HOP QDRP) Withhold of 2 percentage points APU for failure to report on quality measures beginning 2008 | None | None | ||
| Payments for capital costs | Separate prospective rates | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | ||
| Other policies | Higher rates in large urban areas; new technology payments; reimbursement for bad debts; no reimbursement for preventable complications starting 2008 | SNF, psychiatric, and rehab units and home health agencies are paid through prospective systems. | The adjusted rate is higher for earlier days of a patient's stay and declines through the 22nd day. | 10% addition for health professional shortage areas | New technology pass-through; transitional corridors; hold harmless for cancer, children's and rural hospitals | Full payment is only given for the procedure with the highest payment rate. Payments for other procedures performed on the same day are reduced to half their usual rates. | NLA=74% of median fee schedule amounts set by 56 carriers. | ||
| Payment System Description | Post Acute Care | Services for Special Populations | |||||
|---|---|---|---|---|---|---|---|
| Skilled nursing facilities (SNF) | Home health agencies | Inpatient rehab facilities | Long term care hospitals | Outpatient dialysis care | Hospice services | ||
| Fiscal Year Began | 1998 | 2000 | 2002 | 2003 | 1982 | 1983 | |
| Basis of Payment | Prospective | Prospective | Prospective | Prospective | Prospective | Prospective | |
| Product Definition | Method of Payment | The labor portion of the SNF base rate is adjusted by the pre-floor and pre reclassified hospital wage index then added to the non-labor portion. The adjusted base rate is then multiplied by the RUG[13]weight to arrive at the payment amount. | The labor portion of the base rate is adjusted by the pre-floor and pre reclassified hospital wage index then added to the non-labor portion. The adjusted base rate is then multiplied by the HHRG[14]weight and adjusted for short stay or high cost outliers | The labor portion of the base rate is adjusted by the hospital wage index and added to the non-labor portion. The adjusted base rate is then multiplied by the CMG[15]weight and adjusted for rural location, share of low income patients, teaching facility and short stay or high cost outliers | The labor portion of the base rate is adjusted by the hospital wage index and added to the non-labor portion. The adjusted base rate is multiplied by the MS-LTC-DRG[16]weight and adjusted for short stay or high cost outliers | The labor portion of the freestanding base composite rate or the hospital-based composite rate is adjusted by the hospital wage index and added to the non-labor portion and to a drug add-on payment. This amount is then multiplied by a case-mix neutrality factor | The labor portion of the four categories of base payments (routine home care, continuous home care, inpatient respite, general inpatient) is adjusted by the hospital wage index and added to the non-labor related portion. |
| Unit of payment | Day | 60-Day episode | Discharge | Discharge | Dialysis Treatment | Day | |
| Classification system | 53 RUGs | 153 HHRGs | 92 CMGs (87 have 4 tiers with separate payment rates =353 separate rates ) | MS LTC DRGs | None | 4 care type groups | |
| Policies defining boundaries | None | Short stay outlier (fewer than 5 visits, high-cost outliers | Short stay outliers/deaths; transfers; high-cost outliers | Short-stay outliers; high-cost outliers; interrupted stays | None | Beneficiary gives up curative treatment | |
| Product Relative Values (RV) | Components of RV | Nursing care; therapy services | Single value for each HHRG | Single value for each CMG/tier | Single value for each MS LTC DRG | None | Combined with base amounts |
| Source of RV | Staff-time studies | Estimated mean cost per HHRG | Hospitals' billed charges | Hospitals' billed charges | None | None | |
| Base payment rate/conversion factor | Components of base amt | Labor-related; other |
Labor-related; other | Labor-related; other | Labor-related; other | Labor-related; other | Labor-related; other |
| Source of base amt | Amount received in 1995, updated for inflation | Spending in preceding system | Projected spending under preceding method | Projected spending under preceding method | 1977-1979 cost reports | Cost data from Medicare demonstration | |
| Adjustments for local market conditions | Labor input prices | Pre-floor and pre reclassified hospital wage index | Pre-floor and pre reclassified hospital wage index | Pre-floor and pre reclassified hospital wage index | Hospital wage index | Hospital wage index | Hospice wage index |
| Other input prices | None | None | None | COLA (Alaska,Hawaii) | None | None | |
| Other payment adjustments | None | Non-routine medical supplies; proportional episode payment adjustment for beneficiary elected transfers | Low income patients; teaching facility | None | Higher rates for hospital-based facilities; adjusted for patient characteristics (age, BMI, body surface area; drug add-on payment | None | |
| Payment update method | SNF market basket index | Home health market basket index | RPL[17]market basket index | No legislative mandate to update payments. CMS updates based on RPL market basket index | Annual updates of add-on payment based on growth in drug expenditures | Hospital market basket index | |
| Reporting incentives | Public reporting | As part of the Home Health Quality Initiative (HHQI), HHAs must report quality measures; otherwise 2 percentage points market basket update is withheld plus public reporting | None | None | Public reporting | None | |
| Payments for capital costs | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | Included in payment rate | |
| Other policies | 128% increase in per-diem for SNF patients with AIDS | Higher rates in rural areas | None | Medicare caps payments to facilities at 3 sessions per week | Annual payment per beneficiary capped | ||
| Payment System Description | Durable medical equipment (DME) | Medicare Advantage (MA) plans | Part D plans | |
|---|---|---|---|---|
| Fiscal Year Began | 1986 | 1998 (M+C) 2006 (MA) | 2006 | |
| Basis of Payment | Prospective | Prospective-Capitation | Prospective-Capitation | |
| Product Definition | Method of Payment | Payment is the lesser of the provider's charge or the state fee schedule amount | All-inclusive A/B capitation rate is determined by multiplying the base rate (which is either the plan's bid or the benchmark) by the enrollee's risk measure, also known as the CMS-HCC[18] weight. | Capitation rate is determined by multiplying the plan's bid by the enrollee's risk measure, also known as the RxHCC[19]; adjusting for other factors; subtracting the enrollee premium; and adding the additional low income subsidy, reinsurance and risk corridor payments |
| Unit of payment | Item | Month | Month | |
| Classification system | HCPCS within 5 equipment categories | CMS-HCCs are based on beneficiaries' diagnosis, age, gender, working age status; Medicaid status and disabled status | RxHCCs are based on beneficiaries' diagnosis, age, gender and disability status | |
| Policies defining boundaries | None | Payment floors for base rate (national and urban). Separate CMS-HCC risk models for aged, disabled, ESRD, new enrollees, and institutionalized. Additional frailty adjustment factor reflecting the average level of functional impairment. | Additional adjustments are made for low income status, and institutionalized status
Separate RxHCC model for new enrollees |
|
| Product Relative Values (RV) | Components of RV | Combined with base amount | One value for each HCC based on diagnosis, age, gender, working age status, Medicaid status, and disabled status. | One value for each RxHCC based on age, gender and disabled status |
| Source of RV | None | The CMS-HCC risk adjustment model includes approximately 70 disease groups comprised of ICD-9 codes that are clinically related and have similar cost complications
CMS uses demographic and diagnostic information from original Medicare and MA organizations to determine beneficiaries' risk scores |
The CMS RxHCC risk adjustment model includes approximately 70 disease groups comprised of ICD-9 codes that are clinically related and have similar cost complications
CMS uses demographic and diagnostic information from original Medicare and MA organizations to determine beneficiaries' risk scores |
|
| Base payment rate/conversion factor | Components of base amt | Single amount | Local/regional benchmarks | Plan bids |
| Source of base amt | Allowed charges in 1986-1987 with exceptions for customized equipment, medications used in conjunction with DME, and home oxygen | County-level payment rates used to pay MA plans before 2006 (based on historical FFS rates, subject to payment floors and minimum updates) | Expected costs for a Medicare beneficiary of average health | |
| Adjustments for local market conditions | Labor input prices | NA | Included in bid | Included in bid |
| Other input prices | Geographic differences reflected in separate fee schedule for each state | None | None | |
| Other payment adjustments | State fee schedules subject to national floor and ceiling. Fees for prosthetics and orthotics subject to regional limits. | Rebates to plans for difference between benchmark and bid rate (if below the benchmark) that can be used to provide additional benefits or reduce premiums)
Enrollees must pay an additional premium for plans with bids above the benchmark Adjustment for beneficiaries utilization of VA and DOD military facilities Risk corridor payments for regional MA plans |
Enrollees must pay a base premium plus any difference between their plan's bid and the nationwide average bid
Beneficiaries may also be subject to a late enrollment penalty In addition to direct subsidy payments for drug coverage, plans also receive low income subsidy payments; individual reinsurance payments; and risk corridor payments |
|
| Payment update method | CPI-U[20] | Plans' bids updated annually
Rise in national growth rate in per capita Medicare spending is used to update the benchmarks each year, subject to a minimum percentage increase MA FFS capitation rates are rebased at lease once every 3 years based on more recent FFS claims data Coefficients in the Part C CMS-HCC Risk Adjustment Model, and frailty adjustment factors are also periodically updated using more recent data |
Parameters for the standard Part D benefit are updated each year based on the estimated annual change in per capita drug spending and the annual percentage increase in the CPI
Coefficients in the Part D RxHCC risk adjustment model were originally developed based on drug expenditure data from FEHB[21] and MSIS[22]and will be updated based on actual Part D utilization |
|
| Reporting incentives | None | None | None | |
| Payments for capital costs | Included in payment rate | Included in payment rate | Included in payment rate | |
| Other policies | ||||
In 2002, CMS launched the Quality Initiative, an effort designed to assure quality health care for all Americans through performance accountability and public disclosure of performance results (http://www.cms.hhs.gov, 2008). The roll-out of this program has occurred over the past few years, continues to expand, and includes performance measurement in six different Medicare health care settings:
To understand whether performance measurement is aligned across the various components of the current FFS payment system, we cataloged the six Medicare performance measurement programs and examined the extent to which these programs are aligned in terms of the clinical conditions measured and measures included.
Across the various settings, CMS collects a total of 249 performance measures for hospital inpatient, hospital outpatient, physicians/practitioners/therapists, skilled nursing facilities (SNF), home health agencies, and dialysis facilities through a variety of methods and with varying types and levels of incentives attached. Four settings have financial incentives associated with the reporting of measures (i.e., “pay for reporting” programs). Reporting performance measures for hospital inpatient, hospital outpatient and home health agencies, while voluntary, is required in order for these providers to receive the full annual payment update/market basket update; providers that do not report the measures forgo 2 percentage points of the update. For the Physician Quality Reporting Initiative (PQRI), participation is voluntary and physicians who submit data on the specified performance measures received a bonus (subject to a cap for reporting in 2007) of 1.5% percent of allowed charges for covered Medicare physician fee schedule services for 2007 and 2008. For 2009 and 2010, the bonus amount is increased to 2% of allowed charges.
Public reporting of performance results occurs for providers in four of the settings as of March 2008: (1) hospital inpatient, (2) home health agencies (HHAs), (3) skilled nursing facilities (SNFs) and (4) dialysis facilities. At this time, physicians participating in PQRI receive a confidential feedback report containing their reporting and performance information mid-year following the end of the PQRI reporting period.
The data used to construct the SNF and home health measures are collected through existing assessment and collection tools. Dialysis facility measures are constructed from Medicare administrative data sources, while new HCPC codes have been developed to enable the construction of measures from physician claims data for PQRI. In 2008, CMS allowed physicians to submit performance data via registries, and seeks to expand registry submissions in 2009 and continue to test data submissions from electronic health records (EHRs) (CMS, 2008). Hospital inpatient and hospital outpatient measures are based on data collected from electronic or paper medical records.
This section provides brief descriptions of the six CMS performance measurement programs. Table 2 summarizes the number of measures included in the programs by measure type (e.g. clinical process of care, patient experience). Nearly 70 percent of the measures across the programs are clinical process of care measures (173 measures). All of the performance measurement programs, except the home health program (HHQI), include clinical process measures. Patient outcome measures are included for five settings (hospital inpatient, physicians, skilled nursing facilities, home health agencies and dialysis facilities), while intermediate patient outcomes are included for 3 settings (hospital inpatient, physicians, and dialysis facilities) and two settings have measures of patient functioning (skilled nursing facilities and home health care agencies). Measures of patient experience are captured for hospital inpatient care. The physician (PQRI) and the hospital outpatient programs include a small number of efficiency (inappropriate use of services) measures and PQRI has two structural measures. PQRI also includes several measures about proper documentation which we have termed “other.” We also list (Table 3) the full set of performance measures that are reported to or constructed by CMS for each of the six settings and whether the same measure used in one setting (e.g., the hospital) is also applied in another provider setting (e.g., PQRI, hospital outpatient). Within each provider setting or payment silo, measures are organized by condition or procedure where relevant.
| Type of Measure | Hospital Inpatient (RHADAPU) | Hospital Outpatient (HOP QDRP) | PQRI | Skilled Nursing Facilities | Home Health | Dialysis Facilities |
|---|---|---|---|---|---|---|
| Clinical Process of Care | 26 | 10 | 131 | 5 | 0 | 1 |
| Patient Outcome | 14 | 0 | 5 | 10 | 4 | 1 |
| Patient Intermediate Outcome | 1 | 0 | 5 | 0 | 0 | 1 |
| Patient Functioning | 0 | 0 | 0 | 4 | 8 | 0 |
| Patient Experience | 10 | 0 | 0 | 0 | 0 | 0 |
| Efficiency | 0 | 1 | 4 | 0 | 0 | 0 |
| Structural/Health Information Technology | 0 | 0 | 2 | 0 | 0 | 0 |
| Other (documentation) | 0 | 0 | 6 | 0 | 0 | 0 |
Reporting Hospital Quality Data for Annual Payment Update (RHQDAPU) Program This program, mandated under the Medicare Prescription Drug Improvement and Modernization Act of 2003[23], collects performance data from hospitals on a set of hospital inpatient measures of clinical quality (both process of care and outcomes) and patient experience with care. This “pay-for-reporting” program provides differential payment updates to Inpatient Prospective Payment System (IPPS) hospitals based on whether they publicly report their performance on the defined set of measures. The original program, established in 2004, required hospitals to report on a set of 10 performance measures in order to receive 0.4 percentage points of their annual payment update. The 2005 Deficit Reduction Act expanded the list of measures and increased the differential payment for reporting to 2 percentage points. The performance results are publicly reported on the CMS Hospital Compare website. The initial RHQDAPU list of measures has since expanded to 41 clinical measures and 10 patient experience measures required for reporting for fiscal year 2009. Of the current list, eight clinical measures are also reported in the Hospital Outpatient Quality Data Reporting Program (HOP QDRP) and/or the PQRI.
Hospital Outpatient Quality Data Reporting Program (HOP QDRP). Under Section 109 of the Tax Relief and Health Care Act of 2006[24], Congress established new requirements for hospitals serving Medicare beneficiaries to report outpatient quality data to secure their full annual update to the Outpatient Prospective Payment System fee schedule. Effective April 2008, hospitals were required to submit performance data on a set of seven measures of care provided in the hospital outpatient setting in order to receive their full annual update in calendar year 2009. For 2009, four new measures have been added. Those that do not participate in the program receive a reduction of 2.0 percentage points in their annual payment update. As this program is just starting, performance data is not yet publicly reported. Five of the measures included in HOP QDRP are emergency department (ED) transfer measures, two measures address perioperative care, and the four new measures address imaging appropriateness and follow-up. The number of measures to be reported for this program is expected to grow, and CMS has sought public comment on an additional 18 measures being considered for future years.
Physician Quality Reporting Initiative (PQRI). The Tax Relief and Healthcare Reform Act of 2006 required Congress to establish a physician quality reporting program. Established in 2007, this is a voluntary reporting program for physicians, practitioners and therapists. The Medicare, Medicaid, and SCHIP Extension Act of 2007[25] authorized the extension of the program through 2010. It also allowed for registry-based reporting and removed the cap on bonuses paid. The initial set of 74 clinical measures was expanded to 119 measures in 2008 and 153 in 2009 and addresses an array of clinical specialty areas. Eligible professionals who successfully report at least 3 of the 153 measures for calendar year 2009 receive a bonus over allowed charges for covered Medicare physician fee schedule services. The Medicare Improvements for Patients and Providers Act of 2007 (MIPPA) increased the bonus payment from 1.5 percent to 2.0 percent for 2009 and 2010. There is currently no public reporting associated with PQRI; providers' results are confidentially reported back to the individual provider mid-year following the end of the PQRI reporting period. The performance measures address 43 conditions or procedures, preventive care, and the use of health information technology (IT). The 2008 measure set included a measure for e-prescribing which was eliminated for 2009 due to the new e-prescribing incentive program included in the MIPPA. The PQRI program has also established measure groups for diabetes, chronic kidney disease, prevention, CABG, rheumatoid arthritis, perioperative care and back pain. Physicians or practitioners that elect to report on a group of measures must report all measures in the group that are applicable to each patient. PQRI measures have some degree of alignment with the hospital inpatient and outpatient measures (i.e., management of acute myocardial infarction, heart failure, perioperative/surgical care and pneumonia). Additionally, several preventive care measures (e.g., influenza and pneumococcal vaccinations) addressed in PQRI align with measures reported by SNFs.
Nursing Home Quality Initiative (NHQI). This reporting program began in 2002 and requires SNFs to provide information about the residents' health, physical functioning, and general function. The measures are constructed with data from the Minimum Data Set (MDS) Repository and the performance results are publicly reported on the CMS Nursing Home Compare website. There is no financial incentive associated with NHQI. A total of 19 measures are to be reported in 2009, with 14 relevant to long stay patients and five relevant to short stay patients; four of the five measures for short stay patients are also used for long stay patients. Long stay patients are those in an extended or permanent nursing home stay, while the short stay patients are usually recovering from a hospital stay and are expected to return home. The measures address vaccinations, pain, pressure sores, urinary incontinence, use of restraints, depression, mobility, urinary tract infections, and weight loss. There is some alignment between the conditions addressed by NHQI and PQRI (i.e., preventive care, depression, urinary incontinence), and there is overlap in the preventive measures (immunizations) included in the programs. Some of the conditions addressed by NHQI align with the home health program, HHQI, (i.e., pain, urinary incontinence), though the measures included in the two programs do not overlap.
Home Health Quality Initiative (HHQI). Beginning in 2000, every Medicare-certified home health agency was required to complete and submit health data on their clients utilizing the Outcome and Assessment Information Set (OASIS) data collection tool. Home health agencies that do not provide their data experience a two percentage point reduction in their annual market basket payment update. CMS began publicly reporting a subset of this information in late 2003 on the CMS Home Health Compare website. In 2005, the NQF endorsed the 10 measures reported on Home Health Compare, and two measures were added to the program for calendar year 2008. The performance measures address ambulation, activities of daily living, medical emergencies and discharge from home care. With the exception of pain, dyspnea, and urinary incontinence, most measures are not specific to a particular disease or condition. None of the measures are included in the other performance measurement programs.
End Stage Renal Disease (ESRD) Quality Initiative. In 2004, CMS required kidney dialysis facilities to report performance for patients with ESRD. CMS currently collects and reports three dialysis facility-specific measures that indicate the adequacy of hemodialysis, control of anemia and survival for patients with end stage renal disease (ESRD). The performance results are reported on the CMS Dialysis Facility Compare website along with the types of services offered by ESRD facilities. There is no financial incentive for reporting currently, however the 2008 MIPPA requires the establishment of a P4P program for ESRD providers effective January 1, 2012 and the establishment of a fully bundled payment system for ESRD facilities by January 1, 2011. The measures are produced from data that comes from the Standard Information Management Systems, which receive data from the ESRD Networks on a monthly basis and from the Renal Management Information System maintained by Medicare. Measures are also under development or have been recently developed for kidney transplant referral, ESRD bone disease and metabolism, and vascular access. The three existing dialysis facility-level measures are not included in the other performance measurement programs.
| Condition | Measure | Overlap with Other Reporting Programs | Measure Type[26] | ||
|---|---|---|---|---|---|
| Hospital Inpatient | Acute Myocardial Infarction (AMI) | Aspirin at arrival | Hospital Outpatient & PQRI | P | |
| AMI | Aspirin prescribed at discharge | None | P | ||
| AMI | ACE-I or ARB for LVSD | None | P | ||
| AMI | Adult smoking cessation advice/counseling | None | P | ||
| AMI | Beta blocker at arrival | None | P | ||
| AMI | Beta blocker prescribed at discharge | None | P | ||
| AMI | Fibrinolytic medication received within 30 minutes of hospital arrival | Hospital Outpatient | P | ||
| AMI | PCI received within 120 minutes of hospital arrival | None | P | ||
| AMI | 30-day AMI mortality | None | O | ||
| Heart Failure (HF) | Discharge instructions | None | P | ||
| HF | Left ventricular function assessment | None | P | ||
| HF | ACE-I or ARB for LVSD | PQRI | P | ||
| HF | Adult smoking cessation advice/counseling | None | P | ||
| HF | 30-day HF mortality | None | O | ||
| HF | 30-day HF readmission* | None | O | ||
| Community Acquired Bacterial Pneumonia (PN) | Assessed and given pneumococcal vaccination | None | P | ||
| PN | Assessed and given influenza vaccination | None | P | ||
| PN | Blood culture performed in the emergency department before the first antibiotic received in hospital | None | P | ||
| PN | Appropriate initial antibiotic selection | PQRI | P | ||
| PN | Initial antibiotic received within 6 hours | None | P | ||
| PN | Adult smoking cessation advice/counseling | None | P | ||
| PN | 30-day PN mortality | None | O | ||
| Perioperative/Surgical Care | Prophylactic received within 1 hour prior to surgical incision | Hospital Outpatient & PQRI | P | ||
| Perioperative/Surgical Care | Prophylactic antibiotic selection for surgical patients | Hospital Outpatient & PQRI | P | ||
| Perioperative/Surgical Care | Prophylactic antibiotics discontinued within 24 hours after surgery end time | PQRI | P | ||
| Perioperative/Sur gical Care | Surgery patients with recommended venous thromboembolism prophylaxis ordered | PQRI | P | ||
| Perioperative/Surgical Care | Surgery patients with recommended venous thromboembolism prophylaxis received within 24 hours prior to or after surgery | None | P | ||
| Perioperative/Surgical Care | Cardiac patients with controlled 6 am post-operative serum glucose | None | IO | ||
| Perioperative/Surgical Care | Surgery patients with appropriate hair removal | None | P | ||
| Perioperative/Surgical Care | Surgery patients on a beta blocker prior to arrival who received a beta blocker during the perioperative period* | None | P | ||
| Perioperative/Surgical Care | Death among surgical patients with treatable serious complications* | None | O | ||
| Perioperative/ Surgical Care | Postoperative wound dehiscence* | None | O | ||
| Perioperative/Surgical Care | Mortality for selected surgical procedures (composite)* | None | O | ||
| Cardiac Surgery | Participation in a systematic database for cardiac surgery* | None | P | ||
| Nursing Sensitive | Failure to rescue* | None | O | ||
| Pneumothorax | Iatrogenic pneumothorax* | None | O | ||
| NA | Accidental puncture or laceration* | None | O | ||
| Abdominal Aortic Aneurysm | AAA mortality rate (with or without volume)* | None | O | ||
| Hip Fracture | Hip fracture mortality rate* | None | O | ||
| NA | Mortality for selected medical conditions (composite)* | None | O | ||
| NA | Complication/patient safety for selected indicators (composite)* | None | O | ||
| Patient Experience | Communication with doctors (composite) | None | PE | ||
| Patient Experience | Communication with nurses (composite) | None | PE | ||
| Patient Experience | Responsiveness of hospital staff (composite) | None | PE | ||
| Patient Experience | Cleanliness of hospital (composite) | None | PE | ||
| Patient Experience | Quietness of hospital (composite) | None | PE | ||
| Patient Experience | Pain control (composite) | None | PE | ||
| Patient Experience | Communication about medicines (composite) | None | PE | ||
| Patient Experience | Discharge information (composite) | None | PE | ||
| Patient Experience | Overall rating of hospital care | None | PE | ||
| Patient Experience | Overall recommendation | None | PE | ||
| Hospital Outpatient | |||||
| AMI | Emergency department transfer: Aspirin at arrival | Hospital Inpatient & PQRI | P | ||
| AMI | Emergency department transfer: Median time to fibrinolysis | None | P | ||
| AMI | Emergency department transfer: Fibrinolytic therapy received within 30 minutes of arrival | Hospital Inpatient | P | ||
| AMI | Emergency department transfer: Median time to electrocardiogram | None | P | ||
| AMI | Emergency department transfer: Median time to transfer for primary PCI | None | P | ||
| Perioperative Care | Timing of antibiotic prophylaxis | Hospital Inpatient & PQRI | P | ||
| Perioperative Care | Selection of prophylactic antibiotic | Hospital Inpatient & PQRI | P | ||
| Low Back Pain/Imaging | MRI lumbar spine for low back pain* | None | E | ||
| Imaging | Mammography follow-up rates* | None | P | ||
| Imaging | Abdomen CT-use of contrast material* | None | P | ||
| Imaging | Thorax CT-use of contrast material* | None | P | ||
| Physicians, Practitioners, Therapists (PQRI) | |||||
| Acute Bronchitis | Inappropriate antibiotic treatment for adults | None | P | ||
| Acute Otitis Externa | Topical therapy | None | P | ||
| Acute Otitis Externa | Pain assessment | None | P | ||
| Acute Otitis Externa | Systemic antimicrobial therapy-avoidance of inappropriate use | None | E | ||
| Age-Related Macular Degeneration (AMD) | Dilated macular examination | None | P | ||
| AMD | Counseling on antioxidant supplement* | None | P | ||
| AMI | Aspirin at arrival | Hospital Inpatient & Hospital Outpatient | P | ||
| Asthma | Assessment of symptoms | None | P | ||
| Asthma | Pharmacologic therapy | None | P | ||
| Back Pain | Initial visit* | None | P | ||
| Back Pain | Physical Exam* | None | P | ||
| Back Pain | Advice for normal activities* | None | P | ||
| Back Pain | Advice against bed rest* | None | P | ||
| Breast Cancer | Hormonal therapy for stage 1C-III ER/PR positive breast cancer | None | P | ||
| Breast Cancer | Pathology reporting: pT and pN category and histologic grade | None | Other | ||
| CABG | Use of internal mammary artery | None | P | ||
| CABG | Pre-operative beta blocker | None | P | ||
| CABG | Prolonged intubation* | None | O | ||
| CABG | Deep sternal wound infection rate* | None | O | ||
| CABG | Stroke/CVA* | None | O | ||
| CABG | Post operative renal insufficiency* | None | O | ||
| CABG | Surgical re-exploration* | None | O | ||
| CABG | Anti-platelet medication at discharge* | None | P | ||
| CABG | Beta blocker at discharge* | None | P | ||
| CABG | Lipid management and counseling* | None | P | ||
| Cancer | Medical and radiation-plan of care for pain* | None | P | ||
| Cancer | Pain intensity quantified* | None | P | ||
| Cancer | Radiation dose limits to normal tissue* | None | P | ||
| Cataracts | Comprehensive preoperative assessment for surgery with IOL replacement* | None | P | ||
| Catheter-Associated Bloodstream Infections | Prevention - central venous catheter insertion protocol | None | P | ||
| Chronic Kidney Disease (CKD) | Laboratory Testing (calcium, phosphorus, iPTH and lipid profile) | None | P | ||
| CKD | Blood pressure management | None | P | ||
| CKD | Plan of care; elevated hemoglobin for patients receiving Erythropoiesis Stimulating Agents | None | P | ||
| CKD | Influenza immunization* | None | P | ||
| CKD | Referral for AV Fistula* | None | P | ||
| Chronic Lymphocytic Leukemia | Baseline flow cytometry | None | P | ||
| Chronic Obstructive Pulmonary Disease (COPD) | Spirometry evaluation | None | P | ||
| COPD | Bronchodilator therapy | None | P | ||
| Colon Cancer | Chemotherapy for stage III patients | None | P | ||
| Community Acquired Bacterial Pneumonia (PN) | Vital Signs | None | P | ||
| PN | Assessment of oxygen saturation | None | P | ||
| PN | Assessment of mental status | None | P | ||
| PN | Appropriate antibiotic selection | Hospital Inpatient | P | ||
| Colorectal Cancer | Pathology reporting: pT and pN category and histologic grade | None | Other | ||
| Coronary Artery Disease (CAD) | Oral antiplatelet therapy prescribed | None | P | ||
| CAD | Beta blocker therapy for patients with prior MI | None | P | ||
| CAD | ACE inhibitor or ARB therapy | None | P | ||
| CAD | Lipid profile* | None | P | ||
| Depression | Antidepressant medication during acute phase for patients with new episode of major depression | None | P | ||
| Depression | Diagnostic evaluation | None | P | ||
| Depression | Assessed for suicide risk | None | P | ||
| Diabetes | Hemoglobin A1C poor control | None | IO | ||
| Diabetes | LDL control | None | IO | ||
| Diabetes | Blood pressure control | None | IO | ||
| Diabetes | Dilated eye exam | None | P | ||
| Diabetes | Urine screening or medical attention for nephropathy | None | P | ||
| Diabetes | Foot exam* | None | P | ||
| Diabetes | Foot and ankle care: neurological evaluation | None | P | ||
| Diabetes | Foot and ankle care: evaluation of footwear | None | P | ||
| Diabetic Retinopathy | Documentation of presence or absence of macular edema and level of severity of retinopathy | None | P | ||
| Diabetic Retinopathy | Communication with the physician managing ongoing diabetes care | None | P | ||
| Endarterectomy | Use of patch during conventional endarterectomy* | None | P | ||
| ESRD | Influenza vaccination | None | P | ||
| ESRD | Plan of care for inadequate hemodialysis | None | P | ||
| ESRD | Plan of care for inadequate peritoneal dialysis | None | P | ||
| ESRD | Hemodialysis vascular access-placement of autogenous arterial venous fistula* | None | P | ||
| ESRD (pediatric) | Adequacy of hemodialysis* | None | IO | ||
| ESRD (pediatric) | Influenza immunization* | None | P | ||
| Falls | Plan of care* | None | P | ||
| Falls | Risk assessment* | None | P | ||
| Glaucoma | Optic nerve evaluation | None | P | ||
| Glaucoma | Reduction of intraocular pressure by 15% or documentation of a plan of care* | None | IO | ||
| Heart Failure | ACE-I or ARB for LVSD | Hospital Inpatient | P | ||
| Heart Failure | Beta blocker therapy for LVSD | None | P | ||
| Hepatitis C | Testing for Hepatitis C Viremia | None | P | ||
| Hepatitis C | RNA testing prior to treatment | None | P | ||
| Hepatitis C | HCV genotype testing prior to therapy | None | P | ||
| Hepatitis C | Consideration of antiviral therapy | None | P | ||
| Hepatitis C | HCV RNA testing at week 12 of therapy | None | P | ||
| Hepatitis C | Hepatitis A vaccination* | None | P | ||
| Hepatitis C | Hepatitis B vaccination* | None | P | ||
| Hepatitis C | Counseling regarding use of alcohol | None | P | ||
| Hepatitis C | Counseling regarding use of contraception prior to starting antiviral therapy | None | P | ||
| HIV/AIDS | CD4+ cell count or CD4+ percentage* | None | P | ||
| HIV/AIDS | Pneumocystis Jiroveci Pneumonia prophylaxis* | None | P | ||
| HIV/AIDS | Adolescent and adult patients with HIV/AIDS who are prescribed potent antiretroviral therapy* | None | P | ||
| HIV/AIDS | HIV RNA control after 6 months of potent antiretroviral therapy* | None | P | ||
| Lung, Esophageal Cancer | Recording of clinical stage* | None | Other | ||
| Melanoma | Follow-up aspects of care* | None | P | ||
| Melanoma | Continuity of care-recall system* | None | S | ||
| Melanoma | Coordination of care* | None | P | ||
| Multiple Myeloma | Treatment with bisphosphonates | None | P | ||
| Myelodysplastic Syndrome (MDS) | Documentation of iron stores in patients receiving erythropoietin | None | P | ||
| MDS and Acute Leukemia | Baseline cytogenetic testing performed on bone marrow | None | P | ||
| Non Traumatic Chest Pain | Electrocardiogram performed | None | P | ||
| Nuclear Medicine | Correlation with existing imaging studies for patients undergoing bone scintigraphy* | None | P | ||
| Osteoarthritis | Assessment of pain and function | None | P | ||
| Osteoarthritis | Assessment for use of anti-inflammatory or analgesic over the counter medications* | None | P | ||
| Osteoporosis | Communication with the physician managing ongoing care post-fracture | None | P | ||
| Osteoporosis | Screening or therapy for women aged 65 and older | None | P | ||
| Osteoporosis | Management following fracture | None | P | ||
| Osteoporosis | Pharmacologic therapy | None | P | ||
| Otis Media with Effusion (OME) | Diagnostic evaluation | None | P | ||
| OME | Hearing testing | None | P | ||
| Perioperative Care | Timing of antibiotic prophylaxis-ordering physician | None | P | ||
| Perioperative Care | Timing of antibiotic prophylaxis-administering physician | Hospital Inpatient & Hospital Outpatient | P | ||
| Perioperative Care | Selection of prophylactic antibiotic | Hospital Inpatient & Hospital Outpatient | P | ||
| Perioperative Care | Discontinuation of prophylactic antibiotic (cardiac procedures) | None | P | ||
| Perioperative Care | Discontinuation of prophylactic antibiotic (non-cardiac procedures) | Hospital Inpatient | P | ||
| Perioperative Care | Venous thromboembolism (VTE) prophylaxis | Hospital Inpatient | P | ||
| Pharyngitis | Appropriate testing for children | None | E | ||
| Prev/Screening | Medication reconciliation after discharge from inpatient setting | None | P | ||
| Prev/Screening | Advance care plan | None | P | ||
| Prev/Screening | Influenza vaccination for patients > 50 | SNF | P | ||
| Prev/Screening | Pneumonia vaccination for patients > 65 | SNF | P | ||
| Prev/Screening | Screening mammography | None | P | ||
| Prev/Screening | Colorectal cancer screening | None | P | ||
| Prev/Screening | Inquiry regarding tobacco use | None | P | ||
| Prev/Screening | Advising smokers to quit | None | P | ||
| Prev/Screening | Universal weight screening and follow-up | None | P | ||
| Prev/Screening | Universal documentation and verification of current medications in the medical record | None | P | ||
| Prev/Screening | Pain assessment prior to initiation of patient treatment | None | P | ||
| Prev/Screening | Screening for clinical depression | None | P | ||
| Prev/Screening | Screening for alcohol abuse* | None | P | ||
| Prev/Screening | Endoscopy and polyp surveillance-interval in patients with history of adenomatous polyps* | None | P | ||
| Prev/Screening | Elder maltreatment screen with follow-up plan* | None | P | ||
| Prostate Cancer | Inappropriate use of bone scan for staging low risk patients | None | E | ||
| Prostate Cancer | Adjuvant hormonal therapy for high-risk prostate cancer patients | None | P | ||
| Prostate Cancer | Three dimensional radiotherapy | None | P | ||
| Radiology | Exposure time reported for procedures using fluoroscopy* | None | Other | ||
| Radiology | Inappropriate use of "probably benign" assessment category in mammography screening* | None | P | ||
| Rheumatoid Arthritis (RA) | Disease modifying anti-rheumatic drug therapy | None | P | ||
| RA | Tuberculosis screening* | None | P | ||
| RA | Periodic assessment of disease activity* | None | P | ||
| RA | Functional limitation assessment* | None | P | ||
| RA | Assessment and classification of disease prognosis* | None | P | ||
| RA | Glucocorticoid management* | None | P | ||
| Stroke | CT or MRI reports | None | Other | ||
| Stroke | Carotid imaging reports | None | Other | ||
| Stroke | DVT for ischemic stroke or intracranial hemorrhage | None | P | ||
| Stroke | Discharged on antiplatelet therapy | None | P | ||
| Stroke | Anticoagulant therapy for atrial fibrillation at discharge | None | P | ||
| Stroke | Tissue Plasminogen Activator (t-PA) considered | None | P | ||
| Stroke | Screening for dysphasia | None | P | ||
| Stroke | Consideration of rehabilitation services | None | P | ||
| Syncope | Electrocardiogram performed | None | P | ||
| Upper Respiratory Infection | Appropriate treatment for children | None | E | ||
| Urinary Incontinence (UI) | Assessment of presence or absence in women aged 65 years and older | None | P | ||
| UI | Characterization of UI in women aged 65 years and older | None | P | ||
| UI | Plan of care for women aged 65 years and older | None | P | ||
| Wound care | Use of compression care in patients with venous ulcers* | None | P | ||
| NA | Functional outcome assessment in chiropractic care* | None | P | ||
| NA | Adoption/use of health information technology (electronic health records) | None | S | ||
| Skilled Nursing Facilities (SNFs) | |||||
| Long-Stay: | |||||
| Prevention | Residents given influenza vaccination during the flu season | PQRI | P | ||
| Prevention | Residents assessed and given pneumococcal vaccination | PQRI | P | ||
| NA | Residents whose need for help with daily living activities has increased | None | F | ||
| Pain | Residents who have moderate to severe pain | None | O | ||
| Pressure Sores | High risk residents who have pressure sores | None | O | ||
| Pressure Sores | Low risk residents who have pressure sores | None | O | ||
| NA | Residents who were physically restrained | None | O | ||
| Depression/Anxiety | Residents who are more depressed or anxious | None | O | ||
| Incontinence | Residents who lose control of their bowels or bladder | None | F | ||
| UI | Residents who have had a catheter inserted and left in their bladder | None | P | ||
| NA | Residents who spent most of their time in a bed or in a chair | None | F | ||
| NA | Residents whose ability to move about and around their room got worse | None | F | ||
| Urinary Tract Infection | Residents with a urinary tract infection | None | O | ||
| Weight Loss | Residents who lost too much weight | None | O | ||
| Short-Stay: | Prevention | Residents given influenza vaccination during the flu season | PQRI | P | |
| Prevention | Residents assessed and given pneumococcal vaccination | PQRI | P | ||
| Delirium | Residents with delirium | None | O | ||
| Pain | Residents who had moderate to severe pain | None | O | ||
| Pressure Sores | Residents with pressure sores | None | O | ||
| Home Health | |||||
| NA | Improvement in ambulation/locomotion | None | F | ||
| NA | Improvement in bathing | None | F | ||
| NA | Improvement in transferring | None | F | ||
| NA | Improvement in management of oral medication | None | F | ||
| Pain | Improvement in pain interfering with activity | None | F | ||
| Dyspnea | Improvement in dyspnea | None | F | ||
| UI | Improvement in urinary incontinence | None | F | ||
| NA | Improvement in the status of surgical wounds | None | F | ||
| NA | Patients requiring acute care hospitalization | None | O | ||
| NA | Patients requiring emergent care | None | O | ||
| NA | Patients requiring emergent care for wound infections | None | O | ||
| NA | Patients discharged to the community | None | O | ||
| Dialysis Facilities | |||||
| ESRD | Anemia control | None | IO | ||
| ESRD | Hemodialysis adequacy | None | P | ||
| ESRD | Patient survival | None | O | ||
Note: P=Process, O=Outcome, E=Efficiency, IO=Intermediate Outcome, F=Functioning, S=Structural, PE=Patient Experience
* Indicates measure was added for the 2009 reporting year
We evaluated the extent of alignment and coordination of measures across the six performance measurement programs. By alignment we mean whether the measures included in these programs address the same conditions or procedures. For conditions and procedures that are addressed by more than one program, we then assess whether the programs include similar measures for that condition or procedure, which we refer to as "overlap." This determination was based on measure titles; we did not obtain actual measure specifications to determine whether the measures were exactly the same. We also provide a brief discussion of the range of measures for conditions or procedures that are addressed in multiple programs.
The performance measures reported in the six settings cover 53 different conditions or procedures as well as patient experience in the hospital setting, the presence of health information technology in physician offices, and some health and functional status measures that are not disease/condition specific for skilled nursing facilities and home health. Of the 249 measures reported in total, 224 (90 percent) are reported only for a single setting. There are some cases where the same conditions are addressed by the various reporting programs, although identical measures are not being collected across the different settings being measured. Table 4 summarizes the type of conditions, diseases, and procedures that are currently addressed to greater or lesser extents by the various reporting programs. Only ten conditions are addressed by performance measurement programs for more than one setting. Three conditions/diseases/procedures are included in programs for three settings: acute myocardial infarction, perioperative/surgical care, and urinary incontinence. Seven conditions are included in programs for two settings: back pain, community acquired pneumonia, depression, end stage renal disease, heart failure, pain, and prevention.
| Conditions/Diseases/ Procedures | # of Reporting Programs Addressing Condition | Hospital Inpatient (RHQDAPU) |
Hospital Outpatient (HOP QDRP) |
Physicians Practitioners Therapist (PQRI) |
Skilled Nursing Facilities | Home Health | Dialysis Facilities |
|---|---|---|---|---|---|---|---|
| Acute Myocardial Infarction | 3 | X | X | X | |||
| Perioperative /Surgical Care | 3 | X | X | X | |||
| Urinary Incontinence | 3 | X | X | X | |||
| Back Pain | 2 | X | X | ||||
| Community Acquired Bacterial Pneumonia | 2 | X | X | ||||
| Depression | 2 | X | X | ||||
| End Stage Renal Disease | 2 | X | X | ||||
| Heart Failure | 2 | X | X | ||||
| Pain | 2 | X | X | ||||
| Prevention | 2 | X | X | ||||
| Abdominal Aortic Aneurysm | 1 | X | |||||
| Acute Bronchitis | 1 | X | |||||
| Acute Leukemia | 1 | X | |||||
| Acute Otitis Externa | 1 | X | |||||
| Asthma | 1 | X | |||||
| Breast Cancer | 1 | X | |||||
| Cataracts | 1 | X | |||||
| Catheter-Associated Blood Stream Infections | 1 | X | |||||
| Chronic Kidney Disease | 1 | X | |||||
| Chronic Lymphotic Leukemia | 1 | X | |||||
| Chronic Obstructive Pulmonary Disease | 1 | X | |||||
| Colon Cancer | 1 | X | |||||
| Coronary Artery Bypass Graft | 1 | X | |||||
| Coronary Artery Disease | 1 | X | |||||
| Delirium | 1 | X | |||||
| Diabetes | 1 | X | |||||
| Diabetic Retinopathy | 1 | X | |||||
| Dsypnea | 1 | X | |||||
| Endarterectomy | 1 | X | |||||
| Falls | 1 | X | |||||
| Glaucoma | 1 | X | |||||
| Hepatitis C | 1 | X | |||||
| Imaging | 1 | X | |||||
| Incontinence (Bowel) | 1 | X | |||||
| Macular Degeneration | 1 | X | |||||
| Multiple Myeloma | 1 | X | |||||
| Myelodyplastic Syndrome | 1 | X | |||||
| Non-Traumatic Chest Pain | 1 | X | |||||
| Osteoarthritis | 1 | X | |||||
| Osteoporosis | 1 | X | |||||
| Otis Media with Effusion | 1 | X | |||||
| Pharyngitis | 1 | X | |||||
| Pneumothorax | 1 | X | |||||
| Pressure Sores | 1 | X | |||||
| Prostate Cancer | 1 | X | |||||
| Rectal Cancer | 1 | X | |||||
| Rheumatoid Arthritis | 1 | X | |||||
| Stroke | 1 | X | |||||
| Syncope | 1 | X | |||||
| Upper Respiratory Infection | 1 | X | |||||
| Urinary Tract Infection | 1 | X | |||||
| Weight Loss (Undesired) | 1 | X | |||||
| Wound Care | 1 | X |
* Includes measures that will be reported in 2009.
Below we describe the areas of alignment and overlap by condition or type of care. For the nine conditions addressed by more than one performance measurement program, Table 5 list the individual measures by condition and indicates the areas of overlap.
| Measure | Hospital Inpatient(RHQDAPU) | Hospital Outpatient (HOP QDRP) | Physicians Practitioners Therapist (PQRI) | Skilled Nursing Facilities | Home Health | Dialysis Facilities | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Conditions Addressed by Three Reporting Programs | |||||||||||
| Acute Myocardial Infarction (AMI) | |||||||||||
| Aspirin at arrival (For HOP QDRP, applies to emergency department transfers) | X | X | X | ||||||||
| Aspirin prescribed at discharge | X | ||||||||||
| ACE-I or ARB for LVSD | X | ||||||||||
| Adult smoking cessation advice/counseling | X | ||||||||||
| Beta blocker at arrival | X | ||||||||||
| Beta blocker prescribed at discharge | X | ||||||||||
| Fibrinolytic medication received within 30 minutes of hospital arrival (For HOP QDRP, applies to emergency department transfers) | X | X | |||||||||
| Emergency department transfer: median time to fibrinolysis | X | ||||||||||
| PCI received within 120 minutes of hospital arrival | X | ||||||||||
| Emergency department transfer: median time to transfer for primary PCI | X | ||||||||||
| Emergency department transfer: median time to electrocardiogram | X | ||||||||||
| 30-day AMI mortality | X | ||||||||||
| Perioperative/Surgical Care | |||||||||||
| Timing of antibiotic prophylaxis-ordering physician | X | ||||||||||
| Timing of administration of prophylactic antibiotic for surgical patients | X | X | X | ||||||||
| Prophylactic antibiotic selection for surgical patients | X | X | X | ||||||||
| Prophylactic antibiotics discontinued within 24 hours after surgery end time: (For PQRI separated into cardiac and non-cardiac procedures) | X | X
(2 measures) |
|||||||||
| Surgery patients with recommended venous thromboembolism prophylaxis ordered | X | X | |||||||||
| Surgery patients with recommended venous thromboembolism prophylaxis received within 24 hours prior to or after surgery | X | ||||||||||
| Cardiac patients with controlled 6 am post-operative serum glucose | X | ||||||||||
| Surgery patients with appropriate hair removal | X | ||||||||||
| Surgery patients on a beta blocker prior to arrival who received a beta blocker during the perioperative period | X | ||||||||||
| Death among surgical patients with treatable serious complications | X | ||||||||||
| Postoperative wound dehiscence | X | ||||||||||
| Mortality for selected surgical procedures (composite) | X | ||||||||||
| Urinary Incontinence (UI) | |||||||||||
| Assessment of presence or absence of UI in women aged 65 years and older | X | ||||||||||
| Characterization of UI in women aged 65 years and older | X | ||||||||||
| Plan of care for women aged 65 years and older | X | ||||||||||
| Improvement in urinary incontinence | X | ||||||||||
| Residents who have had a catheter inserted and left in their bladder | X | ||||||||||
| Conditions Addressed by Two Reporting Programs | |||||||||||
| Community Acquired Bacterial Pneumonia (PN) | |||||||||||
| Oxygenation assessment | X | ||||||||||
| Blood culture performed in the emergency department before the first antibiotic received in hospital | X | ||||||||||
| Appropriate initial antibiotic selection | X | X | |||||||||
| Initial antibiotic received within 4 hours | X | ||||||||||
| Assessed and given pneumococcal vaccination | X | ||||||||||
| Assessed and given influenza vaccination | X | ||||||||||
| Vital signs | X | ||||||||||
| Assessment of mental status | X | ||||||||||
| Adult smoking cessation advice/counseling | X | ||||||||||
| 30-day PN mortality | X | ||||||||||
| Depression | |||||||||||
| Antidepressant medication during acute phase for patients with new episode of major depression | X | ||||||||||
| Patients who have major depression disorder who meet DSM IV criteria | X | ||||||||||
| Assessed for suicide risk | X | ||||||||||
| Residents who are more depressed or anxious | X | ||||||||||
| ESRD | |||||||||||
| Plan of care for inadequate peritoneal dialysis | X | ||||||||||
| Vascular access for patients undergoing hemodialysis | X | ||||||||||
| Influenza vaccination | X | ||||||||||
| Plan of care for inadequate hemodialysis | X | ||||||||||
| Adequacy of hemodialysis (pediatric) | X | ||||||||||
| Influenza vaccination (pediatric) | X | ||||||||||
| Anemia control | X | ||||||||||
| Hemodialysis adequacy | X | ||||||||||
| Patient survival | X | ||||||||||
| Heart Failure - (HF) | |||||||||||
| Left ventricular function assessment | X | ||||||||||
| ACE-I or ARB for LVSD | X | X | |||||||||
| Beta blocker therapy for LVSD | X | ||||||||||
| Adult smoking cessation advice/counseling | X | ||||||||||
| Discharge instructions | X | ||||||||||
| 30-day HF mortality | X | ||||||||||
| 30-day HF readmission | X | ||||||||||
| Pain | |||||||||||
| Improvement in pain interfering with activity | X | ||||||||||
| Residents who had moderate to severe pain | X | ||||||||||
| Prevention/Screening | |||||||||||
| Medication reconciliation after discharge from inpatient setting | X | ||||||||||
| Advance care plan | X | ||||||||||
| Influenza vaccination for patients > 50 (for SNF measure: residents during flu season) | X | X | |||||||||
| Pneumonia vaccination for patients > 65 (for SNF measure: residents assessed and given vaccination) | X | X | |||||||||
| Screening mammography | X | ||||||||||
| Colorectal cancer screening | X | ||||||||||
| Inquiry regarding tobacco use | X | ||||||||||
| Advising smokers to quit | X | ||||||||||
| Universal weight screening and follow-up | X | ||||||||||
| Universal documentation and verification of current medications in the medical record | X | ||||||||||
| Pain assessment prior to initiation of patient treatment | X | ||||||||||
| Screening for clinical depression | X | ||||||||||
| Screening and brief counseling for alcohol abuse | X | ||||||||||
| Endoscopy and polyp surveillance | X | ||||||||||
| Elder maltreatment screen with follow-up plan | X | ||||||||||
* Includes measures that will be reported in 2009.
In recent years, in an effort to assure quality health care, CMS has implemented performance measurement programs for six health care settings: hospital inpatient, hospital outpatient, physician services, skilled nursing facilities, home health care agencies, and dialysis facilities, that include a mixture of financial (for reporting) and non-financial (public reporting) incentives. Collectively, these programs include 249 measures that cover a broad array of measure types and clinical areas. The alignment of these programs, however, is relatively limited. Only ten clinical conditions are addressed by more than one reporting program, and seven of these are addressed by only two programs. The conditions addressed by more than one program have very little overlap of the actual measures or very similar measures included in more than a single program. Thus, the current set of performance measures offer little opportunity to use the performance reporting programs to create joint accountability for the care delivered to patients. This could change, however, as additional measures are included in the programs, particularly if efforts are undertaken to increase alignment of measures across programs and to expand out measures within clinical conditions to address relevant care delivered in various settings.
In this chapter, we summarize our findings from a systematic review of the literature on the use and proposed use of episode-based approaches to payment, performance measurement, and accountability. We also present the results from our discussions with a small set of experts, where we explored issues related to constructing and using episodes of care for the purposes of performance measurement and accountability to better align financial and non-financial incentives to deliver high quality, efficient and coordinated care across an episode of illness or injury.
We organized our review and discussions around four questions:
We searched the databases PubMed, SSRN, EconLit, Sociological Abstracts, Business Practices and Management, and Conference Proceedings for articles published between January 1, 1985 and December 31, 2007. Search terms included episode AND payment OR reimbursement OR performance OR quality; bundl* AND payment OR reimbursement OR performance OR quality; episode AND attribution; bundl* AND attribution; virtual AND provider AND network; accountable AND organization AND payment OR quality; assign* AND responsibility AND physician OR provider; "physician-hospital organization"; "medical home"; "primary care" AND pay* AND responsibility. We added additional references from a previously conducted systematic review of health care efficiency measures, which use episodes of care as the unit of measurement (McGlynn et al., 2008). - We also searched the gray literature for related publications by organizations including CMS, the Medicare Payment Advisory Commission (MedPAC), the Commonwealth Fund, the NQF, and the Leapfrog Group. We performed reference mining by searching the bibliographies of retrieved publications for additional relevant publications.
The search terms yielded 465 total references. Of these, 63 were identified as potentially relevant through a screen of the abstracts. To be eligible for inclusion, a publication needed to discuss the use of episodes for performance measurement and/or payment, the attribution of responsibility for the episode of care, or grouping individual services into episodes. - During the abstraction, 26 additional publications were eliminated as either being off topic or not available even through interlibrary loan. An additional 23 publications were included through the search of the gray literature. In total, we reviewed 60 publications and summarize the findings in the sections that follow.
Current health care quality measurement efforts focus on assessing care for individual indicators of performance for a patient with a specific clinical condition or set of risk factors at discrete points in time (e.g., percent of patients with diabetes who received an HbA1c screening test or percent of women between the ages of 18-54 who received a pap smear). The measurement typically is directed at measuring the actions of a single type of provider, such as the physician or the hospital, and emphasizes assessing the provision of discrete services rather than the full spectrum of services within an episode for any given patient. There are a few cases, more recently, where providers are being held accountable for what percentage of their patient with a particular condition received all recommended services under what is referred to as an appropriate care composite measure, such as for a patient with diabetes (Health Partners, 2007), but again these measurement efforts are limited in scope to providers in a single setting and do not cut across the trajectory of care to involve multiple care settings.
The literature includes a number of proposals for episode-based quality measurement, but most of the proposals have not been tested or implemented. One prominent exception is the use of episodes for measurement of relative resource use, which has become increasingly common in recent years (McGlynn et al., 2008).The IOM has recommended episode-based performance measurement in two recent reports as an approach to address the clinical quality, cost, and outcomes of care (Institute of Medicine Committee on Redesigning Health Insurance Performance Measures, 2006; Institute of Medicine Committee on Redesigning Health Insurance Performance Measures, 2007). The IOM suggested that currently available point-in-time quality measures could be aggregated to the episode level to provide a composite assessment of the quality of care for that episode. An illustration is a Geisinger Health System program where patients undergoing CABG surgery are guaranteed to receive a set of 40 recommended processes of care (Casale et al., 2007). However, significant limitations exist in the number and types of measures for many clinical conditions, specialties and settings of care. Gaps identified by the IOM include transitions across care settings (e.g., hospital to long-term-care facility), patient outcomes over time (e.g., complications of chronic conditions), and measures of the oversupply of services (Institute of Medicine Committee on Redesigning Health Insurance Performance Measures, 2006). The gaps in measures vary by condition, provider type and setting. For example, many currently available diabetes-related measures could be applied to a one-year episode of diabetes care, but most hip fracture-related measures would apply to only the acute portion of the episode of hip fracture care. - -
The NQF is currently examining the joint measurement of quality and cost using episodes as the basis of assessment (National Quality Forum, 2007). In a preliminary report, the NQF recommended development of accountable care entities - either integrated providers or virtual groups - which would be held accountable for the quality and cost of episodes of care instead of individual providers. The NQF's work on how performance would be measured at the episode level is still in development.
MedPAC tested the feasibility of assigning quality indicators related to episodes of care to individual physicians (MedPAC, 2006). However, they did not explicitly perform the quality measurement at the episode level. The quality of care for patients with specific diagnoses was attributed to physicians, and resource use for episodes of care related to the same diagnoses were independently attributed to individual physicians. Both quality measures and resource use measures were attributed based on the number of E&M visits. Using an attribution threshold of 35 percent of E&M visits, the quality of care for 93 percent of patients was attributed to a physician (MedPAC, 2006).
In this section, we discuss ways that episodes have been used or proposed in the literature as the basis of payment, and how payment reform could be aligned with performance measurement. Episode-based performance measurement does not necessarily need to be linked to payment reform. For example, provider performance on episodes of care could be assessed, including both quality of care and relative resource use, and reported back to providers. Public reporting would add an additional incentive for improvement. However, most episode-based approaches discussed in the literature involve a financial incentive linked to performance on the episode.
Different types of financial incentives have been discussed in the literature, and we classified them into two groups based on how they were structured:
Retrospective adjustment of FFS payments would require smaller, incremental changes to current policy, whereas prospective payment approaches represent a larger reform. As discussed in the introduction, some proposals in the literature have included a phased or "building block" approach beginning with retrospective adjustment of FFS payments, which would require relatively minor changes to Medicare policy, then potentially moving towards a prospective payment approach (e.g., Wennberg et al., 2007).
One issue that surfaces when considering episode-based payments is how to divide a single episode of care payment, when multiple providers are involved in the management of the episode. Options discussed in the literature include allowing an entity that has been assigned accountability for the episode to determine their payment arrangements with other participating providers or paying each provider separately by dividing the payment according to a predetermined formula (e.g., based on current Medicare payment rates) (Davis and Guterman, 2007; Network for Regional Healthcare Improvement, 2007). According to proposals in the literature, the first method would provide greater incentives for coordination of care between providers, since they would need to develop formal arrangements with one another (Network for Regional Healthcare Improvement, 2007; Pham and Ginsburg, 2007). Providers could be encouraged to accept payment through an accountable entity through a bonus, with the option to accept lower, separate payments instead (Wennberg et al., 2007; O'Kane et al., 2008).
A broad variety of episode definitions have been used in practice or proposed in the health policy literature. Episodes could be constructed in a variety of ways, encompassing different parts of the continuum of care. Conceptually, health care services could be aggregated into episodes along two dimensions:
(1) Services related to a major inpatient procedure. This type of episode typically bundles together the inpatient and physician services payments related to a major procedure. We found four examples cited in the literature where this type of episode construction has been used for payment and in some cases for quality measurement for coronary artery bypass graft (CABG) surgery.
(2) Services Related to an Outpatient Procedure. In the Cataract Alternative Payment Demonstration, which operated 1993-1996, Medicare tested an episode-based payment for outpatient cataract surgery. The episode included physician and facility fees, intraocular lens costs, and selected pre- and postoperative tests. Payment rates were determined by competitive bidding. The response rate to the demonstration solicitation was very low (3.7 percent). Episode payment rates were negotiated with three participating providers; the payment rates were modestly discounted from non-demonstration payment rates for the same services (2 to 5 percent discount). Patient-level clinical and utilization data were collected using checklists. There was no evidence that service utilization decreased among participating providers during the demonstration compared to a baseline pre-demonstration period. There was also no impact on patient outcomes (e.g., visual acuity, post-operative complications) that could be attributed to the demonstration.
The evaluation contractor, Abt Associates, concluded that the demonstration was a success in meeting its objectives including allowing provider flexibility in managing bundled services, creating incentives for cost-effectiveness, reducing government involvement in pricing services through competitive bidding, and providing insight into quality assurance (Abt Associates Inc., 1997). However, the potential for producing savings while maintaining or improving the quality of care for an episode of cataract surgery was limited, as evidenced by the low participation rate, strong opposition to the demonstration from organized medicine, the low level of savings produced compared to the Participating Heart Bypass Center Demonstration, and the lack of impact on utilization or patient outcomes. These results may have been due in part to declining Medicare cataract surgery payment rates in the years preceding the demonstration, and the low cost of cataract surgery compared to CABG (Abt Associates Inc., 1997). These findings suggest that the potential for achieving the goals of episode-based payment and performance measurement may vary widely between types of episodes.
(3) Contact Capitation for Specialists. In the 1990s, several descriptions were published of "contact capitation" payment arrangements between managed care organizations and specialists in group practices. This episode definition, used for payment, included specialist physician services related to treatment of a particular condition, and in some cases hospital and/or ancillary services (Frank and Roeder, 1999). This type of episode begins with the referral to the specialist and ends after a specified time or clinical endpoint. This method differs from simple capitation in that payment is only triggered if the referral is made (episode begins) and that the provider is only at risk for patients being actively treated for a given condition ("technical risk"). Under simple capitation, the accountable provider assumes the health risks of the defined practice population ("probability risk"). Under contact capitation, the insurer retains the probability risk, but the provider assumes the technical risk for the care episode. This payment arrangement was found to be common among large Independent Practice Associations (IPAs) in the late 1990s (Robinson, 1999). However, the system proved to be administratively complex because of the need for new billing systems that were able to link related services together, and differentiating the bundled services from others that would be paid on a FFS basis (Frank and Roeder, 1999). The literature reviewed did not include any descriptions of quality measurement tied to contact capitation.
(1) Services Related to a Hospitalization. Several proposals in the literature have focused on constructing episodes of care related to a hospitalization. The earlier proposals, starting before the implementation of IPPS, focused on payment only. More recently, the proposals have also included a focus on performance measurement. Under current Medicare payment policy, the hospital facility payment covers the hospital's expenditures related to an admission, including hospital-based labor such as nurses, technicians, and housekeeping, laboratory tests, imaging, administration, and capital. The payments are adjusted for service intensity using diagnosis-related groups (DRGs). Outpatient hospital services related to the hospitalization delivered in the three days pre-hospitalization are also bundled into the hospital payment. However, physician services are paid separately, as are all post-discharge services. Medicare measures hospital-level quality indicators, covering the time period of the hospitalization only, through the Hospital Quality Initiative. Here we describe the various alternative bundling approaches that have been proposed, starting with the earliest proposals and concluding with the options most recently considered by MedPAC.
(2) Preventive Care and Primary Care Episodes. Several recent articles included proposals to create episodes of care covering preventive care or primary care only, with specialty physician care, hospital care, ancillaries, etc. excluded, with the episode capturing up to a year of time. This episode definition has been proposed as a unit for payment and performance measurement for primary care physicians, under which payment levels would be increased over current levels to cover additional coordination activities (Goroll et al., 2007; Network for Regional Healthcare Improvement, 2007; Pham and Ginsburg, 2007 ; Bodenheimer, 2008). To qualify for the payment, providers may be required to demonstrate that they meet criteria for an "advanced medical home" (Bodenheimer, 2008).
(3) Chronic Care Episodes. Several articles proposed bundling together services related to the management of chronic conditions, including services provided by the physician managing the condition and possibly diagnostic tests, with general primary care physician services, specialists, hospital care, long-term care, etc. paid separately (Berenson, 2007; Davis and Guterman, 2007; Network for Regional Healthcare Improvement 2007) . If the chronic condition is managed by a specialist physician, this definition would be very similar to contact capitation. An existing example is the Medicare payment of physicians for management of end-stage renal disease (ESRD). Medicare pays a monthly capitation payment to nephrologists who manage ESRD patients, including assessments and planning, monitoring of tests and dialysis, and managing anemia and other secondary conditions (Leavitt, 2008). Any care provided by the primary care provider or other specialists (e.g. cardiologist) is paid for separately, as is a hospitalization for a complication of dialysis.
(4) Broader Definitions of Episodes. Several articles have proposed using broader definitions of episodes of care to bundle together all services related to a particular condition for the purposes of performance measurement and / or payment (U. S. Office of Technology Assessment, 1986; Davis and Guterman, 2007; Pham and Ginsburg, 2007) .
One issue in defining these broader episodes is to accurately divide a patient's care into these episodes. For example, a patient with both CAD and diabetes could have a blood test. To which of the two episodes, CAD or diabetes, should that blood test be assigned? Two proprietary episode "grouper" software programs (ETG and MEGS) that bundle claims into episodes based on procedure and/or diagnosis codes have become increasingly popular. However, a recent review found little published literature on the clinical validity of the groupers (McGlynn et al., 2008). CMS has funded a study to study the clinical validity but the study is still ongoing.
Most of the work using these proprietary episode groupers has focused on profiling physicians on their resource use. One study compared Symmetry's Episode Treatment Groups (ETGs), Thomson-Medstat's Medical Episode Groups (MEGs), plus four other groupers for consistency and found "moderate to high" agreement between physician efficiency rankings using the various measures (Thomas et al., 2004). MedPAC has tested ETGs and MEGs on Medicare claims data and recommended using them to provide physicians with reports on resource use as a means to lower use of resources and costs within the Medicare program (MedPAC, 2006). MedPAC's analyses focused on the feasibility of application of the groupers using Medicare data, finding that most Medicare claims could be assigned to episodes, most episodes assigned to physicians, and outliers could be identified. However, each of these steps was sensitive to specifications used. The two groupers were fairly consistent on these measures.
MedPAC has found that costs per episode varied widely for some types of episodes; for example, congestive heart failure and diabetes had twice the cost per episode for ETGs compared to MEGs, highlighting the different approaches to creating episodes taken by the two commercial groupers. Comparing variation in costs between geographic areas, MedPAC found that using episodes as the unit of analyses (for some episode types) versus annual per-capita costs yielded different results ( MedPAC, 2006). A qualitative analysis of the use of episode groupers by private health plans for resource use reporting revealed many technical challenges with implementation (Lake et al., 2007). The technical issues included small episode sample size; difficulty in identifying physicians accurately and consistently using claims identifiers; difficulty aggregating data to practice-level indicators; difficulty in determining which specialties should be held responsible for which episodes; and difficulty in establishing the appropriate comparison groups (Lake et al., 2007).
(5) Prometheus Payment. An alternative method for defining episodes has been proposed for use in the Prometheus Payment program, and this approach also considers using a building block approach to episode construction with each building block seen as a smaller, self-contained episode. - The program proposes to develop an evidence-informed case rate (ECR), which would be a single, risk-adjusted, prospective (or retrospective) payment given to providers across inpatient and outpatient settings to care for a patient diagnosed with a specific condition--in effect the defined "episode" under this model. Payment amounts would be based on the resources required to provide care as recommended in well-accepted clinical guidelines. This model calls for a portion of the payment to be withheld and re-distributed based on provider performance on measures of clinical process, outcomes of care, and patient experience with care received. Ten conditions have been chosen for initial development.[28] Some portion of the payment would be bonuses for quality performance using process, outcomes, and patient experience measures (de Brantes and Camillus, 2007). The data sources include both clinical data and claims analysis.
A broad variety of episode definitions have been used or proposed. The greatest amount of activity has focused on developing episodes related to a hospitalization. This type of episode has been discussed mainly in terms of payment applications, although recent examples, such as Geisinger's CABG episode, explicitly include the quality of the care provided during the episode. Proprietary episode groupers are commonly used to define broad episodes of care used for resource use measurement. Other types of episodes definitions, such as outpatient procedure episodes or chronic condition episodes, have been used in limited applications of payment and/or performance measurement applications.
A critical issue within performance measurement is assigning responsibility (also called "attribution") for the services or set of services that are or are not provided to a beneficiary. How an episode is constructed, as illustrated by the building block approach, and then used (e.g., resource use profiling, pay for performance, larger payment and performance measurement reform), implies different issues related to attribution.
An episode-based approach that cuts across the continuum of care would require that accountability for the episode is assigned to an entity or group of entities. The accountable entities would then assume the responsibility for the quality and resource use for a range of services provided during the episode. The accountability could be reinforced in a range of ways, including measurement and reporting of performance and resource use for episodes of care; financial incentives for performance and resource use for episodes of care, or at the extreme, episode-based payment adjusted for performance. In reviewing the literature, we sought to understand how attribution has been addressed either in practice or in concept within the area of performance measurement, as a means to inform the implications of different types of episode constructions and applications.
Our review of the published literature on assignment of accountability for an episode of care revealed two distinct approaches that have been used or proposed for use to assign responsibility:
The main distinction between these two approaches is that under prospective assignment, providers and patients are aware of the accountability before services are delivered, whereas under retrospective assignment accountability is assigned after care is delivered. Prospective assignment of accountability would likely be necessary for prospective payment approaches (the extreme end of the spectrum in the "building block" approach to reform). The retrospective or prospective method for assigning accountability could be used for any of the other approaches discussed.
The entities with accountability can be individual providers, integrated provider organizations, or "virtual groups" - that is, a group of independent providers that create a relationship for the purposes of coordination across the episode of care. Prospective designation allows for some choice by physicians and patients about which providers should be responsible for which patients' episodes of care (Davis, 2007; Pham et al., 2007), but it also creates the possibility of risk selection by incentivizing providers to assume accountability for healthier, more-profitable patients. Several methods for retrospective attribution have been proposed in the literature and are described below.
(1) Individual physician(s). The accountable physician(s) could be identified retrospectively through analysis of claims data, although current provider identifiers imperfectly identify individual physicians and their practice specialty.[29] Commonly proposed criteria include a count of Evaluation and Management (E&M) visits or costs, physician specialty type, or some combination thereof (Cheryl Damberg, personal communication, 8/6/2008).
One study examined attribution for a year of care for Medicare beneficiaries to individual physicians (Pham et al., 2007). The major finding was that dispersion of care among multiple providers made retrospective attribution of accountability difficult. Although the study focused on retrospective assignment of accountability, the dispersion of care observed would also likely prevent physicians from prospectively claiming responsibility for patients who receive much of their care from other physicians. - Four assignment algorithms were tested, mirroring assignment methods currently used in pay-for-performance programs. The four algorithms tested were:
Table 6 summarizes the results of application of these four assignment algorithms. The percentage of all beneficiaries with at least one E&M visit who were assigned to beneficiaries ranged from a low of 65 percent (majority provider algorithm) to a high of 97 percent (multiple provider algorithm). For all four algorithms, on average most Medicare patients a physician treated in a year were not assigned to that physician. That is, most beneficiaries in a physician's practice population received a minority of their E&M services from that physician. This was particularly true for specialists. Under the plurality provider algorithm, which assigns patients to either specialists or generalists, primary care physicians were assigned 39 percent of the beneficiaries for whom they provided services, while specialists were assigned only 6 percent of the beneficiaries they treated. (The study did not test algorithms based on costs rather than visit counts, which would be expected to assign more beneficiaries to specialists.) Care was highly dispersed: under the plurality provider algorithm, in one year the typical beneficiary saw two primary care physicians and five specialists, collectively from four different practices. Higher dispersion of care among physicians was found for patients with more chronic conditions. Many patients also changed physicians year-to-year (based on claims analysis) under all four algorithms.
| Assignment Algorithm | % of Beneficiaries Assigned to a Physician | % of Physician's Patients Assigned to that Physician | % of Beneficiaries Changing Assignment Year-to-Year |
|---|---|---|---|
| (1) Plurality provider | 94 | 12 | 31 |
| (2) Plurality primary care physician | 79 | 47 | 20 |
| (3) Majority provider | 65 | 7 | 37 |
| (4) Multiple provider | 97 | 25 | 27 |
Pham et al. conclude that the dispersion of care observed make it difficult to hold individual physicians accountable for a year of patient care. Episodes of care may be more highly concentrated among physicians, making attribution of accountability for an episode more feasible than for an entire year of care. However, the results also indicate that attribution is very sensitive to the algorithm used, and that each approach likely involves tradeoffs between a number of criteria that may be important.
A RAND study examined the effects of 13 different retrospective attribution rules, in an application where the Symmetry ETG tool was used to construct resource use measures using commercial data from four health plans in Massachusetts (Mehrotra et al., 2007). The 13 rules assignment rules differed on characteristics such as the basis of assignment (e.g. costs versus visits) and whether the episode was assigned to only one or multiple physicians. This study found both significant variation in the fraction of episodes that could be assigned to a physician and also the level of agreement in which physician was held responsible. For example, comparing the results of two different rules found that 50 percent of the episodes were assigned to different physicians. The results demonstrate that different assignment methods can lead to substantially different results on various criteria.
MedPAC conducted several similar analyses, testing assignment of accountability for episodes of care, measured using ETGs and MEGs, to individual physicians. They found that most episodes could be assigned to individual physicians using a threshold of 35 percent of E&M visits. They also explored attribution to multiple providers, but found that few episodes had more than one physician providing more than 35 percent of E&M visits (MedPAC, 2006; MedPAC, 2007d). Some specialties saw a broad range of types of episodes, while other specialties mainly saw a small number of episode types (MedPAC, 2007d).
(2) Individual physician – hospital care only. A variant on assignment of accountability to an individual physician is assignment of services provided during a hospital stay to the attending physician. This model was tested in the study of Physician DRGs mandated by Congress with the implementation of IPPS (Jencks and Dobson, 1985; Mitchell, 1985; Mitchell et al., 1987; Welch, 1989) . The analysis showed that spending on physician services for surgical cases was relatively homogeneous, but that spending for medical cases varied widely. Thus, assignment of responsibility for hospital-based physician services to individual attending physicians would be likely to cause substantial financial risk for the attending physician (Mitchell, 1985; Welch, 1989) . This finding was one of the major reasons that Physician DRGs were not considered further. Subsequent proposals and analyses focused on spreading the financial risk more broadly.
(3) Hospitals. Another attribution approach that has been proposed is to hold hospitals accountable for episodes of care that include a hospitalization in addition to physician services and/or services from other providers, such as skilled nursing facilities (Jencks and Dobson, 1985; Welch, 1989) . One issue that has been raised with this approach is that hospitals may not be able to influence physician and/or post-acute provider care provision (Welch, 1989). One solution that has been tested is gainsharing, which is a payment arrangement by which hospitals incentivize physicians (Wilensky et al., 2006). However, there are several legal restrictions against gainsharing (Wilensky et al., 2006). These regulations are motivated by a concern about the incentives created for skimping on care, selection of healthy patients, and kickbacks from hospitals to physicians for referrals. MedPAC recommended loosening the restrictions against gainsharing given appropriate safeguards for these concerns (MedPAC, 2007). CMS is planning two gainsharing-related demonstrations, the Medicare Hospital Gainsharing Demonstration and the Physician Hospital Collaboration Demonstration (Wilensky et al., 2006).
(4) Integrated Delivery Systems and Physician Group Practices. Existing integrated provider organizations are likely to have the greatest ability to assume responsibility for episodes of care because of the defined relationships between providers (Davis and Guterman, 2007; MedPAC, 2007a; MedPAC, 2007b; MedPAC, 2007c) . For example, integration was considered key to successful implementation of CABG bundling at Geisinger (Casale et al., 2007; Lee, 2007). Examples of integrated organizations with both hospitals and physicians include physician-led multispecialty group practices that also own hospital(s) (e.g., Mayo Clinic, Virginia Mason); hospitals that own physician groups (e.g., Intermountain Healthcare); or physician-hospital organizations (e.g., Advocate Health Partners; these have declined since late 1990s) (Cortese and Smoldt, 2007). However, there are several obstacles to attributing accountability for episodes of care primarily to integrated provider organizations. First, patients have the option to use services outside of the integrated provider organization, limiting control over the episode of care. Second, most physicians are organized in solo or small single-specialty practices, not integrated organizations or large groups (Pham and Ginsburg, 2007). Finally, Medicare currently does not recognize these integrated entities as a provider class eligible for payment (Davis and Guterman, 2007).
(5) Hospital medical staff. This model would assign accountability for acute care episodes to the entire medical staff of a hospital (holding the hospital accountable as well). In most proposals, the medical staff would be defined to comprise both hospital-based physicians such as pathologists and community-based physicians who see patients in the hospital. Since most medical staffs are not true legal organizations, they would have to form new legal entities in order to receive payment, including a performance-based bonus (Jencks and Dobson, 1985; Welch, 1989; Davis and Guterman, 2007) . This would essentially form a multispecialty group practice associated with a hospital (Fisher et al., 2006).
The concept of assigning accountability to a medical staff was initially tested in the context of payment reform after the initial Physician DRG concept - attribution to the attending physician - was defeated (Mitchell et al., 1987; Mitchell and Ellis, 1992) . These claims data analyses showed that paying a medical staff for physician services delivered during hospitalizations involved a more acceptable level of financial risk than paying individual physicians. The concept was then analyzed using claims data as a possible replacement for the Volume Performance Standard (Miller and Welch, 1992). The Volume Performance Standard was meant to control physician spending by linking annual fee schedule updates to the rate of increase in service volume. However, by measuring volume at the national level, the incentive for individual physicians was weak. Creating an equivalent arrangement at a smaller measurement unit, such as the hospital medical staff, would strengthen the incentive. Physician fees would be adjusted based on medical staff resource use in the prior year, so that different hospital staffs would have different payment rates. Neither of these studies explicitly examined quality measurement.
Elliott Fisher and colleagues have tested the feasibility of defining hospital medical staffs, which they call Accountable Care Organizations (ACOs), empirically using insurance claims data (Fisher et al., 2006; Bynum et al., 2007) . The ACOs were designed with the intent to hold them accountable for both quality and resource use. Beneficiaries were assigned to physicians and then through the physicians to hospitals based on service use in a defined time period. Beneficiaries were linked to the physician who was the generalist or medical subspecialist providing the plurality of their ambulatory care visits in a two-year period (the authors did not test how often the assigned physician changed over time). Physicians were assigned to a hospital based on the number of patients for whom they had submitted Part B claims or the number of hospital claims for which they were listed as attending or operating physician during hospitalization. If both of these values were zero, assignment was based on where the patients they treated were hospitalized. Using this method, 94 percent of physicians were assigned to a hospital. One-third of physicians bill at multiple hospitals, but typically provide the majority of their care at one hospital. On average, two-thirds of medical admissions and physician billing for patients were provided by the assigned hospital and medical staff (Bynum et al., 2007) . Tests were favorable for face, discriminant, and predictive validity of assignment (Bynum et al., 2007) . The advantages cited for using ACOs for accountability (compared to individual providers) include larger sample size (98 percent of physicians were assigned to ACOs serving more than 500 Medicare beneficiaries), broader scope of potential performance measures (e.g., measures of the fragmentation of care), and feasibility of including all contributing physicians within the measurement frame. The most important reason for using ACOs as the level of accountability, in the authors' view, is to establish accountability for local decisions about capacity, which drives utilization. In addition, hospitals and extended staffs would have greater incentive to invest in care management and coordination (Fisher et al., 2006). While developed with the intent of assigning a beneficiary to an ACO, the approach could also be used to assign episodes to ACOs and the research has been used as a basis for discussion of episodes by MedPAC in 2007 Commissioners meetings (MedPAC, 2007a; MedPAC, 2007b; MedPAC, 2007c) .
If the medical staff received payments, the organization would then need a process to allocate payment to individual physicians (Miller and Welch, 1992). One model could be contact capitation, where budgets were allocated to departments based on historical costs and then departments paid individual physicians based on productivity (Robinson, 1999). However, if the episode included a significant pre- or post-hospitalization window, it is possible that some physicians providing care would be geographically distant from the hospital (MedPAC, 2007c), which would require the development of alternative methods of payment allocation and performance accountability.
Since the hospital medical staff model uses "virtual" groups as the accountable entities, a significant barrier is the lack of integration between group members. In recent years, relations between physicians and hospitals have become increasingly strained (Fisher et al., 2006; Berenson et al., 2007) . This tension will likely be a significant barrier to holding hospitals and physicians jointly accountable for episodes of care (Pham and Ginsburg, 2007). On the other hand, it is possible that holding hospitals and medical staff jointly accountable for episodes of care could encourage physician-hospital collaboration.
(6) Other Virtual Groups. Some authors have raised the possibility of using other "virtual groups" defined by geographic areas or other characteristics (Davis and Guterman, 2007). No detailed proposals have been made, however.
Accountability for an episode of care could be claimed by a provider prospectively or assigned retrospectively. Approaches that have been tested in the literature include assignment to individual physicians, hospitals, hospital medical staffs, integrated delivery systems, and physician group practices. The majority of attribution approaches that have been tested have focused on attribution to a single entity, although several approaches to joint assignment to multiple providers have been tested. Different assignment methods that have been tested have lead to widely different results on various criteria.
Most proposals in the literature acknowledge the need to risk-adjust episodes of care for payment and some types of performance measurement, particularly for outcome measures, but little detail on specific risk-adjusters is usually provided. Some articles stated that when the focus is on cost/resource use, it is appropriate to use adjusters that explain variation in the time and costs of services provided instead of health outcomes (Goroll et al., 2007; Network for Regional Healthcare Improvement, 2007) . This suggests that two separate sets of risk adjustment may be appropriate for joint assessment of episode quality and resource use.
Several existing risk-adjusters used in payment/resource use measurement could be applied to episodes of care. Inpatient hospital facility payments are currently adjusted using severity-adjusted diagnosis-related groups (MS-DRGs); these could potentially be used to risk-adjust other services bundled in with the inpatient stay. The episode groupers ETGs and MEGs include concurrent (i.e., based on the same time period covered by the episodes) episode-level severity and patient-level risk adjusters. However, one study found that risk scores for ETGs were essentially unrelated to episode costs (Thomas, 2006). On the contrary, another study found that risk adjustment increased explanatory power for costs for a different episode grouper, Common Treatment Categories (Brailer and Kroch, 1999). MedPAC found that when risk adjusters are applied, patients in higher risk categories have higher average per-episode costs (MedPAC, 2006). The IOM identified risk adjustment and its appropriate use as an area requiring additional research in its report Rewarding Provider Performance (Institute of Medicine Committee on Redesigning Health Insurance Performance Measures, 2007).
We held discussions with eight experts to explore issues related to constructing and using episodes of care for the purposes of performance measurement and to better align financial incentives to deliver high quality, efficient and coordinated care across an episode of illness or injury. - Because this area of work is largely in a conceptual state of development, experts were viewed as a key resource for investigating the policy issues of interest, absent published work in this area. The experts were individuals who had experience in one or more of the following areas: 1) constructing episodes of care; 2) using episodes of care for either performance measurement or payment; 3) issues of attribution and case mix adjustment; 4) provision of medical care.
Our discussions with the experts focused on the following topics:
Payment and performance measurement approaches
We asked the experts about a range of episode-based approaches to creating financial and non-financial incentives for performance and efficiency including public reporting/transparency, routine internal feedback for quality improvement, pay for performance, gainsharing between physicians and hospitals, and bundled payments. Many of the experts stated that while non-financial incentives such as public reporting and quality improvement may have some benefit, they believed that financial incentives would be much more effective in effecting change. Some went further to state that smaller financial incentives, such as pay-for-performance payments, would not be sufficient, and that bundled payment would be necessary to achieve significant results, although much more difficult to implement.
Regarding episode-based performance measurement applications, we asked about the adequacy of currently available quality measures - in particular, if the experts perceived problems around alignment of measures between providers and settings, and if they perceived significant gaps. Opinions were somewhat mixed on these issues. Some of the experts raised concerns about the robustness, alignment, and representativeness of currently available measures. They pointed to the numerous gaps in available measures, particularly in the areas of coordination and transitions of care. One expert raised a concern that quality measurement is too difficult to expect that it could be used for some purposes that have been proposed, such as ensuring that there was no skimping on care under bundled payment, where incentives for providing less care exist.
Other experts held the view that quality measurement could be improved for use in episode-based approaches. They pointed towards efforts by the NQF and others in developing measures addressing current gaps. They also described a need for new data collection systems. An example given by one expert is the Society for Thoracic Surgeons database, which includes voluntary submissions by members of clinical data for cardiac surgery patients. This database has allowed more-robust measurement of processes and outcomes for cardiac surgery than for other conditions, allowing for use in episode-based approaches such as the Geisinger heart bypass surgery program. The experts stated that something similar will be necessary for application of episode-based quality measurement to non-cardiac procedures. The adoption of electronic health records was one development that was raised as a possible source of additional clinical data.
Other experts expressed the view that currently available measures are adequate for some uses and that measure availability should not be a barrier to moving forward with episode-based approaches. One expert raised the example of bundled versus separate payments for hospitals and physicians for inpatient care. At the time the inpatient prospective payment system was implemented, many believed that separate payments were necessary in order to create different incentives for physicians and hospitals (physicians are paid FFS and have a financial incentive to provide additional services; hospitals are paid per-discharge and have an incentive to provide fewer services during a hospital stay). However, the expert now believes that quality measurement has now progressed to the point where it can provide a check against financial incentives for both hospitals and physicians to provide less care under bundled payment or gainsharing.
Definition of episodes
We asked experts for their views on the pros and cons of different episode definitions, with particular reference to three potential types of definitions under a building block approach (single setting, multiple types of providers in a single setting, and then across the continuum of Medicare settings). Most experts professed a strong preference for episodes that cut across multiple settings. The main benefit of episode-based approaches to these experts was to create change in the delivery system to reduce fragmentation of care. To these experts, episodes of care that cover only a single setting (e.g., physician and hospital services for inpatient care) do not do enough towards this goal (one expert went as far as to call single-setting approaches "useless"). On the other hand, several experts suggested a different approach: due to the challenges with conducting performance measurement or payment across settings, they suggested focusing on single-setting approaches first, such as gainsharing for physicians and hospitals for inpatient care. If these efforts were successful, the experts believed, they could be expanded to include multiple settings.
When asked about particular conditions or other types of episodes that would be good candidates for initial episode-based approaches, many experts pointed towards high-prevalence, high-cost conditions. The reasons given were that these conditions represented greater potential opportunity for cost-saving and greater volume, which would help balance the variability in content of episodes. Some experts also expressed a preference for starting with episodes that were more discrete (i.e., well-defined beginning and end points).
A particular concern that was flagged my many experts was how to approach complex patients with multiple chronic conditions, who represent a high proportion of Medicare costs. For these patients, experts expressed doubts about whether episodes focusing on each disease separately were appropriate since the patients may be managed more holistically. One expert raised the possibility that treatments for one chronic condition may contraindicate treatments for another, indicating that a more-holistic approach may be preferable to an episode-based approach. Alternative approaches that were raised by experts for complex patients with multiple conditions included medical homes or other arrangements where an organization accepted accountability for performance and a care coordination payment, capitation payment, or other payment for management of multiple conditions.
Attribution
We asked experts for their opinions on various approaches to attribution, including attribution to single versus multiple organizations, prospective versus retrospective attribution, and attribution to integrated versus virtual groups of providers. The area where the experts expressed the strongest opinions was on prospective versus retrospective attribution, where they had differences of opinion. Some experts strongly believed that providers would not "buy in" to episode-based approaches unless they had, at the outset, identified the patients/episodes for which they were accountable, similar to the Medicare Physician Group Practice demonstration model. One expert stated that providers were comfortable with this approach since this was consistent with how they viewed patient care - although they are currently paid per service, they don't tend to think in terms of individual services but rather from when a patient presents with a particular condition until the point where treatment stops. Other experts expressed a concern that very few providers were organized to be able to accept accountability for episodes, and that strong incentives would be required to drive them to organize themselves to do so. Some experts expressed doubts that many providers would voluntarily accept accountability for episodes. These experts favored identifying accountability retrospectively using empirical data, and pointed to studies such as those of "accountable care organizations" of a hospital and associated physicians by Fisher and colleagues as evidence that this approach would be feasible
On a related issue, attribution to real versus virtual groups of providers, there were also differences of opinion. Some experts favored beginning first with allowing integrated provider groups to accept accountability for episodes. Other experts expressed concerns that this would reward existing organizational structures, and that allowing for attribution to virtual groups would allow for more innovation in health care delivery.
Risk adjustment
Most of the experts believed that risk adjustment is very important to episode-based approaches. They pointed to risk adjustment as necessary in order to prevent risk selection by providers and/or insurers. One expert stated that even disregarding other benefits, risk adjustment was necessary to get provider buy-in to episode-based approaches.
However, many of the experts pointed to the difficulty of risk adjustment for care provided over the course of an episode of care, often in multiple settings. Some drew a distinction between risk adjustment models that predict costs, which are relatively well-developed, and models that predict outcomes, which are not well-developed. All of the risk-adjustment models currently in use were considered likely inadequate for use in episode-based approaches. For this reason, other methods for minimizing risk, such as special treatment of outliers, were identified as necessary by several experts.
Our review of the literature on approaches to episode-based payment and performance measurement found that a wide variety of approaches have been proposed, in some cases with a long history. However, relatively few of the proposed approaches have been implemented and remain largely conceptual in nature. Several approaches have been tested in limited applications in the private sector or Medicare demonstrations. For example, bundled payment for an acute episode of care, accompanied by performance measurement in some applications, has been tested in the Geisinger Health System, Texas Heart Institute, and Medicare Participating Heart Bypass Center Demonstration for CABG surgery. These tests have produced favorable results on the costs and quality of care. However, another approach, the Medicare Cataract Alternative Payment Demonstration, had less favorable results, suggesting that effects may vary for different types of episodes. Other episode-based approaches, such as those based on chronic or preventive care episodes, have been proposed frequently but implemented in very limited applications. Earlier proposals, such as Physician DRGs and RAP DRGs in the 1980s, focused on payment approaches, while more recent proposals focus more on performance measurement, as performance measurement methodology has progressed.
Based on the findings of the review, we conclude that the most commonly used episode-based approach is physician relative resource use measurement using broad episodes of care defined via commercial grouper software. The measures have been used in reports to providers, public reports, and P4P incentive programs. However, very limited evidence is available in the literature on the validity of these approaches, and they have recently faced several legal challenges (Lacewell, 2007; Massachusetts Medical Society, 2008). Many of the experts we interviewed expressed the opinion that while reporting and P4P may have some benefits, larger financial incentives will be necessary to drive meaningful change in the health care delivery system.
A central challenge in episode-based approaches is attribution of accountability to one or multiple providers. A variety of attribution methods have been tested, finding that the results of attribution are highly sensitive to the methods. Some episode-based approaches that have been implemented, such as the Medicare Participating Heart Bypass Demonstration, use prospective designation of accountability, whereby providers assume accountability for a patient population before care is delivered. Episode-based resource measurement, on the other hand, typically uses retrospective attribution to single providers based on utilization and/or costs.
Experts were split on the relative merits of these two approaches. Proponents of prospective designation argued that this approach is necessary for providers to feel "ownership" of an episode of care, while proponents of retrospective designation argued that it enables participation of a larger number of providers, many of whom are not highly integrated with other providers.
Overall, the findings of the literature review suggest episode-based approaches to performance measurement and payment hold promise for improving quality and efficiency through increased coordination over the continuum of care. However, significant methodological and administrative barriers remain to widespread implementation of these approaches.
This chapter summarizes our approach and findings from conducting quantitative analyses of episodes of care data generated from two commercially available episode grouper tools (i.e., Symmetry ETGs and Thomson MEGs). These analyses were intended to explore issues related to the construction and use of episodes of care for the purposes of performance measurement and aligning incentives to deliver high quality care. - We examined a set of episodes that were constructed using existing commercial episode grouper tools as a matter of convenience in an effort to explore a range of issues.[30]
The episode groupers utilize the primary diagnosis on claim line items to create and place the line items into episode. Thus, a condition consistently coded as a secondary diagnosis will not have its own episode. Only certain types of claims, as determined by procedure and revenue codes, can start an episode such as evaluation and management procedure codes, surgery procedure codes or specific inpatient facility revenue code. Ancillary claims, such as pharmacy and laboratory, and other services can be grouped into an existing episode, but do not start an episode. Each episode that does not represent a chronic condition has a "clean period" during which no claims for that condition can appear before a new episode of the same type can start. This clean period varies by specific episode. -
The goal of this project was not to critique the validity or applicability of existing grouper software tools, or to explicitly compare the tools, but rather to conduct a variety of exploratory analyses to illustrate the types of issues that would need to be considered if performance measurement or financial incentives were to be aligned around an episode of care, regardless of what tool (either de novo or existing) would be used to define an episode. Most of these issues we addressed would benefit from additional analyses to better understand the questions raised by these exploratory analyses.
In considering the findings contained in this report, readers should be aware that the results partly reflect the design features of the two commercially available grouper software tools that were used to construct episodes in this project. As such, other types of episode constructions could yield different results. Additionally, the variation in results observed across states may be an artifact of variations in coding practices in different regions and future work should attempt to understand the extent of variation in coding practices.
Our analyses focused on informing a number of overarching questions:
How much variation is there in the number of episodes, standardized payments for episodes, and the types and combinations of settings in which care was delivered?
To what extent does patient complexity, as assessed by the total number of episodes assigned to a beneficiary, influence what we observe?
What is the impact of various attribution rules, in terms of the percent of episodes that could be attributed to providers under each rule?
How much variation exists across the three states in the number and cost of episodes, the settings in which care was delivered, as well as how well various types of attribution rules worked?
Figure 1 provides a high-level illustration of the approach used in our analyses. The study population for this work consisted of Medicare FFS beneficiaries who were continuously enrolled in FFS Medicare Part A and Part B for 2004-2006, whose reason for eligibility was their age, and whose primary residence in 2005 was in one of three states: Florida, Oregon, or Texas. As a result of our inclusion criteria, we excluded beneficiaries enrolled in a Medicare Advantage plan for any of the analyses period. Claims data for the medical services received by individuals enrolled in a Medicare Advantage plan are not reported to Medicare, making it impossible to accurately create episodes of care for these individuals. We also excluded individuals who aged into Medicare over the time period of 2004-2006 or were eligible for Medicare due to end-stage renal disease. We did not exclude individuals who died during the time period as long as they met our other eligibility criteria.
The three states included in our analyses were selected in part because we sought states that 1) had a mix of urban and rural areas, 2) would facilitate an understanding of the issues associated with "snowbirds" who spend part of the year in a warm climate, and 3) had variation in the presence of long-term care hospitals to understand the effect their supply may have on the settings in which beneficiaries receive care. Furthermore, careful consideration was given to the geographic areas included in previous episodes of care work performed by MedPAC and Acumen, LLC (on behalf of CMS). -
We used three years of claims data (2004-2006) for the construction of episodes of care. This provides a year of data as the primary period of focus and allows looking forward and backward to complete the episodes. We used Medicare Standard Analytic Files for inpatient (including those for acute care hospitals, long-term care hospitals, critical access hospitals, and inpatient rehabilitation facilities), skilled nursing facility, outpatient, home health agency, carrier (non-institutional providers including physicians, physician assistants, clinical social workers, nurse practitioners, independent clinical laboratories, ambulance providers, and stand-alone ambulatory surgical centers), durable medical equipment and hospice to construct the episodes of care. This project utilized 100 percent of the claims for Medicare FFS beneficiaries who resided in the three states within the specified time frame of the analysis. Thus, we included all of the claims for these Medicare beneficiaries, even if they receive some of their health care services in other states.
Many of our analyses focused on individuals diagnosed with one or more of a subset of nine clinical conditions in order to better understand similarities and differences between different types of episodes for different types of patients. We sought a mix of acute and chronic conditions that make up a large portion of Medicare cases (i.e., volume) and/or costs. We define and refer to "acute" episodes as those that are time-limited in duration. An acute episode, as used in this report, does not refer to episodes that involve care provided solely in an inpatient acute care hospital setting, although a time-limited event such as a hip fracture episode would involve care in the inpatient hospital setting. Rather, an acute episode is one of short duration (e.g., sinusitis, heart attack, hip fracture), which may touch one or more settings of care including an inpatient acute care hospital.
We also tried to select clinical conditions that cover the spectrum types of conditions and services received by Medicare beneficiaries. For example, we selected a mix of clinical conditions such that some are treated predominantly in a single setting (e.g. ambulatory care) while others are treated in multiple settings including inpatient and post-acute care. To build on the work previously performed by MedPAC, we included some of the clinical conditions that were the focus of their analyses.[31] The following conditions are included in our analyses.
These nine clinical conditions were identified using primary and secondary ICD-9 diagnosis codes in 2005 Medicare claims data. For conditions that are part of the CMS Chronic Care Warehouse, we used the CMS definition. For other conditions, we used published definitions from the literature. Appendix A contains the specific codes and the sources of the codes for each of the above listed conditions.
ETGs and MEGs were run by Acumen, LLC on data for the entire study population (not just those with the above-mentioned clinical conditions) to produce summary statistics. Appendix B presents the specific settings Acumen used to run the analyses for this study.
For each condition, we designated episodes as being "related" or "unrelated" to the specific condition. Appendix C lists the specific episodes within each grouper tool that we considered directly related to the conditions of focus. - Some of the "unrelated" episodes reflect comorbid conditions that commonly co-occur with the condition of focus (e.g. hypertension was considered unrelated to acute myocardial infarction).
Basic descriptive analyses for each state and episode grouper provide a broad overview of the number of episodes comprised by care delivered to Medicare beneficiaries who reside in the three states. These analyses include such summary statistics such as the number of beneficiaries who are in the analytic sample, the number of created and complete episodes created, percentage of claims that cannot be assigned to episodes, average number of episodes per beneficiary, total Medicare payments represented by claims in the sample, and percentage of episodes and percentage of payments represented by conditions of focus.
Additional detailed analyses focus on the clinical conditions listed above. The analyses presented below examined the settings and number of providers that are included in episodes for each of the conditions to facilitate the exploration of issues around alignment of performance measurement and financial incentives across providers and settings. We investigated the other episodes commonly constructed for these beneficiaries to assist our understanding of the extent to which related care might not be captured in the episodes clearly related to the clinical conditions of focus (e.g. home health care after a hospitalization for congestive heart failure). We also explored a variety of attribution rules that could be used to assign accountability to an individual or multiple providers and types of providers.
Complex patients are a particular interest because a substantial fraction of Medicare beneficiaries have multiple chronic conditions. To facilitate our understanding of whether and how having multiple conditions affects the care received for an episode for the conditions of interest in this project (e.g. the costs of the episode, number of settings in which they receive care, the number of providers they see as part of the episode, and the number of other types of episodes experienced); we stratified many of the condition-specific analyses by the level of comorbidity experienced by patients. We used the total number of episodes experienced by a beneficiary to assess patient burden of comorbidity and created three levels of comorbidity: up to 5 episodes, 6-11 episodes, 12 or more episodes. In terms of the number of episodes experienced by our study population, these categories represent the lowest 25 percent, the middle 50 percent and the upper 25 percent. The condition-specific analyses were also stratified by state in order to examine the extent to which there are differences in episodes and their composition across the three states included in the analyses.
We begin our presentation by examining the results generated by ETGs and MEGs to provide a reader with a sense of their comparability. For the remainder of the chapter, our discussion focuses on the results generated by ETGs, as the MEGs results were not substantively different. The full set of results for both ETGs and MEGs are presented in the Appendix D.
To provide a sense of scale, Table 7 provides summary statistics on the number of Medicare beneficiaries residing in each of the three states in 2005 who were continuously enrolled in Medicare FFS, 2004-2006, the number of Medicare claims in 2005 for these beneficiaries and the total Medicare payments for these claims.
| State | # of Beneficiaries | # Medicare Claims in 2005 | FFS Medicare Payments for 2005 Claims | 2005 FFS Medicare Payments per Beneficiary |
|---|---|---|---|---|
| Florida | 1,682,031 | 58,532,070 | $14,096,159,338 | $8,380 |
| Oregon | 222,691 | 5,623,819 | $1,307,129,151 | $5,870 |
| Texas | 1,596,950 | 48,959,417 | $13,465,355,633 | $8,432 |
Table 8 presents for both ETGs and MEGs the percent of 2005 claims the grouper did not assign to an episode and what these unassigned claims translated into in terms of the percent of 2005 Medicare FFS payments that were not assigned to an episode. We also present the total number of episodes created by the two groupers for the continuously enrolled Medicare beneficiaries in our study population and the average number of episodes per continuously enrolled beneficiary. We then show the percent of all episodes that were identified as being related to the nine conditions of focus in this project and the percent of Medicare payments the episodes related to the nine conditions represented.
| State | % Claims Not Assigned to an Episode | % Payments Not Assigned to an Episode | # of Episodes of Any Type | Average Number of Episodes per Beneficiary | % of Episodes Related to Conditions of Focus | % of Medicare Payments for Episodes Related to Conditions of Focus | |
|---|---|---|---|---|---|---|---|
| ETGs | |||||||
| Florida | 9.6% | 5.2% | 12,773,401 | 8.0 | 13.1% | 34.7% | |
| Oregon | 10.8% | 4.5% | 1,252,148 | 6.1 | 14.2% | 34.0% | |
| Texas | 10.2% | 5.2% | 10,243,694 | 6.9 | 15.0% | 37.2% | |
| MEGs | |||||||
| Florida | 12.9% | 7.6% | 13,474,905 | 8.4 | 13.3% | 27.2% | |
| Oregon | 12.3% | 5.3% | 1,380,593 | 6.6 | 14.3% | 27.8% | |
| Texas | 12.5% | 5.5% | 11,018,315 | 7.3 | 14.8% | 31.2% | |
Both groupers assigned a high fraction of both claims and payments to an episode. Only approximately 10 percent and 12.5 percent of claims for ETGs and MEGs respectively were not assigned to an episode; these claims represented 4.5 percent to 7.6 percent of total Medicare payments made, depending on the state and specific grouper. The types of claims most frequently not assigned to an episode were durable medical equipment and laboratory tests. The vast majority of episodes created were deemed complete (approximately 97 percent for ETGs and 89 percent for MEGs). For purposes of this project an episode was deemed complete if it either began and ended in 2005 or began in 2004, with the necessary clean period for the specific episode observed, and ended in 2005.
A small portion of continuously enrolled Medicare FFS beneficiaries did not have any episodes, ranging from 4.2 percent ( Florida using MEGs) to 7.6 percent ( Oregon using ETGs). Most of these individuals did not have any claims. Individuals with at least one episode had an average of 6.1 ( Oregon) to 8.0 ( Florida) ETG episodes and 6.6 ( Oregon) to 8.4 ( Florida) MEG episodes. This variation in the number of episodes could partly be due to differences in practice styles across regions, which could trigger more episodes in one area than another. Another possibility is that the Medicare beneficiaries residing in Oregon may be healthier than those in Florida. The underlying reasons for variation in the number of episodes per enrollee is an area for future research.
Episodes identified as being related to the nine conditions of focus represented a relatively small portion of the total number of episodes (13.1 to 15.0 percent). They represented a substantially larger portion of Medicare payments, however, ranging from 27.2 percent to 37.2 percent of payments. While ETGs and MEGs captured very similar percentages of claims in episodes related to the conditions of focus, ETG episodes related to the conditions represented a larger portion of total Medicare payments than MEG episodes.
As stated in the overview of our analyses, we sought to focus on conditions that are common among Medicare beneficiaries. Table 9 presents the number and percent of continuously enrolled Medicare FFS beneficiaries identified as having each of the conditions of focus using both primary and secondary diagnoses that appeared in the 2005 claims data. The selected conditions were fairly common among the continuously enrolled beneficiaries, with between 0.8 percent (bacterial pneumonia) and 17.7 percent (diabetes) experiencing each of the conditions. Three of the conditions were experienced by more than 10 percent of the beneficiaries: COPD, congestive heart failure and diabetes.
| Condition | # of Continuously Enrolled FFS Beneficiaries with Condition | % of Continuously Enrolled FFS Beneficiaries with Condition |
|---|---|---|
| AMI | 37,464 | 1.1% |
| Bacterial Pneumonia | 28,617 | 0.8% |
| Breast Cancer | 55,129 | 1.6% |
| Cerebrovascular Disease | 129,271 | 3.7% |
| COPD | 364,691 | 10.4% |
| Congestive Heart Failure | 513,000 | 14.7% |
| Diabetes | 620,141 | 17.7% |
| Hip Fracture | 35,576 | 1.0% |
| Low Back Pain | 283,869 | 8.1% |
Back to List of Figures and Tables
While we used both primary and secondary diagnoses to identify the conditions of focus, the episode groupers use primary diagnoses on selected types of claims to trigger the creation of episodes.
Back to List of Figures and Tables
Back to List of Figures and Tables
The analyses presented in this section examine the extent to which there is variation in the average total payments per episode across the nine conditions and within episodes related to each of the nine conditions. These average payments have been standardized based on 2005 payment rates and payment policy to exclude variations in resource use due to geographic differences (e.g. wage adjustments) and policy considerations (e.g. payment to teaching hospitals). For example, for inpatient acute care hospitals stays, the base Medicare payment was multiplied by DRG weight for the DRG on the claim and adjusted for transfers and high-cost outliers. Thus, we did not include adjustments for area wages, IME payments or disproportionate share hospital (DSH) payments. Appendix D provides information on Medicare FFS payment policy in 2005 and the approach taken to standardize costs for each type of Medicare provider.
Back to List of Figures and Tables
Back to List of Figures and Tables
Back to List of Figures and Tables
Extent to Which Beneficiaries' Care is for Episodes Related to Conditions of Focus
Figures 9 and 10 show, on a per capita basis, how much of the care received by beneficiaries diagnosed with each of the nine conditions is for ETG episodes related to the condition.
Back to List of Figures and Tables
Back to List of Figures and Tables
Back to List of Figures and Tables
Back to List of Figures and Tables
To describe the unrelated episodes, Table 10 lists the average number of unrelated episodes for beneficiaries diagnosed with AMI, diabetes and hip fracture as well as the five most common unrelated episodes for each of the three conditions. Some of the unrelated episodes are very common across the three conditions, such as hypertension and fungal skin infection for ETGs, while for MEGs the commonalities were essential hypertension, and encounters for preventive health services.
| AMI | Diabetes | Hip Fracture | |||
|---|---|---|---|---|---|
| ETGs | |||||
| Average # unrelated episodes per beneficiary | 8.8 | 8.0 | 10.4 | ||
| 5 most common unrelated episodes: % of beneficiaries experiencing | |||||
| Hypertension | 63.1% | 65.6% | 67.3% | ||
| Congestive heart failure | 53.7% | Not in top 5 | 29.8% | ||
| Diabetes | 34.5% | Related to Diabetes | Not in top 5 | ||
| Cerebrovascular accident | 22.2% | Not in top 5 | Not in top 5 | ||
| Fungal skin infection | 17.0% | 19.3% | 26.8% | ||
| Ischemic heart disease | Related to AMI | 37.7% | 36.3% | ||
| Cataract | Not in top 5 | 27.3% | Not in top 5 | ||
| Hyperlipidemia | Not in top 5 | 23.2% | Not in top 5 | ||
| Infection of lower genitourinary system, not sexually transmitted | Not in top 5 | Not in top 5 | 26.7% | ||
| MEGs | Average # unrelated episodes per beneficiary | 8.1 | 7.5 | 8.6 | |
| 5 most common unrelated episodes: % of beneficiaries experiencing | |||||
| Coronary artery disease | 62.3% | 29.7% | Not in top 5 | ||
| Essential hypertension | 51.3% | 57.3% | 53.0% | ||
| Encounter for preventive health services | 32.4% | 44.5% | 33.7% | ||
| Congestive heart failure | 32.2% | Not in top 5 | Not in top 5 | ||
| Arrhythmias | 21.0% | Not in top 5 | 18.2% | ||
| Cataract | Not in top 5 | 22.4% | Not in top 5 | ||
| Other inflammations and infections of skin and subcutaneous tissue | Not in top 5 | 20.4% | 22.9% | ||
| Urinary tract infections | Not in top 5 | Not in top 5 | 18.9% | ||
The relatively small portion of care represented by the related episodes, together with the relative frequency of some of the unrelated episodes, suggests the complexities of defining what constitutes an episode of care and raises questions about how the tension between segmenting and "bundling" care could be balanced. Here we use beneficiaries diagnosed with AMI and the episodes created with ETGs to highlight this complexity and examine beneficiaries who experienced an AMI with the various combinations of vascular disease episodes of care shown in Figure 13.
We identified the ETGs' ischemic heart disease episodes as related to AMI diagnosis; no other ETG episodes were designated as related to AMI. Virtually all of the beneficiaries with a primary or secondary diagnosis of AMI in 2005 also had an ischemic heart disease episode. However, as shown in Table 11 below, only 13 percent of beneficiaries with AMI only had an ischemic heart disease episode (Patient 1). As shown in Table 9 above, 63 percent of the beneficiaries with AMI also had a hypertension episode. However, there were only 15 percent of beneficiaries with AMI who had only ischemic heart disease and hypertension episodes (Patient 2). As additional conditions that are prevalent in AMI patients are added, it represents a smaller, but still substantial portion of AMI patients. It is significant to note that as an AMI patient has additional vascular disease comorbidities that could "travel" together, not only are the total costs of caring for the patient affected, but the standardized payments for the ischemic heart disease episode increase substantially as well, as illustrated in the last row of Table 11.
| Episode Combinations | % of those Beneficiaries Diagnosed with AMI | Standardized Payments for Ischemic Heart Disease Episode (AMI-related Episode) | Total Standardized Payments for Beneficiaries with AMI |
|---|---|---|---|
| Patient 1: Only ischemic heart disease | 13% | $20,106 | $26,885 |
| Patient 2: Ischemic heart disease and hypertension | 15% | $21,834 | $32,696 |
| Patient 3: Ischemic heart disease, hypertension, and hyperlipidemia | 7% | $24,657 | $32,264 |
| Patient 4: Ischemic heart disease, hypertension, hyperlipidemia, cerebrovascular accident, congestive heart failure | 2% | $28,613 | $61,322 |
Medicare beneficiaries received care for episodes related to the nine conditions of focus from a wide variety of providers and in numerous settings. Figure 14 presents the median number of providers delivering services during episodes related to each of the nine conditions. Providers were categorized as primary care physicians (specialties of family practice, internal medicine, general practice, geriatrics and genecology), specialists (all other physician specialties), and other providers (e.g., physical therapists, dieticians). We present only the information from ETGs as that produced by MEGs was not substantively different.
Back to List of Figures and Tables
Across most of the nine conditions we examined, we observe a median of one primary care physician involved in the management of the episode. For episodes related to breast cancer and low back pain, more than half of episodes did not include any primary care physicians. Only episodes related to AMI had a median number of primary care type physicians involved that was more than one. Involvement of specialists varied more across the episodes related to the nine conditions, with AMI and hip fracture having the largest number of specialists involved (median of six and five, respectively), while episodes related to diabetes had the fewest (median less than one). Many of the episodes also involved other types of providers, most notably hip fracture (median of two). Larger numbers of providers involved in the treatment of an episode increases the likelihood that coordination challenges in the delivery of care will occur.
Back to List of Figures and Tables
The number of physicians providing services during an episode only provides a partial picture of the potential complexity of an episode. Patients may flow between various health care settings and provider types, as shown in Figure 16, and Medicare has different performance measurement programs and payment systems for separate settings. In Figure 17, we show the number of settings involved in ETG episodes related to each of the nine clinical conditions of focus. There are nine settings captured by Figure 17: physician ambulatory services (i.e. services provided in the community), ambulatory surgical centers, hospital outpatient (includes the physician services delivered in hospital outpatient departments), inpatient acute care (including physician services), long-term care hospitals, inpatient rehabilitation facilities, skilled nursing homes, home health and hospice. Durable medical equipment (DME) and outpatient laboratory services are not included as separate settings for this figure. While there are some substantive differences in these results by the two episodes groupers, we present here only the results of ETGs for the purpose of simplicity. The results for MEGs are presented in the tables in the appendices.
Back to List of Figures and Tables
The number of settings involved in episodes varied both within a condition and between conditions. For example, while approximately 50 percent of ETG episodes related to low back pain involved only one setting, more than 50 percent of episodes related to hip fracture involved four or more settings. For cerebrovascular disease, over 20 percent of episodes fell into each of our four categories. The fraction of episodes involving just one setting ranged from 4.0 percent of AMI-related episodes to 50.6 percent of low back pain episodes. At the other end of the spectrum, the number of episodes involving at least four settings ranged from 4.4 percent for diabetes to 57.3 percent of hip fracture episodes. The large number of settings involved in a substantial portion of these episodes creates a number of complexities for aligning either performance measurement or financial incentives.
Back to List of Figures and Tables
Figures 18-20 illustrate the different settings of care that patient with ETG episodes related to AMI, diabetes and hip fracture, respectively, "touch". Comparable information for the other conditions are provided in Appendix E. Also, in Appendix E we report the percentage of episodes related to the nine conditions for both groupers that involve each setting; these tables include DME and outpatient laboratories. In Figures 18-20, we categorize settings by ambulatory care (i.e. hospital outpatient, physician office, ambulatory surgical centers), acute inpatient care (hospital acute inpatient care), post-acute care (home health care, skilled nursing facilities, inpatient rehabilitation facilities, long-term care hospitals), and special populations (hospice). For each setting, we report in parentheses the percentage of episodes related to the condition that involve that setting. For example, 88.5 percent of episodes related to AMI involve the hospital outpatient setting (upper left portion of figure). As part of this analysis, we report the number of performance measures for the condition that are currently reported to Medicare for each setting below the percent of episodes involving the setting. We also report at the bottom of each figure the most common combinations of settings that occur in episodes related to the condition. We focus on combinations that occur in more than 10 percent of episodes. We use this information to assess the extent to which the measures reported to Medicare for the condition align with the settings in which the care for episodes related to the condition is delivered and identify gaps in existing measures.
In addition to the condition specific-measures that are currently reported to Medicare for each patient of the settings of care, we recognize that there may be other measures that are potentially relevant to patients with each condition. For example, there will be a subset of AMI patients that will have a CABG performed in the hospital during the episode of care related to their AMI. For these patients, the CABG measures as well as the perioperative/surgical care measures would be relevant. Therefore, we address measures for other conditions that are potentially relevant for the condition of focus (e.g. AMI). Additionally, there are SNF, home health and PQRI prevention/screening measures that are not condition-specific that may be particularly relevant to patients with our conditions of focus. We indicate those measures that clinical experts at RAND believe may have particular relevance for each of the conditions in Tables 14 and 15.
Other Potentially Relevant Measures. There are number of measures that may apply to subsets of AMI patients. These include CABG/Cardiac Surgery, Heart Failure, and Perioperative measures. Additionally the PQRI measures calling for an electrocardiogram for non-traumatic chest pain or syncope may apply to patients with episodes of care related to AMI.
Back to List of Figures and Tables
| Measure Condition | Measure | Hospital Inpatient |
Hospital Outpatient/ED | Physician |
|---|---|---|---|---|
| AMI | Aspirin at Arrival | X | X | X (inpatient)* |
| AMI | Aspirin at discharge | X | ||
| AMI | ACE-I or ARB for LVSD | X | ||
| AMI | Adult smoking cessation advice/counseling | X | ||
| AMI | Beta blocker at arrival | X | ||
| AMI | Beta blocker prescribed at discharge | X | ||
| AMI | Fibrinolytic medication received within 30
minutes of hospital arrival |
X | X | |
| AMI | PCI received within 120 minutes of hospital arrival | X | ||
| AMI | 30-day AMI mortality | X | ||
| AMI | Median time to fibrinolysis | X | ||
| AMI | Median time to electrocardiogram | X | ||
| AMI | Median time to transfer for primary PCI | X | ||
| CAD | Beta blocker therapy for patients with prior MI | X |
*This is a PQRI physician-level measure that would apply in a hospital setting
Nearly 90 percent of patients with an episode related to diabetes visited a physician office and 45 percent utilized the hospital outpatient department. Only 15 percent had an acute care hospitalization related to the episode. Additionally, 11 percent utilized home health care and 9 percent a skilled nursing facility. Only two combinations of settings each accounted for more than 10 percent of the episodes; these two combinations accounted for 67 percent of all diabetes-related episodes in our sample. The most common combination involved only physician ambulatory services (41 percent of episodes related to diabetes). There are currently 10 measures reported to CMS for the physician office setting where the majority of the care for diabetes episodes is taking place; these measures are presented in Table 13. The skilled nursing and home health measures are not condition specific and apply to all patients in those settings.
Other Potentially Relevant Measures. The PQRI measure for wound care for patients with venous ulcers is also potentially relevant for individuals with diabetes.
Back to List of Figures and Tables
| Measure Condition | Measure | Physician (Ambulatory) |
|---|---|---|
| Diabetes | Hemoglobin A1C poor control | X |
| Diabetes | LDL control | X |
| Diabetes | Blood pressure control | X |
| Diabetes | Dilated eye exam | X |
| Diabetes | Urine screening or medical attention for nephropathy | X |
| Diabetes | Foot exam | X |
| Diabetes | Foot and ankle care: neurological evaluation | X |
| Diabetes | Foot and ankle care: evaluation of footwear | X |
| Diabetic Retinopathy | Documentation of presence or absence of macular edema and level of severity of retinopathy | X |
| Diabetic Retinopathy | Communication with the physician managing ongoing diabetes care | X |
Over 90 percent of patients with an episode related to hip fracture utilized an acute care hospital, 85 percent utilized the hospital outpatient department (including the emergency department) and 65 percent visited a physician office related to the episode. Additionally, 56 percent utilized a skilled nursing facility, 40 percent home health care 18 percent inpatient rehabilitation. The three most common combinations of settings accounted for 41 percent of the hip fracture-related episodes in our sample. The most common combination of settings involved four settings (hospital acute inpatient, hospital outpatient, physician ambulatory services, and skilled nursing facility) and accounted for only 15.7 of episodes. There is currently only one condition-specific measure reported to CMS for hip fracture and that is for mortality in the acute care hospital setting. The skilled nursing and home health measures are not condition specific and apply to all patients in those settings.
Other Potentially Relevant Measures. As most patients who have a hip fracture will have surgery, the perioperative measures would apply as would the hospital inpatient Patient Safety Indicator for post operative wound dehiscence. Additionally, the PQRI osteoporosis measure calling for management following a fracture would likely apply.
Back to List of Figures and Tables
Non Condition-Specific Measures. The PQRI prevention/screening measures and the Home Health and SNF measures are not condition-specific and are intended to be applied to all Medicare beneficiaries receiving care in those settings. However, in Tables 14 and 15 we specify those measures that clinical experts at RAND determined to be the most applicable to the conditions of interest.
| Measures | AMI | Bacterial Pneumonia | Breast- Cancer | Cerebro-vascular | CHF | COPD | Diabetes | Hip Fracture | Low Back Pain |
|---|---|---|---|---|---|---|---|---|---|
| Medication reconciliation after discharge from inpatient setting | X | X | X | X | X | X | X | ||
| Advance care plan | X | X | X | X | |||||
| Influenza vaccination for patients > 50 | X | X | X | X | X | X | X | ||
| Pneumonia vaccination for patients > 65 | X | X | X | X | X | X | |||
| Screening mammography | X | ||||||||
| Colorectal cancer screening | |||||||||
| Inquiry regarding tobacco use | X | X | X | X | X | ||||
| Advising smokers to quit | X | X | X | X | X | ||||
| Universal weight screening and follow-up | X | X | X | X | |||||
| Universal documentation and verification of current medications in the medical record | X | X | X | X | X | X | |||
| Pain assessment prior to initiation of patient treatment | X | X | X | ||||||
| Screening for cognitive impairment | X | ||||||||
| Screening for clinical depression | X | X | X | ||||||
| Screening and brief counseling for alcohol abuse | |||||||||
| Endoscopy and polyp surveillance--interval in patients with history of adenomatous polyps | |||||||||
| Elder maltreatment screen with follow-up plan | X | X |
| Measures | AMI | Bacterial Pneumonia | Breast- Cancer | Cerebro-vascular | CHF | COPD | Diabetes | Hip Fracture | Low Back Pain | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNF | |||||||||||
| Long Stay: | |||||||||||
| Residents given influenza vaccination during the flu season | X | ||||||||||
| Residents assessed and given pneumococcal vaccination | X | ||||||||||
| Residents whose need for help with daily living activities has increased | X | X | |||||||||
| Residents who have moderate to severe pain | X | X | X | X | |||||||
| High risk residents who have pressure sores | All | ||||||||||
| Low risk residents who have pressure sores | All | ||||||||||
| Residents who were physically restrained | All | ||||||||||
| Residents who are more depressed or anxious | X | X | X | ||||||||
| Residents who lose control of their bowels or bladder | X | X | |||||||||
| Residents who have had a catheter inserted and left in their bladder | X | X | |||||||||
| Residents who spent most of their time in a bed or in a chair | X | X | X | X | |||||||
| Residents whose ability to move about and around their room got worse | X | X | X | X | |||||||
| Residents with a urinary tract infection | X | X | |||||||||
| Residents who lost too much weight | All | ||||||||||
| Short Stay: | |||||||||||
| Residents given influenza vaccination during the flu season | X | ||||||||||
| Residents assessed and given pneumococcal vaccination | X | ||||||||||
| Residents with delirium | All | ||||||||||
| Residents who had moderate to severe pain | X | X | X | X | |||||||
| Residents with pressure sores | All | ||||||||||
| Home Health | |||||||||||
| Improvement in ambulation/locomotion | X | X | X | X | |||||||
| Improvement in bathing | X | ||||||||||
| Improvement in transferring | X | X | |||||||||
| Improvement in management of oral medication | All | ||||||||||
| Improvement in pain interfering with activity | X | X | X | X | |||||||
| Improvement in dyspnea | X | X | |||||||||
| Improvement in urinary incontinence | X | X | |||||||||
| Improvement in the status of surgical wounds | X | ||||||||||
| Patients requiring acute care hospitalization | All | ||||||||||
| Patients requiring emergent care | All | ||||||||||
| Patients requiring emergent care for wound infections | X | X | |||||||||
| Patients discharged to the community | All | ||||||||||
The previous discussion of the settings involved in episodes of care highlighted the prominent position of hospital acute inpatient care for episodes related to AMI and hip fracture. While it is not surprising that multiple different physicians are involved in providing services during an episode, it would be easy to assume that acute inpatient care is provided in a single facility. However, this is not always the case, particularly for AMI patients. Seventeen percent of ETG episodes related to AMI involved more than one acute care hospital (table in Appendix E). This is likely due to patients being transferred from one hospital to another after they have been admitted or being readmitted during the course of the episode to a different hospital. This occurrence was much less frequently observed for the other conditions with less than two percent of episodes involving more than one acute care hospital.
Back to List of Figures and Tables
Attribution of Care to Providers
There is a wide array of attribution rules that can be used to assign episodes to providers of care. The rules can vary in terms of whether a single provider is assigned responsibility versus multiple providers being assigned responsibility. The particular types of services and the threshold used to allocate responsibility can also vary. The rules we used included some that used Evaluation and Management (E&M) visits to allocate responsibility, while others have used costs based on a broader set of professional services. Using E&M visits as the basis for accountability is frequently used in the context of performance measurement, whereby one is interested in determining which physician had the most responsibility for the "management" or trajectory of care. Using attribution methods that include other Part B services or facility care may include services that have such high fixed costs, that they do not necessarily represent any relative level of management, but rather reflect the built-in costs of those services. On the other hand, not including those types of services assumes little to no responsibility for managing the costs of those services or episodes for those that provide the procedures or the facility care.
While there is no universally agreed upon definition of what constitutes "professional services," in previous work spent significant effort creating operational definitions for professional costs a based on a reduced set of HCPCS codes using E&M visits under CMS' Berenson Eggers Type of Service (BETOS) code definition as a starting point as described in Appendix F.
Previous work in attribution has looked at assigning care only to physicians. However, for the purposes of linking performance measurement or financial incentives to episodes, as noted previously, it may also be important to have attribution rules that assign care to facilities. Therefore, in addition to examining the performance of physician-based attribution rules that have been used by others, we introduced new rules that allow assignment of episodes to facilities. Table 16 presents a summary of the attribution rules used in these analyses. For example the "episode payments plurality" rule assigned an episode to the single MD that had the highest portion of professional services payments as long as they met the threshold of having at least 30 percent of the professional payments. If no MD met this threshold, attribution for the episode was not assigned under this rule.
The facility rule could be combined with physician/practice attribution rules to create shared facility-physician attribution rules - the next to the last row in Table 15 is an example of this. The last row of Table 16 includes a shared attribution rule that combines facility attribution with the attending physician for the hospital assigned responsibility for the episode. More sophisticated and complicated attribution rules could be created that utilize a hierarchy of attribution based on a series of if-then statements. For example, attribution could be an individual physician if they account for the majority of outpatient E&M visits; then if no physician met this criterion, attribution could be made to a facility.
| Title of Rule | Signal for Responsibility | Single or Multiple Providers | Relevant cut-off |
|---|---|---|---|
| Episode Payments Plurality | Professional Payments | Single MD | At least 30% professional payments |
| Episode Payments Multiple Physicians | Professional Payments | Multiple MDs | All MD with >25% |
| Episode Visits Plurality | E&M Visits | Single MD | At least 30% E&M visits |
| Facility Payments Plurality | Facility Payments | Single Facility | At least 30% facility payments |
| Facility Payments Multiple Facilities | Facility Payments | Multiple Facilities | At least 25% facility payments |
| Episode Payments Plurality + Facility Payments Plurality | Professional Payments + Facility Payments | Single MD + Single Facility | Facility with at least 30% facility payments or MD with at least 30% professional payments |
In Table 17 we present the portion of episodes related to three conditions, AMI, diabetes, and hip fracture, that could be assigned under each of the attribution rules. The majority of episodes could be assigned to a physician under all of the physician-based rules. While basing attribution on professional services payments resulted in only a small increase compared to the use of E&M visits in the number of episodes that could be attributed for diabetes (an additional 2.9 percent of episodes), the difference was more substantial for both AMI (and additional 12.8 percent of episodes) and hip fracture (an additional 14.2 percent of episodes). Similarly, while moving the threshold from 30 percent to 25 percent of professional services payments resulted in being able to attribute an additional seven percent of AMI-related episodes to physicians, this had much less of an impact on the attribution of diabetes-related episodes (increase of 0.6 percent of episodes attributed) and hip fracture-related episodes (an additional 1.4 percent of episodes attributed).
The fraction of episodes that could be assigned to a facility varied greatly by condition. The variation is driven by whether facilities are involved in the care for episodes related to that condition. For example, 99.2 percent of episodes related to AMI include inpatient care and 93.0 percent of all episodes related to AMI can be assigned to a facility. In contrast, 14.8 percent of episodes related to diabetes involve inpatient care and only 8.4 percent of episodes can be assigned to a facility.
| Attribution Rule | AMI | Diabetes | Hip Fracture |
|---|---|---|---|
| Episode Visits Plurality | 73.4% | 82.2% | 81.7% |
| Episode Payments Plurality | 86.2% | 85.1% | 95.9% |
| Episode Payments Multiple Physician | 93.2% | 85.7% | 97.3% |
| Facility Payments Plurality | 93.0% | 8.4% | 89.7% |
| Facility Payments Multiple Facilities | 93.0% | 8.4% | 89.8% |
| Episode MD Payments Plurality or Facility Payments Plurality | 98.9% | 86.3% | 98.6% |
There may be concerns that if beneficiaries receive care in many settings, their care could be fragmented and it might be difficult to identify a provider who meets the minimum thresholds for attributing episodes. The data supported this concern for some, but not all, of the conditions. In general, the more settings that were involved in an episode, the more likely an episode could be assigned to a facility (i.e., the episode was more likely to involve inpatient care). Also, when multiple settings were involved, the facility care was typically the most costly. Despite representing a large portion of the total costs, it is unclear whether the facility should have much responsibility over overall costs or quality of the episode, given that the decision to admit a patient to a facility may have occurred outside of the facility (i.e., with the ambulatory physician). For physician-based rules, the results were mixed.
Back to List of Figures and Tables
The previous table and figure show that episodes can be assigned to providers, but this does not guarantee that the attribution will have face validity with the provider. While a majority of the costs of care in an episode with a facility admission will be driven by the facility costs, it may be less clear whether the physician who delivered care before the admission or the physician who managed the patient inside the admission had more responsibility over the costs of that episode and how to divide responsibility. Of potential concern is that an assigned provider, either a physician or a facility, may actually provide a relatively small fraction of the care in terms of costs and that this may create face validity problems in making the assignment.
This is borne out in the data. In Table 18 we show results for three rules: "episode payments plurality", "facility payments plurality" and "episode payments plurality + facility payments plurality." We show data for ETG episodes; MEGs produce similar results. The fraction of payments for services delivered by the provider(s) to which the episode is attributed varies substantially by both attribution rule and condition; a rule with a high fraction for one condition may have a low fraction for another condition. Rules that assign care to both a physician and a facility had a larger fraction of payments being delivered by the responsible provider. These data show the utility of multiple attribution, but also raise questions regarding if the rule were based on single attribution to a physician and multiple physicians are involved, which physician is more responsible for managing the costs of the episode? The preferred attribution rule would likely be determined by what is trying to be accomplished from a policy perspective, the type of episode that is being measured, and the application.
| Condition | Episode Payments Plurality | Facility Payments Plurality | Episode Payments Plurality + Facility Payments Plurality |
|---|---|---|---|
| AMI | - 6.5% | 66.4% | 73.0% |
| Diabetes | 29.0% | - 5.0% | 34.0% |
| Hip Fracture | - 8.9% | 54.3% | 63.1% |
Geographic Variation and Out of State Care
Much of the data presented in the chapter has been aggregated across the three states, Florida, Oregon and Texas. Figure 23 shows the average standardized payments per ETG episode by state for each of the nine conditions. As shown, there is substantial variation in the payments per episode, but the pattern by state is not completely consistent. For most conditions, Oregon has lower standardized payments per episode than either Florida or Texas. For some conditions, Florida and Texas have very similar average standardized payments per episode, but Texas has substantially higher payments for bacterial pneumonia, cerebrovascular disease and hip fracture, while Florida has higher average standardized payments for congestive heart failure. These differences could be driven by differences in the number of episodes per beneficiaries in the three states, which could be interpreted as differences in case mix or health of the beneficiaries. The variations could also be due to variations in practice patterns or differences in the use of different care settings, such as the use inpatient rehabilitation facilities versus SNFs. It will be important in future work to distinguish how much of the differences observed are a function of these various factors and to consider the implications for performance measurement and financial incentives.
Back to List of Figures and Tables
Implications of Beneficiaries with High Disease Burden
To understand the extent to which episodes may differ for complex patients compared to less complex patients, we conducted a series of analyses using the number of episodes experienced by a beneficiary as a proxy for patient complexity. Beneficiaries were separated into three categories based on the number of ETG episodes they were assigned: up to 5 episodes (approximately 25 percent of beneficiaries), 6-11 episodes (approximately 50 percent of beneficiaries), and 12 or more episodes (approximately 25 percent of beneficiaries). In this section, we present selected results from these analyses.
Back to List of Figures and Tables
In this chapter, we presented the results of exploratory analyses to identify issues related to constructing and using episodes of care the purposes of measurement and aligning incentives to deliver high quality care. The episodes of care were constructed for convenience using by two commercial episode groupers, Symmetry ETGs and Thomson MEGs.
We found that beneficiaries with the nine conditions we examined experienced an average of 10 episodes of any kind during the measurement year, most of which were not related to nine conditions of focus in this study. Many of the unrelated episodes were common among a large proportion of beneficiaries across the nine study conditions, such as hypertension, congestive heart failure, and fungal skin infections. It is unclear whether physicians and other providers would view a beneficiary's multiple episodes as defined in this study as distinct issues to be managed separately or as related issues to be managed jointly.
We found that standardized payments per episode varied widely both across and within the nine conditions, In addition, there was an inverse relationship was observed between standardized episode payments and the coefficient of variation. We used fairly broad groupings of patients based on the nine conditions. Heterogeneity within a condition might be reduced if subgroups of patients were created. For example, instead of grouping together all diabetics, separating them into categories based on the degree of advancement of their disease. There is also a need to understand the key sources of variation in standardized payments and which sources need to be accounted for in the episode construction or patient group creation, versus which are sources of variation you could seek to eliminate through the application of episodes for performance measurement or financial incentives.
Beneficiaries who experienced a greater total number of episodes (both related and unrelated to conditions of focus) had higher average standardized payments per episode and more providers involved in the delivery of care for each episode related to the conditions of focus. This suggests the need to not only risk-adjust for the severity of the specific condition of focus, but also the other conditions experienced by the beneficiary.
Across the nine conditions, there was no standard care pattern of types of providers and settings involved for the related episodes. Even for patients with the same condition, there was substantial variation in care trajectories. Often care cuts across three settings of care for any given condition. During a single episode of care, the care provided was often dispersed among multiple specialists, but usually involved a single primary care physician (PCP). These PCPs may offer a foundation for coordinating the care across an episode.
Care patterns showed variation across the three states we examined. Some of the variation that was observed is likely related to differences in the supply of different types of health care providers in different geographic health care markets. For example, inpatient rehabilitation facility (IRF) care was more common for episodes in Texas, where these types of facilities are relatively numerous. In Oregon and Florida, the use of IRFs was less common than in Texas, but use of SNFs was more common. The implications of these supply-related variations in care patterns are not clear.
A significant fraction of episodes could be assigned to a provider for most of the attribution rules we studied. However, we did observe variation in what proportion of the episodes could be assigned depending on the rule and the type of condition. Some conditions are addressed primarily in an ambulatory setting and in these types of episodes, a facility-based rule led to a smaller share of episodes being assigned. For other conditions, an individual provider may represent only a small fraction of total episode payments (e.g., physicians in an AMI episode represent only 6.5% of total costs, whereas the facility represents 66.4%), and in this situation, rules that would assign the episode to this single physician may not be as appropriate. These findings illustrate that a single approach to attributing episodes to providers may not be appropriate.
Variation existed across the three states in the average number of episodes per beneficiaries, both overall and for beneficiaries with each of the nine conditions focus, average standardized payments for episodes related to the nine conditions, the involvement of different post-acute care providers, and the percent of episodes for which beneficiaries received care outside of their state of residence. The mean number of total episodes of all types per beneficiary varied widely among the three states in our analysis, averaging 6.1 episodes per beneficiary in Oregon, 6.9 in Texas and 8.0 in Florida. The average standardized payment per episode for the episodes related to the nine conditions varied in a consistent pattern across the nine conditions, and Oregon consistently had lower average per-episode payments than Florida or Texas. The reasons behind these geographic variations in per episode payments and frequency of episodes are unclear.
These results suggest that the optimal way in which episodes would be constructed would depend on how they would be applied and on policy considerations, such as promoting improved coordination among providers in the delivery of care across a patient's care trajectory within an episode. Because this study relied on the use of two existing commercially available episode groupers, what we observed in the data analyses we performed was influenced by how each of the grouper tools constructs an episode, and those reading this report should bear this in mind. For example, distinguishing between acute events and chronic episodes is an important consideration. There are chronic episodes with acute exacerbations (such as ischemic heart disease with a heart attack), strictly chronic episodes (ongoing management of diabetes), and strictly acute episodes (such as hip fracture), and the policy considerations are likely to differ depending on the type of episode being considered and the application.
Current Medicare performance measurement and payment policies are structured in ways that foster setting-based, provider-centric care delivery, as their design emphasizes measurement of and payment for individual services delivered by individual providers in separate settings of care. These design features foster and reinforce a silo-based approach to care management, which contrasts sharply with an average Medicare beneficiary's care needs and care experiences. As the analyses in this study reveal, Medicare beneficiaries frequently have multiple, complex chronic conditions and typically receive care from multiple providers, who often practice in different settings of care. Beneficiaries' needs might be better service by a more coordinated and integrated approach to care delivery.
Existing payment and accountability structures pose challenges in being able to close the quality gap and provide cost-efficient care to an ever-growing population of Medicare beneficiaries. Silo-based approaches to performance measurement, accountability and payments do not provide the stimulus to deliver care in a patient-centered and coordinated fashion. Recent reform proposals have called for approaches that would better align and strengthen provider incentives (both financial and non-financial) to deliver care in a more proactive and holistic way (Baucus, 2008). Applying episodes of care as the basis for performance measurement, accountability and payment is one potential reform mechanism that could drive the system towards a more patient-centered care focus, improve quality and lead to improved efficiencies in the use of resources. Additional research is needed to examine the practical application and implementation options of an episode-based approach to Medicare FFS.
This report summarizes the findings from an exploratory examination of issues related to the construction of episodes of care for different clinical events/conditions and the potential application of episodes within Medicare for payment and performance measurement purposes. As we summarize the key lessons that emerged from our review of the literature, expert discussions, and data analyses and consider the policy implications, we do so within the framework of a building block approach to constructing and applying episodes of care that was outlined at the start of this report. - The findings contained in this report reflect the design features of the two commercially available grouper software tools that were used to construct episodes in this project. Other types of episode constructions could yield different results. Additionally, some of the observed variation in results across states may be an artifact of variations in coding practices in different regions and future work should attempt to understand the extent of variation in coding practices.
This study identifies a number of important issues that need to be examined in more depth, should Medicare decide to pursue any of the possible paths towards using episodes of care as a basis for performance measurement, accountability, or payment. We highlight seven important findings and consider their implications with respect to constructing and applying episodes of care for various purposes. We remind readers of this report that the observed results are, in part, related to how the commercial episode grouper tools define what claims get assigned to an episode (i.e., the underlying grouper logic used to construct an episode) as well as variations in coding practices among providers in what diagnosis they code as primary versus secondary and the completeness of this coding. - Alternative types of episode constructions could yield different results.
1. Medicare beneficiaries have a large number of different episodes types per year.
The Medicare beneficiaries for the nine conditions we examined had an average of 10 episodes during the year, and the majority of episodes were unrelated to the condition that was used as a criterion for inclusion of the beneficiary in this study. Most episodes were of varying types (i.e. not repeated occurrence of the same type of episode). Many of the other unrelated episode types were common among beneficiaries across the nine study conditions, such as fungal skin infections, hypertension, COPD.
From a performance measurement and payment perspective, the large number of episodes per beneficiary--some of which might benefit from coordinated management--raises questions about the degree to which care for a particular beneficiary should be examined holistically, or alternatively, split into small units of analysis such as within specific types of episodes. How one defines an episode of care represent a point on a continuum of different levels of aggregation of services, ranging from the sum of all services provided to a beneficiary per year (such as a per-capita approach) to each of the separate services that are used as a basis for current FFS payments. However, there is a large middle ground, in terms of the ways in which services could potentially be grouped to better align care delivery and incentives for providing the right care, between these two extremes. - In considering the specific application of the episode it is important to conditioner: 1) What is the optimal way to define an episode? and 2) How much aggregation of services does the episode construction entail?
In general, a broader episode definition lends itself to a more holistic view of patient care, while narrower definitions provide more of a condition-specific (or, with an even narrower definition, a treatment- or service-specific) perspective on care. Broader episode definitions will include more variability in the service content of the episode and a greater number of providers involved in care, creating greater complexities for performance measurement and structuring payments. For example, the inclusion of more services that touch more providers across more settings of care presents challenges for assigning accountability to a single provider or multiple providers who may or may not feel "ownership" of management of the episode depending on their level of involvement. Depending on the amount of variability in the content of the services provided within an episode construct, this could increase the financial risk to providers in the context of a bundled payment if the variation is large.
Ultimately, the specific application should drive the construction of the episode and it is possible that that episode definitions may need to vary depending on the application. For quality measurement, the episodes that were generated from the commercial grouper tools within the context of this study may be too narrow to optimize patient management for some conditions. Many conditions are interrelated and so is their management-such as the case for management of ischemic heart disease, hypertension, hyperlipidemia, and diabetes; in such cases, quality measurement approaches using a broad episode definition encompassing a cluster of related conditions may be more appropriate than measures for tranches of care related to each condition separately. Additional work is required to better articulate what types of episodes are clustered together and represented related conditions, and to assess the implications for coordinated patient management among the array of providers involved in a beneficiary's care. Existing performance measures focus on discrete services within single conditions, and little work has been done to define how to optimize the management of patients with co-occurring conditions and to develop associated integrated performance measures
In contrast, the episode definitions used in this study may be too broad for some payment applications. The substantial variation in standardized payments for some episode types that we observed when applying the ETG and MEG grouper tools suggests that the type of care being delivered within some types of episodes may be heterogeneous and reflect care for different types of patients. Providers may be placed at financial risk when variations are due to underlying differences in the severity or types of cases being managed. Additional work to understand the extent to which the episodes within a given condition reflect similar patient populations would help determine whether the variation is a function of differences in patients vs. care management practices. To the extent that the variations are due to variations in practice patterns for an otherwise homogeneous group of patients, dampening down on the variation through a "bundled" payment may be appropriate while not exposing providers to undue risk.
The episode constructions within the ETGs and MEGs are fairly broad and include all providers and settings, but they were not developed for the purpose of quality measurement or payment applications. [32] Use of off-the shelf grouper tools was done for convenience to illustrate some of the types of issues that would need to be considered if episode-based approaches were applied. Narrower episode definitions could be constructed either by using different algorithms, further limiting the services that were considered to be part of a single episode, or by considering only certain providers or settings within the ETG and MEG episode groupings; additionally, broader definitions, including per-capita analyses, could be considered. In our discussions with experts, they noted that more-narrowly defined episodes, such as those encompassing a single setting (e.g., hospital inpatient) were the most feasible and a good starting point; however, to achieve substantial benefits, multiple settings would have to be grouped together in the episode (e.g., hospital, ambulatory, post-acute care), and doing so would strengthen incentives for care coordination.
It is unclear whether physicians and other providers would view a beneficiary's multiple episodes as defined in this study as distinct issues to be managed separately or as related issues to be managed jointly. If providers viewed certain episodes as related issues that should be managed jointly (e.g., episodes of ischemic heart disease, hypertension, and hyperlipidemia), then it may be appropriate to expand episode definitions under some approaches to group related conditions. One possibility would be to create bundles of episodes that commonly co-occur and which would benefit from a more integrated management approach.
It is also unclear whether the same provider would be attributed primary responsibility for multiple different types of episodes. Our analysis did not assess whether the same or different providers were involved in managing the different types of episodes for a single Medicare beneficiary, and future analyses could examine how many unique providers are involved in managing all the various episodes for a single Medicare beneficiary. It is possible that several related episodes for a patient could be attributed to different providers - for example, a patient with an AMI could have had an ischemic heart disease episode attributed to a cardiologist, a hypertension episode attributed to a primary care physician, and a diabetes episode attributed to an endocrinologist. Future research could test the extent to which different episodes for a single beneficiary are attributed to one or multiple providers using common attribution rules, and whether these assignments match the perceptions of the physicians involved in delivering the care as to who is responsible for managing which aspects of care and whether there should be joint management and accountability (absent explicit organizational relationships such as in integrated provider organizations).
2. Standardized payments varied widely across and within episode types.
Among the episodes that were related to the nine study conditions, there was substantial variation in average standardized payments,[33]both across episode types and among different episodes of the same type. Per episode average payments for ETGs related to the nine study conditions ranged from an average of $1,306 (episodes related to diabetes) to $21,976 (episodes related to AMI). This is unsurprising, since these conditions have very different resource requirements - AMI requires hospitalization, and perhaps surgery, and rehabilitation, while diabetes typically is managed on an ambulatory basis.
Even among episodes of the same type, as defined by the ETG and MEG grouper tools, there was substantial variation in average payments per episode. The coefficient of variation for an episode type was inversely related to the average cost of that episode type, ranging from 72 percent (episodes related to hip fracture) to 269 percent (episodes related to diabetes). Large variation in average payments per episode highlights the need to understand the extent to which episodes are homogeneous in their construction (i.e., are they measuring the same type of care for the same type of patient or are there different subpopulations of patients within the episode category which accounts for the variation?). There is a need to understand the key sources of variation in payments and which sources need to be accounted for in the episode construction versus which sources could be minimized through application of episodes for performance measurement and/or payment. Variations due to underlying differences in the severity of patients would need to be controlled for in the construction and application of the episode; otherwise, unintended consequences could occur such as avoidance of more difficult cases if the financial risk exposure or challenges in managing the patient to the performance indicators is too great.
The degree of variation in average payments per episode has implications for performance measurement and payment. For example, performance measures that focus on resource use will require a large number of episodes to develop reliable estimates of performance if there is a large amount of variation, since reliability is inversely related to variation. In approaches that tie some portion or all reimbursement to an episode, a high coefficient of variation could suggest financial risk for the accountable entity unless the entity has a large number of episodes to absorb the variation. There are several potential approaches to managing the risk associated with variation in average episode payments that were proposed in the literature review and expert discussions. Risk mitigation techniques include the exclusion of outliers, risk adjustment, and narrower episode definitions.
3. The care trajectory and care patterns differ within and across episode types.
Our analyses examined the number of settings and types of providers that were involved in episodes related to the nine study conditions. Across all nine conditions, there was no standard pattern of types of providers and settings involved in the management of the episodes. The variations in care patterns and trajectories observed across and within episode types signals potential opportunities (i.e., to dampen down on unnecessary variation in care) and challenges (i.e., a one-size-fits-all approach may not be feasible) when considering performance measurement and/or payment applications.
The number and types of settings involved in episodes varied across the nine study conditions. Fifty-seven percent of hip fracture episodes included more than four settings, and only seven percent involved a single setting. At the other extreme, 52 percent of low back pain episodes involved only a single setting (typically ambulatory care) while only five percent involved more than 4 settings.
The number and types of settings also varied among episodes related to a single condition. There was no standard care pathway, or combination of settings, for episodes related to any of the conditions. For example, the most common combination of settings in AMI-related episodes was hospital inpatient, hospital outpatient, and ambulatory, but this combination occurred in only 41 percent of AMI-related episodes. Fourteen percent of AMI-related episodes involved only hospital inpatient and hospital outpatient care, while 12 percent involved hospital inpatient, hospital outpatient, ambulatory, and home health. Episodes related to other conditions had even more permutations of settings involved (e.g., the most common combination for hip fracture-related episodes was hospital inpatient, hospital outpatient, ambulatory, and skilled nursing facility – only 16 percent of episodes). The second most common combination for hip fracture included these settings plus home health (13 percent of episodes).
Applying the ETG and MEG episode definitions, episodes related to chronic conditions (e.g., diabetes, low back pain, CHF) may or not include a hospitalization related to exacerbation of the condition. Fifteen percent of diabetes-related episodes, 11 percent of low back pain episodes, and 55 percent of CHF-related episodes included inpatient hospital care. In an application that would hold providers accountable for measures of resource use during an episode, this expensive inpatient care would lead to penalties for the providers accountable for these episodes; this may or may not be desirable depending on whether the hospitalization is potentially avoidable through appropriate management of the condition in the ambulatory setting.
Care patterns showed regional variation across the three states. Some of the observed variation is likely related to differences in the supply of different types of health care providers in different geographic health care markets. For example, inpatient rehabilitation facility (IRF) care was more common for episodes in Texas, where these type of facilities are relatively numerous. In Oregon and Florida, use of IRFs was less common than in Texas, but use of SNFs was more common. The implications of these supply-related variations in care patterns are not clear and could be considered in future research exploring the potential applications of episodes of care constructs.
The lack of standard, or even predominant, patterns of care for a large fraction of any particular episode type could present challenges to approaches that include an element of standardization (note: some of the variability may be an artifact of the way in which the grouper tools assign claims). For AMI-related episodes, should the episode definition and, in turn, performance measurement, encompass home health care if home health is provided for only a small fraction of all patients having an AMI event? Is it fair to compare the quality of episodes including home health with episodes that do not include home health? Or should all settings be included in episodes irrespective of the variation in the extent to which settings appear in an episode and that each setting has its own set of accountabilities—since patients will follow different trajectories based on market structures, provider management preferences, and patient characteristics? In some cases, care in a particular setting may itself be an indicator of poor quality – e.g., hospitalization for exacerbation of CHF—which would suggest the importance of a more inclusive approach to defining an episode. Again, future research would help inform these questions.
The variability in the number of providers and settings encountered during a patient's trajectory for any of the nine conditions we examined highlights the potential challenges for providers to coordinate care, or in some approaches, form virtual groups to assume shared accountability when these configurations are not reoccurring. Given that we examined only one condition at a time, the picture could be even more complex when attempting to group together a broader array of episodes that a Medicare beneficiary has in a given year when there are an even greater number of providers involved who theoretically could be working to coordinate the care for the patient. The involvement of multiple providers located in different settings poses questions about how a bundled payment for an episode would be distributed. Possible approaches suggested in the literature and expert discussions include predetermined arrangements between the providers and/or a Medicare formula for allocating payments.
4. During a single episode of care, the care provided was often dispersed among a large number of specialists, but typically involved a single primary care physician.
For most of the nine study conditions examined, the condition-related episodes involved a median of one PCP (meaning half of the episodes for any given condition involved only one PCP). Episodes related to AMI involved a median of two PCPs, and episodes related to breast cancer and low back pain involved a median of zero PCPs.[34] For episodes that did not involve any PCPs, this may pose challenges for determining who to hold accountable and who would be responsible for coordinating care. Among those episodes involving a PCP, the PCPs could be located in ambulatory, hospital outpatient, or inpatient settings; as such, an AMI-related episode which involved two PCPs could indicate care from two hospitalists during a single inpatient stay. Because most episode types typically involved a single PCP, these PCPs could potentially provide a foundation for coordinating the care for a beneficiary, if the PCP is also managing care for other episode types the beneficiary may experience. This study did not use a cross-condition approach to examine whether there were multiple PCPs involved in managing a beneficiary's care across different episode types. Future work should explore whether there are multiple different PCPs involved in managing care across the entire set of episodes for any given Medicare beneficiary to ascertain whether a single PCP exists to coordinate care.
To the extent that co-occurring and related conditions (e.g., hypertension and hyperlipidemia) are grouped into a single broader episode construct, there may be a greater number of physicians involved in management of the patient. Our analysis examined only the number of providers involved within a single episode. To better understand the opportunities for and challenges associated with coordinating care, assigning responsibility for management, and aligning financial incentives, future analyses could look across all episodes for a beneficiary to estimate how many different providers are caring for a beneficiary.
The median number of specialists involved per episode was generally higher. The lowest median number of specialists was for diabetes-related episodes (zero), and low back pain and congestive heart failure involved a median of one specialist. The episode types related to conditions typically involving inpatient stays-AMI and hip fracture-involved the largest median number of specialists (six and five, respectively). These medians reflect specialists in both inpatient and outpatient settings, and so include anesthesiologists, radiologists, pathologists, and other hospital-based specialty care, including consultations. For episode-based performance measurement and payment approaches, the number of specialists raises a question about how many of these specialists should be held accountable for episode performance. Are all five specialists involved in the median hip fracture-related episode responsible for the performance measures available for hip fracture? Are different performance measures available for the care provided by different specialties? How would financial incentives, such as pay-for-performance be directed-to one, some or all physicians involved in the episode?
Although we observed a fairly high degree of dispersion of care during most episode types among multiple physicians, the dispersion was not as great as that observed by Pham et al. (2007) in per-capita analyses of FFS Medicare beneficiaries. The Pham study, which found multiple physicians involved in a FFS beneficiary's care within a given year (frequently there was more than one PCP caring for the beneficiary as well as multiple specialists) concluded that the dispersion of care across so many practitioners would prove challenging to assigning responsibility for all care to any single physician or group of physicians in a pay for performance context. Using narrower constructions of episodes, in contrast to examining all care received by a Medicare beneficiary within a year, could mitigate these concerns to some degree. The dispersion we observed will be an important design consideration, particularly in the attributing episodes to physicians for measurement or payment purposes. With multiple providers involved in the care delivery, several questions arise that warrant further investigation: 1) Who is accountable for the care delivered (one, some or all providers) with an episode of care and how might that vary under more narrow versus broader episode constructions? 2) What operational challenges exist related to being able to measure and assign responsibility to one or more physicians (i.e., unique physician IDs would need to exist on all Medicare claims and include the provider who rendered the service)?[35]
5. Different methods for assigning responsibility for an episode to one or more providers yield different results.
The published literature finds that different methods for attributing episodes of care to providers have yielded different results, in terms of which physicians are assigned responsibility and what proportion of episodes can be assigned. Our analyses of Medicare data produced similar results in terms of variability. However, it is notable that even with the dispersion of care noted above, a significant fraction of episodes were assigned to some provider(s) for most attribution rules and conditions we studied.
For example, the six attribution rules we tested assigned between 73 percent and 99 percent of AMI-related episodes to physicians and/or hospitals. - The lowest attribution rate occurred when accountability was assigned to a single physician based on a plurality of E&M visits, while the highest attribution rates occurred when accountability was assigned to a single physician and/or hospital based on a plurality of physician costs and hospital costs. The attribution results varied by the type of episode: using a plurality of visits to assign accountability to a single physician, successful attribution occurred for 73 percent of AMI-related episodes, 81 percent of bacterial pneumonia-related episodes, and 94 percent of breast cancer-related episodes. The sensitivity of attribution results to methods suggests careful consideration of the algorithm chosen and that the approach may need to vary depending on the condition, specific application and stated policy goals. For example, enhancing care coordination signals to providers may be the desired policy goal and holding multiple providers accountable may be a strategy that helps promote this change in culture; yet given the dispersion of care, gaining acceptance of joint responsibilities among providers could be challenging.
One unresolved issue is how the providers to whom care is attributed perceive the attribution. - Particularly for episodes in which care is highly dispersed across multiple providers, the question arises as to whether the provider(s) assigned accountability feels overall responsibility for the episode and is able to affect performance on either cost or quality metrics for the episode of care?- This may differ depending on what type of care is provided within the episode. For example, for episodes where the majority of episode costs are facility costs, which physicians should be held accountable if one were to use a single attribution model?- Should it be the physician who managed the patient in the facility or the physician who managed the physician prior to the admission or both?- Further, should the facility also be accountable for the episode costs?- The extent of involvement of various providers varied by type of episode, highlighting potential issues related to who is held responsible for and able to affect care trajectory in the episode. Given that the current performance measurement and payment environment is one that does not engender notions of joint accountabilities among providers, absent an already formed group or system, reforms could require a substantial culture shift in order to assign multiple accountabilities across an episode of care. - However, formation of these types of groups may be part of the policy goal. Testing alternative approaches with physicians to understand their reaction to various assignment methods could inform how best to proceed.
6. Differences exist between geographic areas in per episode payments and care patterns for similar episodes of care.
The mean number of total episodes of all types per beneficiary varied widely among the three states in our analysis, averaging 6.1 episodes per beneficiary in Oregon, 6.9 in Texas, and 8.0 in Florida. In our analyses, average 2005 per-capita payments were highest in Florida and Texas ($8,380 and $8,432, respectively) and lowest in Oregon ($5,870). This implies that the cost per episode is lower, on average, in Oregon than in Texas and Florida. This could be due to either a higher proportion of lower-cost episode types in Oregon or to lower cost per episode of a particular type in Oregon. The differences in per-episode payments observed in our analyses are not due to price differences since we applied standardized prices to the services within episodes. Geographic variations in practice patterns are common, and undoubtedly contribute to some of the observed variation in the number of episodes per beneficiary as well as the average payments per episode.
The average standardized payment per episode for the episodes related to the nine conditions varied in a consistent pattern across states, although the state with the highest average payments per episode varied across the nine study conditions. For example, Florida had the highest average payments per AMI-related episodes ($22,206, compared to $22,011 in Texas and $19,837 in Oregon). But Florida had the lowest average payments per cerebrovascular disease-related episode ($7,524, compared to $7,996 in Oregon and $10,690 in Texas). Oregon had lower average per-episode payment than Florida and Texas for episodes related to eight of the nine study conditions; only for cerebrovascular disease did Oregon have higher average per-episode payments as compared to Florida. Florida had the highest payments for episodes related to AMI and Texas had the highest average payments for episodes related to the other eight study conditions.
The reasons behind these geographic variations in per episode payments and frequency of episodes are unclear. Part of the observed differences could be related to the claims data used to create episodes and regional differences in claims coding practices among providers. For example, coding practices in Florida, such as the way in which diagnoses are listed on claims, could potentially trigger a greater number of episodes for care than in Oregon or Texas. However, other differences are also likely to be important drivers of observed differences across regions, including patient characteristics, regional variations in practice behavior, and the availability of health care resources (such as primary care physicians, specialists, and types of care facilities). A better understanding of the relative contributions of these various factors to the observed geographic differences could be important, particularly for payment-based applications of episodes.
7. A significant proportion of episodes involved care in multiple states.
A large proportion of episodes involved care delivered in multiple states, suggesting potential challenges for care coordination and creating accountable groups of providers for an episode when they are not geographically proximate. Out-of-state care, particularly when not geographically promixate, could likely make it more difficult to coordinate the actions of providers and to then hold them jointly accountable for payment or quality within an episode--although this problem may diminish in the long run as providers adopt and use electronic information systems that can cross communicate. The rate with which multi-state care occurred varied across states and clinical conditions.
Out-of-state care occurs for various reasons. For example, beneficiaries may spend significant amounts of the year in different states (e.g., snowbirds), beneficiaries may live near state borders and they elect to receive care from providers in the bordering state, or beneficiaries may obtain care at referral centers (e.g., Mayo Clinic). The highest rate of cross-boarder care was for AMI-related episodes for beneficiaries in Oregon; 19 percent of all AMI-related episodes involved care in another state. The lowest rate was for diabetes-related episodes for beneficiaries in Texas; where three percent received some portion of their care in another state. For most conditions, Oregon beneficiaries were most likely to receive care in another state, and Texas beneficiaries were least likely. The frequency of multiple-state care also varied by condition, and was most common for AMI and breast cancer-related episodes. In episodes that involved out-of-state care, that care accounted for a large percentage of total payments for the episode (between 30 and 60 percent, varying by condition).
Using a building block approach, one could build an episode by starting narrowly to reflect the services delivered by one provider in a single setting for a specific illness or injury, then expand more broadly to reflect the services delivered in a single setting by multiple providers (such as the physician and the hospital during an inpatient stay), and finally encompass the entire continuum of services received across multiple settings and providers for treatment/management of a specific condition. Other variations along this continuum could also be considered. As one explores different types of episode constructions, it is worth noting that depending on the application, the episode constructions could be identical or differ. How an episode is ultimately constructed will be contingent on the feasibility of the approach, the proposed application, and desired policy objectives.
There are a number of ways in which episode-of-care based approaches to performance measurement and payment potentially could be incorporated into Medicare--in the near term within existing Medicare payment and program structures as well as over a longer period of time, by building capacity and through reform of existing structures. Although not an exhaustive list, we present some options for consideration:
There is an absence of solid empirical work related to and few real-world applications of episode-based approaches that provide guidance on how best to construct and apply episodes of care in the context of performance measurement and/or payment policy. The work done within this project was exploratory in nature and represents only a first step in a much larger process to flesh-out episode of care-based approaches to performance measurement and payment. Our exploration highlighted a number of issues and gaps in the knowledge base, where additional research studies and/or testing in the form of small pilot studies or demonstrations could further advance Medicare's capabilities to apply episodes of care in various ways to drive improvements in quality and cost-efficiencies.
Although not an exhaustive list, additional research that could be considered includes:
On a limited basis, explore how to define episodes of care: HHS could select a limited (e.g., 5-10) number of high volume/high cost clinical conditions, and explore how to define episodes using different build outs per a building block approach (e.g., hospital-based only including hospital and physicians, ambulatory and hospital providers, etc.). The purpose of this work would be to test the face validity of different episode constructs with physicians and institutional providers. Providers would be asked to consider the various constructs as they apply to the various functionalities that HHS is exploring, such as aligning measurement activities, profiling physicians, building financial incentives, and bundling payments. This work could help flag potential problems with various approaches and help engage providers in the development process. As part of the work to define how to construct episodes, consideration will need to be given to how to distinguish different types of episodes, such as chronic episodes with acute exacerbations, strictly chronic episodes, and strictly acute episodes (among others). Such distinctions might be important depending on the actual application of the episodes, such as whether the episodes are being used for performance measurement or for payment.
This work would allow HHS to test the feasibility of being able to expand out beyond the minority of highly integrated delivery system to all types of settings/locations the notion of an accountable group of providers who could be held responsible for performance and/or payment purposes. Given variation in types of inter-relationships and connections between providers in a local health care market, the proposed work would explore whether virtual groups are a viable concept. This work could explore with providers differences between patient-driven (empirical analysis of actual care seeking patterns) versus provider-driven (how providers see themselves as related within a community) patterns of care to define the virtual group.
| Condition | ICD-9 diagnosis codes | How selected | Source for dx codes |
|---|---|---|---|
| Acute myocardial infarction | 410.xx (only first for second Dx on the claim | At least 1 inpatient claim with DX code during 1 year period | CMS Chronic Care Warehouse |
| Bacterial pneumonia | 481.xx-483.xx (any Dx on claim) | At least 1 inpatient, or 2 HOP or Carrier claims with DX codes during 1 year period | Rello et al. |
| Breast cancer (limited to women) | 174.xx, 233.0 (any Dx on claim) | At least 1 inpatient, or 2 HOP or Carrier claims with DX codes during 1 year period | CMS Chronic Care Warehouse |
| Cerebrovascular disease | 433.xx; 434.xx (any Dx on claim) | At least 1 inpatient, or 2 HOP or Carrier claims with DX codes during 1 year period | Bravada (2003) |
| Chronic obstructive pulmonary disease- - | 491.0, 491.1, 491.20, 491.21, 491.22, 491.8, 491.9, 492.0, 492.8,- 494.0, 494.1, 496 (any Dx on claim) | At least 1 inpatient, SNF, HHA or 2 HOP or Carrier claims with DX codes during 1 year period | CMS Chronic Care Warehouse |
| Congestive heart failure | 398.91; 402.x1; 404.x1; 404.x3; 428.xx;- (any DX on claim) | At least 1 inpatient, HOP or Carrier claim with DX codes during 2 year period | CMS Chronic Care Warehouse |
| Diabetes | 250.xx, 357.2, 362.01, 362.02, 366.41 (any DX on the claim) | At least 1 inpatient, SNF, HHA or 2 HOP or Carrier claims with DX codes during 2 year period | CMS Chronic Care Warehouse |
| Hip fracture | 808.0x 808.1x, 808.2x, 808.3x, 808.41, 808.42, 808.43, 808.49, 808.51, 808.52, 808.53, 808.59, 808.8x, 808.9x, 820.0x; 820.1x; 820.2x; 820.3x; 820.8x; 820.9x; (any Dx on claim) | At least 1 inpatient claim with DX code during 1 year period | CMS Chronic Care Warehouse |
| Low back | 724.2x; 724.3x; 724.5x; 724.6x; 846.xx; 847.2x (any Dx on claim) | At least 1 inpatient, or 2 HOP or Carrier claims with DX codes during 1 year period | CMS Imaging 1 Measure for back pain |
Constructing Episodes of Care Using Symmetry and Medstat Groupers
The episode groupers utilize the primary diagnosis on claim line items to create and place the line items into episode. Only certain types of claims, as determined by procedure and revenue codes, can start an episode such as evaluation and management procedure codes, surgery procedure codes or specific inpatient facility revenue code. Conceptually, episodes are determined to be complete if one observes an adequate "clean period" ahead of the initial date on the claims and also observes an appropriate clean period after the final date on the claims. Clean periods, or intervals during which there are no claims associated with a given episode type, are used by the grouper packages to determine whether two claims are close enough together in time to be considered part of the same episode. Each episode type (ETG for Symmetry and MEG for Medstat) has an associated clean period that is set by the groupers on consultation with physicians. These clean periods range from 0 days to 999 days. Acute episode types have shorter clean periods; chronic episode types have longer clean periods. The notion of a clean period does not fit well with the concept of a chronic disease. With a three year window of data for our analysis, it is extremely difficult for chronic episodes to be deemed complete (since they need clean periods of 180 to 365 days.[37]) Recognizing this issue, episode groupers typically set fixed annual lengths for those episodes associated with chronic diseases, and one episode commonly immediately follows another; no clean periods are imposed. Following this convention, we rely on calendar years for measuring the lengths of chronic episodes.
Prior to running the episode groupers, the user must construct files to meet each grouper's specifications. Additionally, options in each grouper's configuration files must be set so the software properly reads the information on the input files and constructs episodes in a manner suiting the user's needs. MaCurdy et al. (2008) evaluated the functionality of each grouper in producing episodes of care using Medicare claims data and developed a set of baseline file configurations and settings adapted to structure of Medicare claims. The episodes for this analysis are created using the baseline settings established by MaCurdy et al., with one exception: Medstat episodes are created using an adaptation of the Build Admissions feature, which groups all claims concurrent with an inpatient stay to the episode associated with the stay. Following is a brief overview of the settings used to construct the episodes of care used in this analysis.
Specifications for Creating Symmetry Records
To create episodes of care, Symmetry inputs service-level records with each input record containing information on a single service item and up to four diagnoses per record. These records also include data on dates of service. Services are always identified on an institutional claim (IP, OP, SNF, HH and HS claims) by a revenue center code, and if there are HCPCS/CPT codes on a claim, each always corresponds to single revenue center code. So in creating service-level inputs from institutional claims, we use a single revenue center code as the principal designator of the service and include procedure codes when present. A service record from an institutional claim also includes up to the first four diagnosis codes listed on parent record[38] For non-institutional services, Medicare's PB and DME claims are readily separated into line items associated with individual HCPCS or CPT codes; these claim types have no revenue center codes. Each input record constructed from a PB and DME claim consists of a single procedure code and its corresponding line-item diagnosis. Consequently, in addition to diagnosis information in a Medicare setting, the ETG grouper primarily relies on revenue center codes to group IP/SNF/HS claims, procedure codes to group PB and DME claims, and it can use either or both types of codes to group OP and HH claims.
In addition to using input files, the user can influence grouping outcomes through a configuration file, which we largely set to Symmetry's default settings. Among the default settings we use is Symmetry's link facility records feature, which connects claims associated with hospital stays into "confinements." We use this feature since Medicare IP claims are not necessarily separate admissions. We also use Symmetry's ETG-specific clean periods and default annual truncation of chronic episodes when creating episodes. We do not, however, use the "summarize complete episodes only" feature as suggested by Symmety's documentation because we want to analyze both incomplete and complete episodes.
With non-institutional claims, the cost of the procedure is identified with each line item, thus there is no ambiguity in assigning the cost of services to episodes. However, costs of services on institutional claims cannot be disaggregated from the Medicare payment for the parent claim. This does not pose a problem when all services from the parent claim are grouped to a single episode, but when the input records of an institutional claim are assigned to two or more episodes, the ETG grouper offers no guidance for how to divide the cost of this claim across its associated episodes. We implement a plurality rule to allocate costs when service-level inputs for a single institutional claim are grouped to multiple episodes. This rule assigns the cost of the institutional claim to the episode that captures the largest number of service-level inputs from the parent record. In the case of a tie, costs are evenly split between episodes.
Specifications for Creating Medstat Records
Regardless of whether a Medicare claim comes from an institutional or non-institutional source, the MEG grouper accepts one input record per claim. Medstat primarily relies on diagnosis codes for grouping, thus all available diagnosis codes from a claim are included on a Medstat record. This record distinguishes IP and PB claims from other types of Medicare claims, but it does not differentiate among the other distinct types of Medicare claims as the source of diagnoses. Switching claims from one of these types to another results in no change in constructed episodes. An input record accepts data on procedure codes appearing on the claim (not revenue center codes). This procedure information is primarily used to determine whether a claim represents an x-ray/lab event—which cannot start an episode—and in some instances to assist the grouper in deciding how to interpret secondary diagnoses on the claim.
When inputting files into Medstat, we configure the software's options either to their defaults or to the settings most parallel to Symmetry. The episode length limit in Medstat's configuration file is set to make it comparable to Symmetry's episode limit of 365 days, and the chronic episode length is set to a year so as to construct chronic episodes that are comparable to Symmetry's annually truncated episodes. We also configure the grouper to divide some chronic MEGs into chronic conditions and acute flare-ups. Finally, we create inpatient stays, or admissions, from IP claims using Medstat's Build Admissions feature, which is similar in design to Symmetry's link facility records feature. These admissions are then used to group the episodes; every claim in a given admission will always be placed into the same episode of care.
In addition to the standard grouper configuration options, we rely on an adaptation of Medstat's software that groups all claims concurrent with an IP stay into the same episode as the IP claim. MaCurdy et al. (2008) refer to this adaptation as the “All Services Admissions Build.” We selected this approach for running the Medstat grouper to mimic some common payment patterns observed in Medicare data. Medicare pays for near-daily Evaluation & Management (E&M) services by a physician during a hospital admission, and post acute care in the form of SNF claims, which must closely follow and be directly linked to a related IP stay. Inspection of claims submission patterns in Medicare data clearly reveals the influence of these payment practices. By using the “All Services Admissions Build” adaptation of the Medstat grouper, one ensures that relevant Part B physician claims concurrent with a hospital stay are grouped into the same episode as the IP claim paying for this stay, and, further, that a SNF claim immediately following this stay is also grouped to the same episode. Although the “All Services Admissions Build” adaptation offers a mechanism for guaranteeing the bundling of relevant claims into the same episode, this feature represents a philosophical shift in the meaning of an episode in the sense that claims issued during an IP stay are no longer grouped according to diagnosis but are instead grouped merely on the basis of whether their dates fall within the IP admission. When grouped on the basis of diagnoses, the Medstat software assigns many claims concurrent with a hospital stay to episodes different from IP claim, which more closely corresponds to the grouping results produced by Symmetry.
Unlike Symmetry, which groups service-level items, Medstat groups claim-level items. This is an important distinction for cost allocation. Specifically, whereas services from a parent claim can be grouped to multiple episodes by Symmetry, claims are always grouped to a single episode by Medsat. As a result, the complete cost from an IP claim is always assigned to a single Medstat episode.
MaCurdy, Thomas, Jason Kerwin, Jonathan Gibbs, Eugene Lin, Carolyn Cotterman, Margaret O'Brien-Strain and Nick Theobald. 2008. "Evaluating the Functionality of the Symmetry ETG and Medstat MEG Software in Forming Episodes of Care Using Medicare Data." Burlingame, CA: Acumen, LLC.
| Condition | ETGs (version 6.0) | MEGs |
|---|---|---|
| Acute myocardial infarction | 386500: Ischemic heart disease | 11: Acute myocardial infarction |
| Bacterial pneumonia | 437400: Bacterial lung infections | 510: Pneumonia: bacterial |
| Breast cancer (limited to women) | 635600: Malignant neoplasm of breast | 212: Neoplasm, malignant: breast, female
427: Encounter for Chemotherapy 431: Encounter for Radiation Therapy |
| Cerebrovascular disease | 316000: Cerebral vascular accident | 395: Cerebrovascular disease, chronic maintenance
396: Cerebrovascular disease with TIA 397: Cerebrovascular disease with stroke |
| Chronic obstructive pulmonary disease- - | 439300: Chronic obstructive pulmonary disease (COPD) | 500: Chronic obstructive pulmonary disease |
| Congestive heart failure | 387100: Heart failure, diastolic
386800: Congestive heart failure |
9: Congestive heart failure |
| Diabetes | 163000: Diabetes | 49: Diabetes mellitus type 1 Maintenance 50: Diabetes mellitus type 2 and hyperglycemic states maintenance 51: Diabetes mellitus with complications |
| Hip fracture | 712903: Open fracture or dislocation - thigh, hip & pelvis 713103: Closed fracture or dislocation - thigh, hip & pelvis |
360: Fracture, dislocation or sprain: hip or pelvis 348: Fracture: Femur, Head or Neck |
| Low back pain | 711908: Major joint inflammation, back
712208: Joint degeneration, localized, back 713109: Closed fracture or dislocation of trunk 714608: Minor orthopedic trauma - back 714908: Other minor orthopedic disorders - back 715108: Orthopedic deformity - back 719908: Orthopedic signs & symptoms - back |
365: Herniated intervertebral disc
374: Osteoarthritis 389: Other arthropathies, bone and joint disorders 391: Other spinal and back disorders 405: Injury: spine and spinal cord |
Average payments were standardized for each setting based on 2005 payment rates and payment policy to exclude variation in resource use due to geographic factors (i.e., area wages, geographic differences in medical liability costs, and urban/rural status) and policy considerations (i.e., indirect medical education (IME), and disproportionate share (DSH) payments for hospitals). This was done to make variations in standardized payments reflect differences in the services being delivered rather than differences in the cost of doing business where the services are delivered or policy considerations. Adjustments for high cost and low cost outliers were made for settings that identified outliers; outlier adjustment were made for acute care hospitals, long-term care hospitals, inpatient rehabilitation facilities, inpatient psychiatric facilities, home health care, and hospital outpatient services. In order to more accurately reflect payments that would be paid by Medicare, we reduced standardized payments by setting-specific patient copayment percentage. We did not adjust standardized payments for patient deductibles as these would vary based on the other services the beneficiary had previously received during the calendar year.
Acute Care Hospital
| Medicare PPS Base rate (adjusted for area wages) * DRG weight + IME payment + DSH → (adjusted for transfers)1 = Payment (adjusted for high cost outliers) |
RAND Standardized payment |
Summary Comments: The difference between the Medicare PPS payment and the RAND standardized payment is that we did not adjust the payment for IME and DSH as these reflect issues associated with achieving certain policy objectives. We did not adjust for area wages so that variations in standardize payments reflect differences in the number and types of admissions rather than differences in the cost of doing business where the services are delivered. We treated Critical Access Hospitals the same as acute care hospitals.
Skilled Nursing Facility (SNF)
Medicare PPS SNF per diem base rate (adjusted for area wages) * RUG weight * LOS = Payment |
RAND Standardized payment |
Long Term Care Hospital (LTCH)
| Medicare PPS LTCH base rate (adjusted for area wages) * LTC DRG weight = Payment (adjusted for high cost or short stay outliers) |
RAND Standardized payment |
Summary Comments: The difference between the Medicare PPS and RAND standardized payment method is that we did not adjust the payment for area wages. We did not adjust for area wages so that variations in standardized payments reflect differences in the number and types of LTCH admissions rather than differences in the cost of doing business where the services are delivered.
Inpatient Rehabilitation Facility (IRF)
| Medicare PPS IRF base rate (adjusted for area wages) * CMG weight = Payment (adjusted for high cost or short stay outliers) |
RAND Standardized payment |
Summary Comments: The methodology is the same for the Medicare PPS and the standardized payment except that we did not adjust the payment for area wages or outliers. We did not adjust for area wages so that variations in standardized payments reflect differences in the numbers and types of admissions rather than the cost of doing business where the services are being delivered.
Inpatient Psychiatric Facility (IPF)
| Medicare PPS IPF per diem base rate (adjusted for area wages) * PPS adjustment factor (DRG, age, comborbidity) * per diem adjusters + payment for ECT treatments = Payment (adjusted for high cost outliers |
RAND Standardized payment |
Summary comments: The methodology is the same for the Medicare PPS and the standardized payment except that we did not adjust the payment for area wages. We did not adjust for area wages so that variations in standardized payments reflect differences in the numbers and types of admissions rather than the cost of doing business where the services are being delivered. In the Medicare PPS system, the per diem adjuster for the first day of the stay is different for facilities that do and do not have an emergency department. We used an average of these two weights.
Home Health
| Medicare PPS Home health base rate (adjusted for area wages) * HHRG weight = Payment (adjusted for high cost or short stay outliers) |
RAND Standardized payment |
Summary comments: The difference in the methodology is that RAND did not adjust the payment for area wages. We did not adjust for area wages so that variations in standardized payments reflect differences in the frequency and types of home health care being delivered rather than differences in the cost of doing business where the services are delivered.
Ambulatory Surgical Center (ASC)
ASC Fee Schedule1 |
RAND Standardized payment |
| Medicare PPS Payment for the lab service = the lesser of the provider's charge, the carrier fee schedule amount or the National Limit Amount (NLA is 74% of the median of fee schedule amounts set by 56 carriers) |
RAND Standardized payment |
Summary comments: We utilized the same methodology to reach the standardized payment as MedPAC used in the standardization of payments in the June 2006 Report to Congress, “Increasing the Value of Medicare”. According to the MedPAC Payment Basics, most lab services are paid at the NLA rate.
Physician Services
| Medicare PPS Conversion factor * (Work RVU * Work GPCI + PE RVU * PE GPCI + PLI RVU * PLI GPCI) → Payment modifier1 → Adjustment for provider type2 → Geographic adjustment = Payment |
RAND Standardized Payment |
Summary comments: RAND utilized the same methodology as the Medicare PPS but excluded all geographic adjustments (e.g. area wages and medical liability costs). We did not include geographic adjustments so that variations in standardized payments reflect differences in services being delivered rather than differences in the cost of doing business where the services are delivered.
Anesthesia
| Medicare PPS Anesthesia conversion factor (adjusted for geographic area) * (base units + time units) = Payment1 |
RAND Standardized payment |
Summary comments: Unlike the Medicare PPS, we did not adjust the conversion factor for geographic area. We did not include geographic adjustments so that variations in standardized payments reflect differences in services being delivered rather than differences in the cost of doing business where the services are delivered.
Hospital Outpatient Services (including Part B drugs)
| Medicare PPS Conversion factor (adjusted for area wages and geographic factors) * APC relative weight + new technology pass-through payments + rural SCH add-on + hold harmless1 = Payment2 (adjusted for high cost outliers) |
RAND Standardized Payment |
Summary Comments: In calculating the standardized payment, we did not adjust for area wages, new technology pass-through payments (which represent no more than 2% of hospital outpatient costs), rural community hospital add-ons, or hold-harmless payments. For partial hospitalization payments, we first calculated the average payment per unit of service by HCPCS code. The standardized payment for each patient hospitalization admission was then computed by multiplying the average payment per unit of service for the corresponding HCPCS code by the number of service units. We did not include geographic adjustments so that variations in standardize payments reflect differences in services being delivered rather than differences in the cost of doing business where the services are delivered.
Hospice
| Medicare PPS Daily base rate for 4 payment categories (adjusted for area wages: labor-related portion varies by payment category) = Daily payment |
RAND Standardized payment |
Summary comment: The difference in the methodology is that RAND did not adjust the payment for area wages. We did not include area wage adjustments so that variations in standardize payments reflect differences in use and types of hospice services being delivered rather than differences in the cost of doing business where the services are delivered.
Durable Medical Equipment
Medicare PPS |
RAND Standardized payment |
Summary comment: The difference in the methodology is that RAND took an average of the state-specific fee schedules to remove the adjustment for geographic differences in prices for equipment and did not reduce payment if the provider's charge was less than the fee schedule amount.
Ambulance Services
Medicare PPS |
RAND Standardized Payment |
Summary Comment: The difference in the methodology is that RAND did not adjust for wage and geographic differences and calculated average rates for each HCPCS first within each state, then across all states.
(as of 12/08/2008, includes measures for 2009 reporting)
Back to List of Figures and Tables
Nearly all (97%) patients with an AMI episode utilized an acute care hospital, 86 percent utilized the hospital outpatient department (which includes the emergency department), and 23 percent visited a physician office for that episode. Additionally, approximately 17 percent of patients utilized home health and 10 percent a skilled nursing facility. The three most common combinations of settings accounted for 67 percent of all AMI episodes in our sample. While there are nine clinical measures reported for the hospital facility (and one for physicians in the hospital setting) and five measures for the emergency department, there is only one measure for care delivered in a physician office. The skilled nursing and home health measures are not condition specific and apply to all patients.
| Measure Condition | Measure | Hospital-Inpatient | Hospital Outpatient/ED | Physician |
|---|---|---|---|---|
| AMI | Aspirin at Arrival- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - | X | X | X (inpatient)* |
| AMI | Aspirin at discharge- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - | X | ||
| AMI | ACE-I or ARB for LVSD | X | ||
| AMI | Adult smoking cessation advice/counseling | X | ||
| AMI | Beta blocker at arrival | X | ||
| AMI | Beta blocker prescribed at discharge | X | ||
| AMI | Fibrinolytic medication received within 30 minutes of hospital arrival | X | X | |
| AMI | PCI received within 120 minutes of hospital arrival | X | ||
| AMI | 30-day AMI mortality | X | ||
| AMI | Median time to fibrinolysis | X | ||
| AMI | Median time to electrocardiogram | X | ||
| AMI | Median time to transfer for primary PCI | X | ||
| CAD | Beta blocker therapy for patients with prior MI | X |
*This is a PQRI physician-level measure that would apply in a hospital setting
Other Potentially Relevant Measures
There are number of measures that may apply to subsets of AMI patients. These include CABG/Cardiac Surgery, Heart Failure, and Perioperative measures. Additionally the PQRI measures calling for an electrocardiogram for non-traumatic chest pain or syncope may apply.
Over 80 percent of patients with a diabetes episode visited a physician office and 30 percent utilized the hospital outpatient department. Only 4 percent had an acute care hospitalization related to the episode. Additionally, 8 percent utilized home health care and 7 percent a skilled nursing facility. The two most common combinations of settings accounted for 71 percent of the diabetes episodes in our sample. There are currently 10 measures reported to CMS for the physician office setting where the majority of the care for diabetes episodes is taking place. The skilled nursing and home health measures are not condition specific and apply to all patients.
| Measure Condition | Measure | Physician (Ambulatory) |
|---|---|---|
| Diabetes | Hemoglobin A1C poor control | X |
| Diabetes | LDL control | X |
| Diabetes | Blood pressure control | X |
| Diabetes | Dilated eye exam | X |
| Diabetes | Urine screening or medical attention for nephropathy | X |
| Diabetes | Foot exam | X |
| Diabetes | Foot and ankle care: neurological evaluation | X |
| Diabetes | Foot and ankle care: evaluation of footwear | X |
| Diabetic Retinopathy | Documentation of presence or absence of macular edema and level of severity of retinopathy | X |
| Diabetic Retinopathy | Communication with the physician managing ongoing diabetes care | X |
Other Potentially Relevant Measures
The PQRI measure for wound care for patients with venous ulcers is also potentially relevant for individuals with diabetes
Eighty three percent of patients with a hip fracture episode utilized an acute care hospital, 81 percent utilized the hospital outpatient department (including the emergency department) and 59 percent visited a physician office related to the episode. Additionally, 56 percent utilized a skilled nursing facility, 40 percent home health care 18 percent inpatient rehabilitation. The two most common combinations of settings accounted for 32 percent of the hip fracture episodes in our sample. There is currently only one measure reported to CMS for hip fracture and that is for mortality in the acute care hospital setting. The skilled nursing and home health measures are not condition specific and apply to all patients.
| Measure Condition | Measure | Hospital Inpatient |
|---|---|---|
| Hip Fracture | Hip Fracture Morality Rate | X |
Other Potentially Relevant Measures
As most patients who have a hip fracture will have surgery, the perioperative measures would apply as would the hospital inpatient Patient Safety Indicator for post operative wound dehiscence. Additionally, the PQRI osteoporosis measure calling for management following a fracture would likely apply
Eighty two percent of bacterial pneumonia episodes involved an acute care hospital, 62 percent involved the hospital outpatient department and 47 percent a physician office visit. Additionally, in nearly 28% of the episodes, patients utilized a skilled nursing facility, in 8 percent they utilized home health care, and 5 percent of episodes involved a stay in a long term care hospital. The three most common combinations of settings accounted for 43 percent of the bacterial pneumonia episodes in our sample. There are eight measures reported for bacterial pneumonia in the acute inpatient setting, no measures reported for the hospital outpatient setting and four measures reported for care in a physician office. The skilled nursing and home health measures are not condition specific and apply to all patients in these settings.
| Measure Condition | Measure | Hospital Inpatient | Physician (Ambulatory) |
|---|---|---|---|
| PN | Oxygenation assessment | X | |
| PN | Assessed and given pneumococcal vaccination | X | |
| PN | Assessed and given influenza vaccination | X | |
| PN | Blood culture performed in the emergency department before the first antibiotic received in hospital | X | |
| PN | Appropriate initial antibiotic selection | X | X |
| PN | Initial antibiotic received within 4 hours | X | |
| PN | Adult smoking cessation advice/counseling | X | |
| PN | 30-day PN mortality | X | |
| PN | Vital signs | X | |
| PN | Assessment of mental status | X |
Other Potentially Relevant Measures
For patients who are hospitalized with bacterial pneumonia, the "Failure to Rescue" measure may apply. For those patients with HIV/AIDS who are presenting with pneumonia, the PQRI HIV/AIDS measures would be relevant.
| Measure Condition | Measure | Physician
(Ambulatory) |
| Breast cancer | Hormonal therapy for stage 1C-III ER/PR positive breast cancer | X |
| Breast cancer | pT and pN category and histologic grade | X |
Other Potentially Relevant Measures
For those patients requiring surgery, the inpatient or outpatient perioperative measures would apply. Additionally, the PQRI measure for nuclear medicine, "Correlation with existing imaging studies for patients undergoing bone scintigraphy" and the mammography follow-up rates measure may be relevant for some patients.
| Measure Condition | Measure | Physician |
|---|---|---|
| Stroke | - CT or MRI reports | X |
| Stroke | Carotid imaging reports | X |
| Stroke | DVT for ischemic stroke or intracranial hemorrhage | X (Inpatient)* |
| Stroke | Discharged on antiplatelet therapy | X (Inpatient)* |
| Stroke | Anticoagulant therapy for atrial fibrillation at discharge | X (Inpatient)* |
| Stroke | Tissue Plasminogen Activator (t-PA) considered | X (Inpatient)* |
| Stroke | Screening for dysphagia | X |
| Stroke | Consideration of rehabilitation services | X |
*These are PQRI physician-level measures that would likely apply within the hospital inpatient setting.
Other Potentially Relevant Measures
For a subset of patients with cerebrovascular disease, the PQRI endarterectomy measure would be relevant as would the perioperative measure for recommended venous thromboembolism.
| Measure Condition | Measure | Physician (Ambulatory) |
| COPD | Spirometry evaluation | X |
| COPD | Bronchodilator therapy | X |
Other Potentially Relevant Measures
The inpatient and PQRI pneumonia measures would be relevant to those patients who develop pneumonia as a complication of COPD.
| Measure Condition | Measure | Hospital Inpatient | Physician (Ambulatory) |
| HF | Discharge instructions | X | |
| HF | Left ventricular function assessment | X | |
| HF | ACE-I or ARB for LVSD |